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ABSTRACT

Jarmusch, Alan Keith. Ph.D., Purdue University, December 2016. Ambient Ionization ‐
Mass Spectrometry: Advances toward Intrasurgical Cancer Detection. Major Professor: R.
Graham Cooks.

My dissertation research has focused on the development of ambient ionization –
mass spectrometry (MS) for clinical measurements, specifically intrasurgical cancer
detection. The molecular differences between normal and cancerous tissue were
detected via direct tissue analysis in vitro by touch spray ionization (TS) or by analyzing
sectioned or smeared tissue using desorption electrospray ionization (DESI). The physical
form of the tissue, e.g. in vitro sampling, sectioned, or smeared, was inconsequential in
differentiating normal from cancerous tissue; however, the spectra acquired by TS and
DESI differed due to differences in ionization processes. We envision that TS‐MS and DESI‐
MS could impact diagnostic medicine, for example in providing surgeons with rapid, near
real‐time information as to tissue disease state, i.e. normal or tumor. Disease state
information provided to surgeons about discrete pathologically ambiguous areas, ideally
intrasurgically via TS or DESI‐MS smear analysis, could improve the completeness of
tumor resection while minimizing unintended damage to adjacent tissue.

xxi
Touch spray ionization was developed for intrasurgical detection of cancer; TS
greatly simplifies MS analysis by using the same device for in vivo sampling and
subsequent ionization. Frozen tissue sections were sampled and analyzed by TS‐MS
providing the ability to differentiate normal from human prostate cancer, via lipid profiles,
using multivariate statistics. The next proof‐of‐concept step for TS‐MS was the analysis
human kidney cancer specimens in vitro, immediately following resection. TS‐MS analysis
of untreated kidney tissue emulated intrasurgical use, e.g. the presence and co‐sampling
of biofluids such as blood. Regardless, normal renal tissue and kidney cancer was
differentiated using lipid profiles and multivariate statistics.
Desorption electrospray ionization (DESI) ‐ MS imaging of tissue sections
differentiated normal from tumor in all cancers studied. DESI‐MS imaging of human
prostate and human kidney tissue sections were performed to corroborate TS‐MS results.
Human brain cancer, a major focus of my dissertation research, was studied by imaging
tissue sections using DESI‐MS to establish the characteristic chemical features, e.g. lipid
and metabolite profiles, that distinguish normal brain parenchyma from gliomas and
different brain tumors. It was found that information in the negative ion mode lipid profile,
positive ion mode lipid profile, and negative ion mode metabolite profile is able to
discriminate brain parenchyma (grey and white matter) and gliomas, the most common
form of malignant brain tumor. Further, the negative mode lipid and metabolite profiles
also proved capable of discriminating different types of brain tumors (gliomas,
meningiomas, and pituitary tumors) which account for ~80% of all central nervous system
tumors. DESI‐MS imaging of effaced or otherwise pathologically ambiguous frozen tissue
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sections offered the ability to determine the underlying brain parenchyma in cancerous
samples – something that traditional morphologic evaluation was not able to determine.
Further, DESI‐MS was able to detect molecular changes resulting from varying amounts
of glioma tumor cells present within infiltrated tissues. The tumor cell percentage of these
samples was predicted using N‐acetyl‐aspartic acid, a neurometabolite which was found
to decrease in cancerous tissue, and matched well with histopathologic evaluation.
The transition from DESI‐MS imaging of sectioned tissue to DESI‐MS analysis of
tissue smears was driven by the time restriction of intrasurgical application. The potential
of DESI‐MS analysis of smears was first demonstrated upon canine non‐Hodgkin’s
lymphoma fine‐needle aspirate smears which provided similar sensitivity and specificity
values to that of tissue section imaging but is technically less demanding and decreased
analysis time. DESI‐MS imaging of tissue sections established that MS profiles contained
the sufficient information for diagnosis; whereas DESI‐MS analysis of tissue smears made
the intrasurgical analysis of human brain tumors feasible. The observed lipid or
metabolite profiles were not significantly altered by the physical act of smearing and their
signal intensities were comparable to those of tissue sections. Further, the chemical
information obtained from tissue smears was equivalent to those of tissue sections as
determined by canonical component analysis. The culmination of my dissertation
research was the creation and implementation of an intrasurgical DESI‐MS tissue smear
analysis method for human gliomas. Preliminary results from the initial intrasurgical cases
analyzed using the developed DESI‐MS method are discussed.
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CHAPTER 1.

1.1

INTRODUCTION

Ambient Ionization – Mass Spectrometry

Ambient ionization refers to a family of methods that produce gas‐phase ions
outside of the mass spectrometer. Ionization occurs under ambient conditions (e.g.
temperature, pressure, and humidity) from untreated samples, greatly reducing or
eliminating sample preparation (e.g. extraction, desalting, and pre‐concentration). (1, 2)
Desorption electrospray ionization (DESI) was the first ambient ionization method,
reported in 2004, (3) since then more than forty ambient ionization methods have been
described. (4, 5) Ambient ionization methods differ in detail (e.g. spray‐based, plasma‐
based, and laser‐based) and in the degree to which ionization is coupled to desorption
which can occur via heating, acoustics, momentum transfer, and others. (2, 6) Simplicity
and rapid analysis are emphasized; rapid analysis is primarily obtained via relaxed sample
pretreatment and lack of chemical separation prior to MS. Ambient ionization methods
display near universal applicability with sensitivity allowing for the detection of various
compound classes in minute quantities, even when present in complex mixtures (e.g.
tissue and biofluids); compounds are measured via mass‐to‐charge ratios, the ions serving
as surrogates of neutral analytes. The lack of chemical separation is compensated by the
analytical sensitivity and chemical specificity of mass spectrometry. Additional chemical
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specificity can be obtained via ion fragmentation and multiple stages of mass analysis (i.e.
tandem mass spectrometry or MSn, where “n” is equivalent to the number of mass
analysis stages) which provides structural information. Reduction of sample handling,
increased analysis speed, and MS sensitivity and chemical selectivity make ambient
ionization – MS well suited in clinical applications.

Desorption Electrospray Ionization (DESI)
DESI generates ions via a strongly coupled desorption and ionization process.
Charged solvent is pumped through fused‐silica capillary and emitted as charged droplets
with a coaxial flow of gas (typically nitrogen) which serves to direct the droplets and assist
in droplet evaporation. The charged solvent droplets impact a surface and create a thin‐
film of solvent into which molecules (i.e. analytes) are dissolved from the analyzed
material (e.g. tissue). Subsequent droplets impact the thin‐film and splash, via
momentum transfer, charged microdroplets toward the mass spectrometer. (7, 8) The
microdroplets undergo evaporation and Columbic fission (due to excess surface charge)
in processes similar to those in electrospray ionization, yielding gas‐phase ions. Selection
of the DESI solvent system determines the solubility of analytes (following solubility rules),
while other parameters like pneumatic pressure and geometry of the spray, e.g. angle of
incidence, affect the efficiency of desorption/ionization process and the spatial resolution
in the case of DESI imaging experiments.
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Substrate‐Based Ambient Ionization
A group of ambient ionization methods exist which rely on spray‐based ionization
from non‐porous and porous substrates, (4) e.g. probe electrospray ionization (PESI), (9)
touch spray ionization, (10), and paper spray. (11) The substrate‐based methods are
unique in that the substrate is used for sample collection (or is the sample) and as the
means of ionization. Ionization typically occurs from a sharp tip, naturally present or
created, which is used to generate a strong electric field; however, a sharp tip is not
necessary as long as a sufficiently strong electric field is created. Solvent or innate fluid
present in the sample is electrified and is emitted as charged droplets which undergo
evaporation and Coulombic fission, processes of electrospray ionization, eventually
yielding analyte ions. Substrate‐based ionization methods have varying amounts of
desorption and ionization coupling, but the process of sampling and analysis is considered
to involve two‐steps. The characteristics of substrate‐based ambient ionization are
advantageous for clinical MS applications; sampling directly onto the substrate can be
performed remotely, transported, and rapidly analyzed by MS.
Substrates are divisible based on porosity. Non‐porous substrates, such as metal,
were initially used for ionization, e.g. use of acupuncture needles in PESI is an early
example. Non‐porous surfaces are amenable provided they are conductive and terminate
in a sharp tip or can otherwise produce a sufficient electric field. Porous substrates, such
as paper, wood, (12) plants, (13) and swabs, (14, 15) have been also used and can either
be organic (e.g. cellulose) or synthetic (e.g. rayon). Porous substrates provide the ability
to selective adsorb components in a mixture, viz. cellulose can be used to selectively
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absorb polar compounds which interact with the hydroxyl group. Further, such substrates
can be chemically modified to adsorb components using targeted interactions, e.g.
electrostatic interaction. Paper spray ionization, an illustrative method, has been
performed using a variety of modified surfaces including hydrophilic and hydrophobic
treatments to cellulose paper. (16) When the substrate can serve both as the means for
sample collection and ionization, straightforward analysis of either solid or liquid samples
can occur without pretreatment or even sample handling.

1.2

Mass Spectrometry Imaging

Mass spectrometry imaging detects chemical information across two spatial
dimension. (17, 18) MS imaging is analogous to light‐based chemical imaging techniques,
e.g. fluorescence microscopy, Ramen imaging, etc, in regards to detecting chemical
information over space; however, detection by mass spectrometry typically offers greater
molecular specificity and sensitivity via mass measurement. Sampling occurs from voxels
(i.e. three dimensional pixel) based on the thickness of the material and the depth
sampling of the ionization method, e.g. solvation by thin‐film or ablation by laser. The
hyperspectral MS images (two spatial dimensions and “x” number of m/z dimensions with
associated abundance measurement) provide a unique series of molecular photographs,
i.e. ion images (m/z value and their corresponding MS abundance), can be used to unravel
spatial – chemical relationships.
MS imaging can be performed by a number of ionization methods, principally
secondary ion – mass spectrometry (SIMS), (19, 20) matrix‐assisted laser desorption
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ionization (MALDI), (21, 22) and DESI. (5, 23) DESI is performed under ambient conditions
whereas SIMS and MALDI are generally carried out within the vacuum of a mass
spectrometer. Spatial resolution is one difference between these three ionization sources
and range from SIMS, smallest (tens of nm‐to‐μm), to DESI, largest (tens of μm‐mm). The
minimum spatial resolution is typically defined by the limitations imposed by the
ionization mechanism. SIMS is typically performed using a primary ion bean of elemental
atoms (e.g. Cs+) or atomic clusters which impact a surface sputtering secondary ions. The
sputtering depth is dependent on the current density of the ion bean, nanometers in
static SIMS or up to a few micrometers via the cumulative effect of sputtering in dynamic
SIMS. MALDI is performed by irradiating a matrix‐coated sample with a laser; spatial
resolution is determined by matrix crystallization and laser wavelength. MALDI‐MS,
specifically coupled to time‐of‐flight mass analyzers, has been used extensively for MS
imaging. MALDI has been very successful in the analysis of proteins and lipids due to softer
ionization (i.e. imparting less thermal energy into molecular bonds and thereby avoiding
ion fragmentation) than SIMS, but cannot achieve the same spatial resolution. The spatial
resolution in DESI is limited initially by size of the emitted droplets and later by the size of
the thin‐film which develops on the surface – the size of the thin‐film is determined by
surface wetting and the angle of incidence of impinging droplets. DESI‐MS imaging (DESI‐
MSI) is commonly performed in a line‐by‐line fashion by continuously scanning the DESI
spot (i.e. area covered by the thin‐film) laterally across the sample in the x‐dimension,
and then stepping a defined distance in the y‐dimension, repeatedly. When performed
under ambient conditions has significant advantages over other MS imaging techniques

6
which the full scan mode, every MS image pixel contains a mass spectrum that spans a
user defined m/z range of a single ionization mode (i.e. positive or negative). The ability
to analyze samples require the sample to be inserted into vacuum (e.g. SIMS) or
pretreatment of samples (e.g. MALDI), particularly in the growing area of clinical MS
imaging.

1.3

Ambient Ionization – Mass Spectrometry in Medicine

Diagnosis is an essential facet in medicine. Ambient ionization ‐ MS is applicable in
a number of areas of diagnostic medicine, notably point‐of‐care clinical measurements,
pathology, and surgery. (24, 25) The aforementioned areas have unique questions and
desired performance criteria; therefore, the tools and methods by which the questions
are addressed are slightly different. Point‐of‐care measurements are generally simple (e.g.
one analyte) but need be made quickly, typically at a cost in confidence. Pathology
requires significantly more detailed information obtained via tissue biopsy and genetic
testing, generally at the expense of time. Surgery seeks to answer simple diagnostic
questions (e.g. “is this cancerous or not”) but contends with much more difficult practical
questions, “what is the relative good, compared to harm, in surgically removing tissue.”
Ambient ionization – MS has the potential to assist in the molecular diagnosis in all cases,
leveraging mass spectrometry’s sensitivity and molecular specificity, and improve patient
care via rapid chemical measurement. The latter two cases, pathology and surgery, have
been the major focus of my dissertation research.
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There exists a large body of scientific work demonstrating that ambient ionization
– MS is capable of acquiring chemical information that differentiates between normal and
cancerous tissue. Numerous ambient ionization methods have been used to analyze
tissue in MS imaging and non‐imaging modes including DESI, rapid evaporative ionization
(REIMS), (26) PESI, and others. These studies have identified specific molecules (e.g. N‐
acetyl‐aspartic acid in gliomas (27) as well as patterns of ions and their relative MS
abundance (i.e. profiles) as potential biomarkers. Lipid profiles, a pattern of fatty acids
and phospholipids, and multivariate statistics have been used to provide differentiation
in human cancers of the brain, (27‐29) kidney, (30, 31) liver, (32) prostate, (33, 34) breast,
(35) stomach, (36) and others – primarily by DESI‐MS imaging of frozen tissue sections.
Advancement of these in vitro studies into clinical use is currently ongoing with
intrasurgical assessment of cancer being a major focus. Two schools of thought have
emerged – involving either online or offline measurements. (25) The online approach
aims to integrate ambient ionization with current medical devices, such as the
electrocauterization tool in REIMS (also known as the iKnife). Spectra are obtained very
rapidly (seconds) with the MS instrument being located directly or closely to the operating
room, and can potentially provide predicted disease state, i.e. normal versus cancer, in
near real time – initial studies using the iKnife are ongoing at Imperial College. (26)
However, the online ambient ionization methods tend to be destructive and do not offer
the ability to corroborate predictions by pathology, the gold standard of diagnosis. The
offline approach aims to insert MS into the normal pathology workflow, analyzing biopsy
tissue immediately within the operating room. Further, the offline methods can be less
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destructive to tissue morphology/cytology, e.g. DESI‐MS using the appropriate solvents,
and allow pathologic evaluation post analysis on the same sample. Initial work in
translating DESI‐MS imaging into the operating room was performed in collaboration with
Brigham and Women’s Hospital; (29) however, intrasurgical analysis was never
demonstrated. A major part of my dissertation work has been transferring DESI‐MS
technology and knowledge accumulated in the laboratory into a feasible method for
intrasurgical diagnosis of tissue.

1.4

Research Objective

The development of ambient ionization – mass spectrometry for medical
measurements, namely intrasurgical cancer detection, was the overarching objective of
my dissertation research. The molecular information that differentiated cancer from
normal was found in lipid and metabolite profiles, analyzed by multivariate statistics. We
sought to acquire the molecular information rapidly within the operating room. Two
methods, touch spray and DESI, were developed for this purpose. One advantage of TS is
that analysis is greatly simplified by using the same device for in vivo sampling and
subsequent ionization. Touch spray is intended for in vivo sampling within surgery to
assist in determine the disease state of discrete areas that a surgeon finds suspicious. The
TS methodology aligns closely with the online intrasurgical methods, in vivo sampling and
rapid analysis (seconds). Human prostate and kidney cancer were used to test the
performance of TS‐MS. The transition from DESI‐MS imaging of sectioned tissue to DESI‐
MS analysis of tissue smears was a significant development, driven by the time restriction
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of surgical application. The chemical information obtained from tissue smears were able
to equivalently differentiate canine non‐Hodgkin’s lymphoma and human brain cancer
compared with tissue sections – the traditional sample upon which to perform MS
imaging and disease state differentiation. The use of tissue smears for intraoperative
analysis falls under the offline intrasurgical analysis, and does not require major
modification to current practice. We imagine that intrasurgical MS analysis of smeared
biopsy tissue can offer the surgeon reliable pathologic information on a timescale ten
times faster than current pathology, which can also be corroborated via standard
pathologic evaluation. The culmination of my research is the development and
implementation of an intrasurgical DESI‐MS analysis method and multivariate
classification system for human brain tumors.
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CHAPTER 2.

DEVELOPMENT OF TOUCH SPRAY IONIZATION FOR INTRASURGICAL
CANCER DETECTION

2.1

Introduction

Touch spray ionization (TS) was developed explicitly for sampling and analysis in
situ.(1) Intrasurgical analysis of tissue during tumor removal is intended to provide
surgeons with rapid molecular‐based pathologic information in pathologically
ambiguous areas. Surgical removal of tumors remains one of the primary treatment
options for cancer. We developed and evaluated the ability of TS‐MS to detect the
chemical changes associated with cancer, namely lipid profiles (i.e. m/z values and
corresponding MS abundance). Prostate and kidney cancers are of utmost importance
as they cause a significant fraction of cancer related fatalities in the United States.
Prostate cancer represented ~10.7% (~180,000 cases) of all newly diagnosed cancer
cases and there were an estimated 61,560 new cases of kidney cancer, 3.7% of all new
cancer cases, in the United States of America in 2016. (2) Histopathology remains the
gold standard for diagnosis, and while highly informative, the time required for analysis
is generally incompatible with the needs of surgeons. Intrasurgically, surgeons seek a
rapid assessment of the disease state, i.e. normal or tumor, of suspicious areas,
particularly near the boundary of resection (i.e. surgical margin).
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Ambient ionization ‐ mass spectrometry (MS) can address this need by making rapid
chemical measurements and objective prediction of disease state, i.e. normal versus
tumor. Lipids are not currently used as diagnostic markers of cancer but use is growing
as well as scientific interest. DESI provides a key connection between the information
from histopathology and the characteristic mass spectra of each disease state. DESI‐MS
can be operated in an imaging mode, collecting mass spectra, pixel by pixel, over two
dimensional space to create a 2D molecular image, i.e. ion image. DESI‐MS imaging has
been previously used to study human prostate (3, 4) and kidney (5, 6) cancers which
reported the lipid profiles of normal and cancerous tissue. The analysis of smeared
tissue biopsies by DESI‐MS, an offline ambient ionization approach to intrasurgical
measurement, is useful for intrasurgical measurement of human brain tumors
(discussed in later chapters). The intended use of TS‐MS is quite different, online
intrasurgical measurement; a user‐guided method in which a spot of interest is directly
sampled with a probe, e.g. teasing needle, and transferred to the interface of a mass
spectrometer, and ionized by the application of solvent and high voltage. TS produces
information‐rich spectra which are similar to DESI, but in a localized and very rapid
process which typically takes a few seconds.
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2.2

Experimental

2.2.1 Human Subjects
Radical prostatectomy specimens were obtained from consented patients
undergoing treatment at Indiana School of Medicine (IUSM) following an Institutional
Review Board (IRB) approved study, Indiana University (IU) #1205008669R004 and
Purdue University (PU) #1203011967. Biopsies were obtained from specimens after
resection using a disposable biopsy gun (Max‐core disposable core biopsy instrument,
Bard Biopsy Systems, Tempe, AZ). Biopsies (approximately 4‐15 mm x 1 mm x 1 mm)
were subsequently frozen, cryosectioned at 15 μm, and thaw mounted to glass
microscope slides. Sections were stored at ‐80°C prior to MS analysis. The same slide
analyzed by DESI‐MS imaging was hematoxylin and eosin (H&E) stained and examined
by an expert pathologist. Adjacent sections (separated by ~15 ‐ 60 μm) were analyzed by
TS‐MS by sampling areas of 1‐4 mm2 from regions of known pathology.
All kidney specimens were acquired from patients undergoing nephrectomy
(partial or radical) for the treatment of renal cell carcinoma and were handled in
accordance with approved IRB protocols (IU #1205008669R004 and PU #1203011967).
A small portion (approximately 3 x 3 x 3 mm) of tumor and adjacent normal kidney
tissue (if present) was obtained in the pathology lab (University Hospital, Indianapolis)
and analyzed on site using TS‐MS. The tumor and normal specimens provided were
noted as such by pathology, grossly. TS‐MS analysis was performed while the tissue was
fresh (not frozen or fixed). Subsequent to TS‐MS analysis, the biopsy specimens were
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snap frozen in liquid nitrogen and transported back to Purdue University on dry ice for
DESI‐MSI analysis. Specimens were embedded in Optimal Cutting Temperature polymer
(Sakura Finetek, Torrance, CA) and sectioned on a cryotome (10 μm thickness) and thaw
mounted on glass slides. DESI‐MS imaging was performed on the tissue sections. Tissue
sections were stained afterwards and evaluated by an expert pathologist – results
matched gross pathology in nearly all cases. Specimens were obtained from 21 subjects
over the period March 14, 2014 to May 12, 2015. Pathologic evaluation of specimens
not included in this study determined the following subtypes for the 21 subjects: 15
clear cell RCC, two papillary RCC, and three unclassified RCC, and one oncocytoma.

2.2.2 Methods

2.2.2.1 DESI‐MS Imaging
A laboratory‐built DESI ion source, similar to the commercial 2D source from
Prosolia, Inc. (Indianapolis, IN, USA) was coupled to a linear ion trap mass spectrometer
(LTQ, ThermoFisher Scientific). DESI‐MS was performed in the imaging mode, collecting
mass spectra over 2D space by coordinating instrument duty cycle with motion stage
speed. The negative ionization mode was used collected. Automatic gain control (AGC)
was inactivated. The DESI‐MS spray solvent was dimethylformamide (DMF)‐acetonitrile
(ACN) at a 1:1 ratio (v/v), delivered at 1.0 µL/min flow rate using the instrument syringe
pump. The use of DMF‐ACN (1:1) was used to minimize alteration of tissue morphology
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(33). Typical DESI source parameters were used. Prostate and kidney sections were
imaged at a lateral spatial resolution of 200 μm and 250 μm, respectively.

2.2.2.2 Touch Spray ‐ MS
TS‐MS was performed upon human prostate specimens, frozen and sectioned, at
Purdue University. The TS probe used was a commercially available teasing needle
purchased from Fisher Scientific (Pittsburgh, PA, USA). Methanol was used as spray
solvent and 1.0 μL was applied manually via an adjustable pipette (Eppendorf Research‐
2.5 μL). A linear ion trap mass spectrometer (LTQ, Thermo) was used for the TS
experiments with the same operating parameters as those used in the DESI experiments
except that the voltage applied to the TS probe was 4 kV and the automatic gain control
was active. TS was performed by touching and desorbing material onto a teasing needle
from regions of interest of 1‐4 mm2. After sampling, the tip of the probe was aligned
with the inlet of the mass spectrometer, held in place by a ring stand and clamp, and
high voltage and solvent were applied. Ions were generated in pulses of signal that were
a few seconds in duration. The data acquired within this period were averaged and used
for subsequent data analysis. Tissue from an additional 6 subjects was analyzed directly
after surgical resection in a research building adjacent to the frozen pathology
laboratory in University Hospital. These specimens were analyzed using the same TS
methodology but the specimens were not frozen or sectioned.
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All kidney specimens were analyzed by TS‐MS immediately following resection in a
research building adjacent to the frozen pathology laboratory in University Hospital. TS‐
MS was performed on the fresh (not frozen or fixed) tissue specimens using a metal
teasing needle to scrape small amounts of cellular material from the bulk tissue (22).
The probe was positioned in front of the mass spectrometer with the metal tip pointing
at the inlet (~5‐8 mm), a high voltage (4 kV) was applied, and a 1.0 μL aliquot of
methanol was added to initiate ionization. Data acquired from a single sampling (touch)
were averaged and used for subsequent data analysis.

2.2.2.3

Multivariate Statistics

Principal component analysis (PCA), using the non‐linear iterative partial least
squares algorithm, was performed on the TS‐MS and DESI‐MSI data using MATLAB
(MathWorks, Natick, MA) and in‐house routines which were described in previous work.
(3, 5) Data were normalized using standard normal variate (SNV) transform to correct
for baseline shifts and global variation in signal intensities, and then mean‐centered
prior to PCA. Linear discriminant analysis (LDA) was performed in MATLAB on the PCA
compressed data (i.e. PCA‐LDA) to discriminate between disease states (i.e. normal
versus tumor). PCA‐LDA models were validated via cross validation using five deletion
groups.
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2.3

Results and Discussion

2.3.1 TS‐MS Analysis of Mouse Brain Tissue
The lipid profiles of brain tissue have been extensively studied using ambient
ionization ‐ mass spectrometry, i.e. DESI, (7‐9) which therefore constitutes a biological
standard by which to qualitatively measure the performance of TS. A minute amount of
cellular and extracellular material was transferred to a TS probe using light abrasive
force on the biological material. For the sake of demonstration, mouse brain tissue
sections were sampled in this manner removing material in a circle (diameter <1 mm).
TS mass spectra, negative ion mode, displayed in Figure 2‐1 are similar to those acquired
with DESI from the same region. The spectra are dominated by signals due to fatty acids
(m/z <300), fatty acid dimers (m/z 300‐700), and glycerophospholipids (m/z 700‐1000).
The relative abundances of m/z 788.5 (PS 36:1), 834.5 (PS 40:6), 885.5 (PI 38:4), and
888.5 (ST 24:1) were used to qualitatively assess neural composition (white and grey
matter). Grey matter and white matter have characteristic peaks of m/z 834 and 888,
respectively. The transverse plane of mouse brain possesses horizontal symmetry in the
stained tissue, visible in the various features stained (e.g. cerebellum and corpus
callosum). Touch spray was performed at six positions (Figure 2‐1) annotated upon the
H&E stain. The TS mass spectra from the mouse olfactory bulb (Figure 2‐1, point 1)
displayed unique ions detected at m/z 806.5 (PS 38:6) and 909.5 (PI 40:6) corresponding
to parallel earlier findings using DESI.(7) Similarly, the mass spectra recorded from point
2 indicated an increased percentage of white matter, corresponding to the corpus
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callosum. The spectra recorded at point 5 reflect a high percentage of gray matter
(periaqueductal gray and/or cerebellum). At other points a mixture of gray and white
matter was observed with point 3 corresponding to the thalamus, point 4 to
periaqueductal gray with white matter potentially from the posterior commissure, and
point 6 primarily white matter from the granular layer of the cerebellum with some gray
matter. Neuroanatomical location was approximated using the Allen Mouse Brain Atlas.
(10)
The reproducibility of touch spray was further assessed using coronal mouse
brain sections. These sections are comprised of grey and white matter, reflected in the
spectra, whose distribution is symmetrical, vertically, between right and left
hemispheres. Touch spray was performed at six equally spaced points across one
coronal section (Figure 2‐2). Mass spectra were reproducible in terms of the prominent
glycerophospholipids ions seen and also in terms of their approximate relative
intensities. They were similar between points of related neural composition; for
example, A and F indicated grey matter which produces patterns including a base peak
at m/z 834.5 and major peaks at m/z 788.5 and 885.5 whereas B and E displayed greater
abundance of m/z 888.5 indicating the presence of white matter. Data were collected
from all three planes, i.e. coronal, transverse, and sagittal (data not shown) which
correctly reflected the correct composition, grey or white matter, based on
neuroanatomical location.
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2.3.2 Human Prostate Cancer
The potential of TS‐MS for prostate cancer differentiation was explored by
analyzing radical prostatectomy specimens in vitro, and comparing with DESI‐MS results
which served as a reference method. Initially, we qualitatively compared the spectra,
namely the lipid profiles, that were acquired by each method. The primary components
of

the

prostate

lipid

profile

(negative

mode)

are

glycerophospholipids:

phosphotidylethanolamines (PE), phosphotidylserines (PS), phosphotidylcholines (PC),
and phosphatidylinositols (PI). Lipids from these classes were observed in the average
normal (74 samples) and tumor (26 samples) mass spectra shown in Figure 2‐3 for DESI
(A and B) and TS (C and D). Spectral differences between normal and tumor were seen
in both average DESI and TS spectra, but the spectra from DESI and TS were clearly
different from each other. The prostate cancer DESI spectrum (red) appeared to have an
increased relative abundance of m/z 786, 794, 861, and 863 as well as an altered ratio
between m/z 788 and 885, relative to the normal (green) DESI spectrum. The prostate
cancer TS spectrum (red) also appear to have the same differences as well as variable
levels of additional m/z values (e.g. m/z 737 and 844). Differences in the mass spectra
between DESI and TS were also noted, namely the increased abundance of chlorinated
adducts of PC lipids (e.g. 794, 820, 844). This observation would suggest that some
differences between the ionization methods can be attributed to different tolerance to
the salt content in the complex matrix when analyzed with no sample pretreatment ‐ TS
has a lower salt tolerance than DESI. This observation is likely due to the differences in
extraction and desorption operations of the two methods. Extraction in DESI occurs in
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the thin film of solvent which is subsequently splashed by additional droplet impact,
generating ions. Extraction in TS occurs directly into the solvent from which ions are
being directly generated. The average ion intensity in TS is two orders of magnitude
greater than that in DESI, suggesting that the extraction/desorption process in TS is
indeed more direct and short‐lived, yielding greater ion current.

2.3.2.1

Multivariate Analysis of DESI‐MS and TS‐MS Data

Principal component analysis (PCA), an unsupervised multivariate statistical
method, was used to comprehensively explore the DESI‐MS data. The PCA score plot,
shown in Figure 2‐4, indicated separation of normal (green) and tumor (red) samples (12
human subjects, 100 samples). The PCA loading plot indicated which ions contributed to
the observed separation in the PCA score plot. Linear discriminant analysis was
performed subsequent to data compression by PCA and validated by cross validation
(Table 2‐1) which resulted in a sensitivity, i.e. proportion of samples predicted as
positive for the disease among samples that are diseased, and specificity, i.e. proportion
of samples known not to be diseased that are predicted as such, of 96.2% and 98.6%,
respectively.
The same tissue sections were evaluated by TS‐MS, 100 samples from 12 subjects.
TS‐MS sampling of these samples was targeted, i.e. sampling was performed based on
histopathology performed prior to MS analysis. This was the initial step in exploring if
TS‐MS was able to detect the same chemical information as DESI and if that chemical

24
information was able to separate normal from tumor samples. The TS‐MS data were
analyzed by PCA which resulted in the separation of normal (green) and tumor (red) in
Figure 2‐5. The corresponding PCA loading plot indicated important ions in making that
distinction. PCA‐LDA cross validation, Table 2.2, yielded a sensitivity of 88.5% and
specificity of 98.6%.

2.3.3 Human Kidney Cancer
TS‐MS study of prostate cancer provided the first evidence that chemical
information indicative of disease state could be obtained; however, that study was
performed on frozen tissue sections which does not accurately emulate intrasurgical
material. TS‐MS was used to study healthy renal tissue and kidney cancer, i.e. renal cell
carcinoma (RCC), specimens immediately following resection. Lipid profiles were
collected and evaluated for their ability to distinguish disease state as an initial step
towards analyzing, intrasurgically, discrete areas of pathologic ambiguity. TS‐MS analysis
was performed on the Indiana University medical campus immediately after resection,
in a research building (R3) adjacent to the frozen pathology lab at University Hospital.
Tissue was fresh (not frozen or fixed) and contained biofluids (e.g. blood). TS‐MS was
performed by sampling a small area of the biopsies (multiple times for some samples),
many sampling events contained some amount of blood. Subsequent to TS‐MS analysis,
the biopsy specimens were snap frozen in liquid nitrogen for DESI‐MS imaging (DESI‐
MSI). DESI‐MSI was performed to complement TS‐MS results. The solvent used for DESI‐
MS imaging preserves tissue morphology and allowed subsequent staining of the same
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tissue, improving correlation with histopathologic evaluation. (11) Previous DESI‐MS
imaging studies of RCC in the negative ionization mode indicated the ability to
differentiate RCC and healthy renal tissue with multivariate statistics. (6)

2.3.3.1 Differentiation of Healthy and Renal Cell Carcinoma by Touch Spray – MS and
Comparison with DESI‐MS
Principal component analysis (PCA) was performed on TS‐MS data. The PCA
score and loading plots are shown in Figure 2‐6. Separation between RCC (red) and
healthy renal tissue (blue) is observed in the score plot. Differences in m/z abundances
are apparent in the average mass spectra of healthy renal tissue and RCC. Healthy renal
tissue gives more abundant ions m/z 794 and 792 (tentatively identified as chlorinated
adducts of PC 34:1 and PC 34:2, respectively), and m/z 844 and 885 (tentatively
identified as chlorinated PC 38:4 and deprotonated PI 38:4, respectively) is relatively
more abundant in RCC. Cross validation of a discriminant model, linear discriminant
analysis (LDA) on the PCA compressed data, was performed. The sensitivity was 96.1%
and specificity was 98.1% using five deletion groups and five principal components,
Table 2‐3. While these results are encouraging, a larger sample size is required to
validate the method’s diagnostic capabilities. Note, histopathologic subtypes of the
specimens were provided by pathology performed on independent samples; however,
the number of samples in each subtype was too small to comment on the ability of TS‐
MS to delineate RCC subtypes.
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PCA of the DESI‐MS data (i.e. regions of interest, ROI) provided similar results to
TS but slightly better separation in the PCA score plot (Figure 2‐7). Cross validation (five
deletion groups) was performed on the DESI PCA‐LDA model. The sensitivity was 100%
and specificity was 86.7% using three principal components, Table 2‐4. The DESI‐MS
spectra, Figure 2‐7, were visually different than the TS‐MS spectra (Figure 2‐6); however,
differences between normal and RCC were still present – an observation similar to that
of TS and DESI analysis of prostate cancer tissue. The major difference between the
spectra were the relative abundance of chlorinated adducts – more abundant in TS than
in DESI. (1) The difference in abundance can be attributed simply to differences in
ionization mechanisms, increased biofluid content of fresh renal tissue for the fresh
tissue analyzed by TS‐MS, and perhaps to the use of different spray solvents (methanol
for TS and 1:1 DMF‐ACN for DESI). The differences observed suggest that both DESI and
TS could be used for differentiating normal from tumor; however, each will require the
development of their own respective spectral databases.

2.4

Conclusions

TS‐MS is envisioned as an online ambient ionization – MS surgical tool for rapid
disease state determination in areas of interest. As a surgical screening tool, TS could
help preserve healthy tissue that may have otherwise been resected for
histopathological evaluation or help with decisions to remove additional diseased tissue,
the state of which was questionable. One alternative online approach would be the
analysis of smeared tissue by DESI‐MS, but in vivo sampling is not possible. One
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important feature of TS is that the means of sampling and ionization are incorporated
into a single device. This allows for very rapid sampling and immediate analysis without
sample preparation or chromatographic separation. Mouse brain tissue served as a
model system by which to demonstration the ability for TS‐MS methodology to obtain
lipid profiles reproducibly and faithfully reproduce the lipid profiles of normal grey and
white matter.
The first step in developing this surgical tool was applying TS‐MS to prostate
cancer, analyzing frozen tissue sections in parallel with DESI‐MS. Differentiation of
normal and prostate cancer samples was obtained with a targeted TS dataset; sensitivity
and specificity of 88.5% and 98.6%, respectively. The next step toward intrasurgical use
was analyzing fresh tissue ex vivo by TS‐MS, healthy renal tissue and RCC were analyzed
directly after surgical resection. The ex vivo analysis provided very similar conditions to
those expected in surgery, e.g. presence of biofluids and unaltered tissue. The sensitivity
of the TS‐MS method for predicting RCC was 96.1% and the specificity was 98.1%. DESI‐
MS was performed after TS‐MS on the same specimens and provided a similar
sensitivity (100%) but worse specificity (86.7%). The analysis of prostate and kidney
cancer illustrated that TS‐MS can provide sufficient diagnostic information via lipid
profiles and multivariate statistics. The most notable differences observed were the
increased presence of chlorinated PCs in the TS‐MS data, e.g. m/z 794 ([PC 34:1 + Cl]‐).
The tolerance of TS‐MS to salts is likely less than that of DESI due to differences in
desorption and ionization mechanism as well as potential differences between the spray
solvents for each method. Regardless, the chemical information obtained by each
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method, independently, was able to distinguish normal from tumor. The applicability of
the technique is likely not exclusive to the cancers studied here, and could be useful in
the surgical treatment of different cancers and diseases. In addition, refinements to the
TS‐MS methodology should be pursued to increase the ruggedness, ease of use, and
reproducibility of the measurements.
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Figure 2‐1 (A) Transverse mouse brain tissue section (H&E stained) with discrete TS‐MS
sampling areas annotated. (B) TS‐MS spectrum of sampling area 1, corresponding to the
olfactory bulb, which contains the unique ion m/z 909.4. (C) TS‐MS spectra of sampling
areas 2‐6.
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Figure 2‐2 Coronal mouse brain tissue section, H&E stained, with sampling points, A‐F,
annotated. Mass spectra corresponding to the sampling points, A‐F, are included with
major ions annotated.
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Figure 2‐3 (A) Average DESI‐MS spectrum, m/z 700 – 1000, for normal human prostate
and (B) average DESI‐MS spectrum of human prostate cancer. (C) Average TS‐MS
spectrum for normal human prostate and (D) average TS‐MS spectrum of human
prostate cancer.

Figure 2‐4 (A) DESI‐MS PCA score plot for normal human prostate (green) and human
prostate cancer (red). (B) PCA loading plot with m/z values annotated.
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Figure 2‐5 (A) PCA score plot for TS‐MS analysis of normal human prostate (green) and
human prostate cancer (red). (B) PCA loading plot for TS‐MS data with m/z annotated.

Figure 2‐6 (A) PCA score plot for TS‐MS data, normal (blue) and human kidney cancer
(red). (B) PCA loading plot with m/z annotated. (C) Average TS‐MS spectrum, m/z 700 –
1000, of normal human renal tissue and (D) average TS‐MS spectrum for human kidney
cancer.
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Figure 2‐7 (A) PCA score plot for DESI‐MS data, normal (blue) and human kidney cancer
(red). (B) PCA loading plot with m/z annotated. (C) Average DESI‐MS spectrum m/z 700 –
1000, of normal human renal tissue and (D) average DESI‐MS spectrum for human
kidney cancer.

Pathology

Table 2‐1 DESI‐MS PCA‐LDA cross validation confusion matrix for human prostate cancer
(tumor) and normal.

Tumor
Normal

DESI Prediction
Tumor
Normal
25
1
1
73
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Pathology

Table 2‐2 Targeted TS‐MS PCA‐LDA cross validation confusion matrix for human prostate
cancer (tumor) and normal.

Tumor
Normal

TS Prediction
Tumor
Normal
23
3
1
73

Pathology

Table 2‐3 TS‐MS PCA‐LDA confusion matrix for human kidney cancer (tumor) and normal.

Tumor
Normal

TS Prediction
Tumor
Normal
73
3
1
53

Pathology

Table 2‐4 DESI‐MS PCA‐LDA confusion matrix for human kidney cancer (tumor) and
normal.

Tumor
Normal

DESI Prediction
Tumor
Normal
16
0
2
13
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CHAPTER 3. CHARACTERISTIC LIPID PROFILES OF CANINE NON‐HODGKIN’S
LYMPHOMA FROM SURGCIAL BIOPSY TISSUE SECTIONS AND FINE NEEDLE ASPIRATE
SMEARS BY DESI‐MS

3.1

Introduction

Non‐Hodgkin’s lymphoma (NHL) is a diverse group of cancers, afflicting canines
and humans. Rates of NHL in canines exceed that in humans; (1) nevertheless, NHL
accounts for ~4.3% of all new cancers in the United States resulting in an estimated
72,500 deaths in 2016. (2) NHL can be broadly defined into two subgroups, B‐cell and T‐
cell, correlated to the lymphocyte immunophenotypes from which the cancer originated;
there are many further subtypes within B‐cell and T‐cell NHL. B‐cell lymphomas are the
more common of the two, particularly diffuse large B‐cell lymphoma, thus they are the
primary focus of this study. Canine lymphoma is currently being considered as a
meaningful comparative model for human NHL, while important in its own right. (1, 3)
The gold standard for diagnosis of NHL is histopathological evaluation of surgically
removed lymph node (whole or in part) via tissue sections, which is commonly
supported by immunohistochemistry. Histopathological diagnosis is based on
morphological and cytological features, such as morphological growth pattern, nuclear
size and shape, and mitotic index. (4, 5) A less invasive alternative to surgical biopsy is
fine needle aspirate (FNA) biopsy, performed using a hypodermic needle that is
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inserted into a suspicious lymph node. A small amount of cellular material is removed,
expelled onto a microscope slide, and smeared to form a cellular monolayer which may
be evaluated using light microscopy following cytochemical or immunocytochemical
staining. Smaller sample size and destruction of nodal architecture, a result of FNA
sampling and smearing, can result in higher rates of false negatives and inconclusive
diagnoses compared to tissue sections.(6) FNA does have advantages over surgical
biopsy and histopathology, in that it is less expensive, less invasive, and less technically
demanding.(7, 8) Both canines and humans with NHL may be significantly debilitated at
the time of initial cancer diagnosis, and a minimally invasive diagnostic technique may
be better suited to these patients than surgical biopsy.
A promising method for improving the diagnostic yield of FNA biopsies is
desorption electrospray ionization – mass spectrometry (DESI‐MS), an ambient
ionization technique which allows for chemical analysis of surfaces, including tissue
sections and tissue smears, at native atmospheric conditions (temperature, pressure,
and humidity). The mechanism of analyte desorption and ion generation has been
extensively studied. (9, 10) DESI‐MS imaging of tissue sections has been applied
previously in canine bladder cancer (11) and human cancers, including those of the liver,
(12) brain, (13, 14) kidney, (15) bladder, (16) and other organs. (15, 17) Further, DESI‐
MS has been applied to human brain tissue smears which are similar to FNA smears, e.g.
used for rapid analysis. Tissue smears, another alternative to tissue sectioning, differ
from fine‐needle aspirate on the method of collection (needle biopsy versus
incisional/excisional biopsy) and the consistency of the cellular material – the latter
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tends to be more aqueous and contain a suspension of cells. Analysis of tissue smears
allowed differentiation of normal brain tissue and gliomas (14) and has been
implemented for intrasurgical analysis, discussed later in this dissertation.
The analysis of lipids that compose cells, structurally and functionally, and tissue
has been the focus of the previously mentioned studies, allowing for differentiation of
cancer from normal tissue without exception. The lipid profile varies with cell
metabolism and signaling and is indicative of disease state. The use of multivariate
statistics for pattern recognition, such as principal component analysis (PCA) followed
by supervised classification techniques (e.g. linear discriminant analysis, LDA), allowed
visualization and classification of differences between samples and complex
relationships within large datasets.
The characteristic endogenous lipids using DESI‐MS from surgical biopsy tissue
sections and FNA smears for disease state differentiation (i.e. normal vs. tumor) in
canine NHL was explored. DESI‐MS imaging of tissue sections detected lipid profiles
indicative of disease state, which established a data set with which to compare FNA
smears. The characteristic lipid profiles obtained from surgical biopsies and FNAs
corroborate histopathology and cytology while providing unique chemical insight.
Comparison between previous data regarding the significant lipids in human NHL and
this canine study provide molecular support for a canine comparative model.
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3.2

Experimental

3.2.1 Materials
Specimens were provided by the College of Veterinary Medicine, Purdue
University. All NHL specimens were collected from pet dogs presented to the Purdue
University Veterinary Teaching Hospital (PUVTH) for medical treatment of their cancer.
At the time of presentation, fine needle aspirate samples were collected from an
affected lymph node in each dog using a 22‐gauge hypodermic needle. FNA samples
were expelled onto glass slides, allowed to air dry, and then stored at ‐80oC until the
time of DESI‐MS analysis. Immediately following FNA, all dogs with NHL underwent
surgical biopsy of the same affected peripheral lymph node. A portion of each biopsy
was fixed in 10% neutral buffered formalin and submitted for histopathologic
confirmation of NHL. The residual portion of each dog’s lymph node biopsy was snap
frozen in liquid nitrogen, and the samples were stored at ‐80oC until the time of DESI‐
MS analysis. Lymph node samples from healthy, purpose‐bred research dogs served as
normal controls. All control animals had been humanely euthanatized as part of an
academic laboratory course within the Purdue College of Veterinary Medicine Doctor of
Veterinary Medicine degree curriculum. Surgical lymph node biopsy and FNA samples of
peripheral lymph nodes were collected immediately post‐mortem from all control
animals in identical fashion to that described for pet dogs with NHL. All lymph nodes
from control animals were confirmed to be histologically normal following light
microscopic review of H&E stained sections from formalin‐fixed tissues by a board‐
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certified veterinary pathologist. All medical and surgical procedures conducted on both
control animals and pet dogs were approved by the Purdue Animal Care and Use
Committee (1111000308 and 1211000780).

3.2.2 Methods

3.2.2.1 DESI‐MS Analysis
Frozen surgical biopsy specimens were cryosectioned at 15μm thickness using a
Cryotome FSE (Thermo, Waltham, MA, USA) and thaw mounted on glass microscope
slides (Gold Seal Rite‐On Microscope Slides, Thermo). Prior to analysis, the slides were
allowed to come to room temperature and briefly dried using an electronic desiccator
(VWR, Desi‐Vac Container, Radnor, PA, USA) for approximately 10 minutes to remove
any frozen condensation resulting from storage. FNA smears were also dried for ~10
minutes prior to analysis, for the same reason, and analyzed under the same conditions.
Normal and tumor samples were randomized over multiple days of analysis, surgical
biopsy tissue sections and specimen matched FNA were analyzed on the same day.
DESI‐MS was performed using a lab built prototype ionization source coupled to a linear
ion trap mass spectrometer (LTQ, Thermo). DESI‐MS was carried out in the negative ion
mode using equal parts dimethylformamide (DMF) and acetonitrile (ACN), preserving
tissue morphology and allowing subsequent histopathology to be performed on the
analyzed tissue section. (18) DESI analysis was performed using the following major
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parameters: automatic gain control (AGC) off, maximum ion injection time of 250 ms
with 2 microscans, 5 kV spray voltage, 180 PSI N2 (gas), incident spray angle was 52˚,
capillary temperature of 275°C, spray‐to‐surface distance ~2 mm, and spray‐to‐MS inlet
distance ~8 mm. Identical DESI‐MS conditions were used to acquire high resolution mass
spectrometry data on an orbitrap mass spectrometer (Exactive, Thermo). HRMS was
interpreted using XCalibur and monoisotopic formulae masses were calculated in
Isopro3. Sample slides were analyzed by securing them to the moving stage. The MS
scan rate was coordinated with the moving stage speed in the “x” dimension (i.e. rows),
defining resolution (200 μm). Upon the completion of each row, the moving stage was
stepped vertically in 200 μm increments defining the “y” resolution. The typical time
required for DESI imaging of a tissue section was less than 20 minutes. Illustrative is
specimen 42, ~20 min, with an imaging area approximately 8.4 mm (width) by 7.6 mm
(height), including the entirety of the tissue section roughly 6.2 mm (width) by 5.8 mm
(height) in dimension.

3.2.2.2 Pathology
Histopathologic review, with tumor subtyping according to World Health
Organization criteria, (4) was performed on formalin‐fixed lymph node tissue sections as
part of routine clinical diagnosis. The clinical diagnosis was used for DESI‐MS data
correlation. Samples demonstrating spatially heterogeneous chemical features were
evaluated post DESI‐MS analysis and annotated by histopathologic review of frozen
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tissue sections. There were no cases in which histopathology review differed between
frozen and formalin‐fixed tissue sections. The annotated regions were used to define
areas associated with non‐malignant morphological features, unless otherwise noted.
Subsequent to DESI‐MS analysis, all FNA slides were stained with Wright’s stain and
evaluated by light microscopy. FNA slides were reviewed by an expert veterinary
cytopathologist, who interpreted the nature of the sample (i.e. lymphoma vs. non‐
lymphoma), the distribution of cells within the sample (i.e. homogenous vs.
heterogeneous distribution of cellular material within the smear), the density of cells
within the sample (i.e. densely cellular vs. sparsely cellular), and whether significant red
blood cell contamination of the sample was present.

3.2.2.3 Data Analysis
Surgical biopsy and FNA smear data acquired using XCalibur 2.0 (.raw) were
converted with an in‐house program into files compatible with BioMap software.
BioMap was used to generate 2D ion images (retaining spatial relationships and
displaying relative mass spectral abundance of particular mass‐to‐charge ratios), select
regions of interest (ROI) based on pathology, and export data for multivariate analysis.
An in‐house MatLab (MathWorks, Inc., Natick, MA, USA) routine was used to explore
chemical features present in two dimensional DESI ion images. PCA was performed
upon MS hyperspectral datacubes, the composite of spatial dimension (“x” and “y”),
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m/z value, and corresponding m/z intensity, and plotted using an interactive brushing
procedure,(19) see Supplemental information for more details.
PCA was used to explore DESI‐MS data and visualize the grouping of samples
resulting from chemical similarity.(20) Multivariate analysis of tissue sections was
performed using in‐house MatLab routines. The mass range was truncated (m/z 700‐
1000) for statistics, as it was empirically found to contain less analytical variability,
providing more consistent and clear separation with regards to disease state (i.e. normal
vs. tumor). Two specimens were excluded from statistics: one lymphoma sample (due to
poor MS signal) and a metastatic carcinoma. MS data were normalized by the total ion
current (TIC) and column‐centered (i.e. mean‐centered). Neither background
subtraction nor a smoothing algorithm was applied to the MS data before PCA. LDA was
performed for discriminant classification after unsupervised data compression by PCA
(i.e. PCA‐LDA), as reported elsewhere. (21) The first 8 principal components (PCs),
accounting for ~90% of total data variation, were used. Classification rates report the
correct classification of samples in the final PCA‐LDA model. Cross validation (CV) with 5
deletion groups was used to test the prediction ability, reported as CV sensitivity and
specificity. Sensitivity was calculated as the percent of the objects in the evaluation sets
correctly accepted by the model. Specificity was calculated as the percent of the objects
of other categories correctly rejected by the model. Average DESI mass spectra obtained
from FNA smears were compared with those of surgical biopsy via multivariate statistics.
A linear discriminant model (i.e. PCA‐LDA) was built in PARVUS (University of Genova,
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Italy) using mass spectra from surgical biopsy tissue sections, to which FNA smear mass
spectra were classified. The results and prediction rates are tabulated.

3.3

Results and Discussion

3.3.1 DESI‐MS Imaging of Lymph Node Tissue Sections
Surgically excised lymph node biopsies were sectioned and analyzed by DESI‐MS
imaging, providing chemical and spatial information concurrently. The methodology
employed follows that of histopathological evaluation of tissue, while providing
molecular information. Tissue diagnosis by DESI‐MS is performed with a spatial
resolution larger than traditional histopathology (hundreds of microns versus tens of
microns); however, it provides chemical information otherwise unobtainable by
traditional histopathology. DESI‐MS analysis of tissue sections aims to explore and
establish the lipid profiles indicative of normal and NHL tumor subtypes. Negative mode
DESI mass spectra showed ionized fatty acids (e.g. oleic acid, m/z 281), fatty acid dimers,
and glycerophospholipids from m/z 700 ‐ 1000 (e.g. PI 38:4, m/z 885). The major
glycerophospholipids (GPL) ions observed included major structural and signaling lipid
classes: phosphatidylinositols (PI), phosphatidylserines (PS), phosphatidylethanolamines
(PE), and phosphatidylglycerols (PG). Tentative identification of the ions were made
using high resolution mass measurements, Table 3‐1, and tandem MS (data not shown).
The majority of lymphoma‐containing tissue sections displayed a conserved pattern of
lipids (i.e. ion, m/z, and corresponding relative abundance), or lipid profile, that
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contrasted markedly with that of normal tissue, and varied more slightly between B‐cell
and T‐cell subtypes. Minute analytical variances in the lipid profile and signal intensity
were attributed to freezing and sectioning artifacts. These small areas contributed
insignificantly upon averaging and did not compromise the ability to ascertain MS
information.
DESI‐MS ion images, two dimensional spatial distribution of m/z versus the
corresponding ion abundance represented in false‐color, revealed the majority of
samples to be chemically homogenous, i.e. to have similar lipid profiles. Diffuse large B‐
cell lymphoma, Figure 3‐1, was particularly homogenous, spatially and chemically,
following the propensity of this cancer to diffusely obliterate normal lymph node
architecture. Normal samples were also relatively homogenous in regards to chemical
composition and spatial distribution. Interestingly, regions of normal lymph node
anatomy, e.g. cortex and medulla, yielded nearly identical lipid profiles although
differing in absolute MS intensity. The similarity of the lipid profile was unexpected as
anatomical distribution of B‐cell and T‐cell lymphocytes is known to differ in lymph
nodes: B‐cells are found in densely packed follicles within the cortex and T‐cells are
present in the surrounding paracortex. The medulla contains a mixture of plasma cells,
macrophages, and T‐cells. The absolute MS signal intensity varied between the cortex
and medulla, the latter yielded less signal. This intensity difference might result from the
anatomical differences between the two regions that are not detected, such as the
greater density of blood vessels and vascular sinuses within the lymph node medulla,
which reduces the overall cellular density. The spatial resolution of DESI‐MS data
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acquisition used does not allow for such anatomical structures to be visualized. MS
imaging at higher resolution (<200 µm), possible by secondary‐ion MS, (22) matrix‐
assisted laser desorption, (23) DESI, (24) and nanoDESI, (25) could visualize these
anatomical regions with a non‐linear increase in analysis time (analysis time increases
with the reciprocal of the square of spatial resolution); however, investigation of normal
lymph node anatomy is beyond the scope of the intended application.
Differences in the chemical information within analyzed tissue sections,
disregarding previously discussed MS intensity differences, were noted in some of the
normal and tumor specimens. In all of these instances (independent of tissue disease
state, i.e. normal versus tumor) the difference resulted from the presence of perinodal
adipose tissue, as determined by post hoc histopathology. Specimen 31 is illustrative,
Figure 3‐1 , a tissue section comprised primarily of a B‐cell tumor with smaller regions of
non‐neoplastic, perinodal adipose tissue. The tumor regions have a common lipid profile
that is homogenous throughout the tumor region; however, the lipid profile of small
regions corresponding to perinodal adipose tissue (outlined) are significantly different
and overall lower in absolute intensity as seen in the ion images (particularly m/z 281.5).
The chemical difference of this region was further explored using PCA and an interactive
brushing procedure, see
Figure 3‐2. The PCA score plot, displaying each pixel of specimen 31, indicated
three groups: B‐cell lymphoma associated pixels (red selection), perinodal adipose
associated pixels (green selection), and background associated pixels (black). The results
of visual interpretation and PCA correlated well with the pathological assessment,

48
considering the differences in spatial resolution of MS imaging and histopathology.
Perinodal adipose tissue was also detected in some normal lymph nodes, for example
specimen 42, as shown in Figure 3‐1. The difference in the lipid profile was again evident
between the two tissue types with negative mode GPL signal only noted in the lymph
node parenchyma. The lack of GPL signal in adipose tissue is likely correlated to
adipocytes (i.e. fat cells), which typically possess a large cytoplasmic volume to GPL
membrane surface area ratio. Further, adipocytes contain greater levels of triglycerides
and cholesteryl esters which are not readily detected in the negative mode with the
solvent conditions chosen; however, previous DESI experiments have detected such
compounds in positive ion mode from biological material with relative ease as silver
adducts. (26)

3.3.2 Differentiating Lipid Profiles in NHL Tissue Sections
The lipid profiles of tissue sections were explored for molecular‐based
differentiation of disease state (normal versus tumor) and NHL tumor subtype (i.e. B‐cell
versus T‐cell). The average DESI mass spectrum (from m/z 700 ‐ 1000) of normal lymph
node (n=22), B‐cell lymphoma (n=22), and T‐cell lymphoma (n=7) tissue sections, green,
blue, and gold respectively, are displayed in Figure 3‐3. The ratio of MS abundance of
m/z 788.3 (PS 36:1), 838.3 (PS 40:4), and 885.5 (PI 38:4) indicated, visually, molecular
differences between disease states. Nearly all B‐cell samples were diagnosed as diffuse
large B‐cell lymphoma, differences in the lipid profile are noted in comparison to the
average normal spectrum. A small number of T‐cell lymphoma tissue sections were
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analyzed, diagnosed as peripheral T‐cell lymphoma, not otherwise specified (n=4) and T‐
zone lymphoma (n=3). Spectral differences were also noted between normal and T‐cell
NHL, but the limited number of samples and multiple T‐cell subtypes preclude definitive
conclusions. Less abundant peaks present in B‐cell and T‐cell lymphoma also differed in
abundance from normal samples including m/z 747.4 (PG 34:1), 773.3 (PG 36:2), 786.4,
812.4, 883.5. These ions and their altered relative abundance mirror those reported
previously by Eberlin et al. in murine and human lymphoma specimens. (27) One
metastatic carcinoma, specimen 12, was analyzed and yielded different lipid profiles
from normal and lymphoma with strong alterations in m/z 819, 834, 865, and 867
(Figure 3‐4). Abbassi‐Ghadi and coworkers have previously analyzed metastatic tumors
in lymph nodes by DESI, concluding that the chemical information corresponded to that
of the primary tumor and had clearly different from adjacent normal lymph node. (28)
Extrapolating from that work, the lipid profile of specimen 12 might correlate with that
of the primary tumor; however, biopsies of the primary tumor were not available for
analysis.
Principal component analysis was performed on the average spectrum of each
tissue section, offering an unbiased method for qualitatively assessing the molecular
information

associated with

the

pathology‐defined

condition.

Disease state

differentiation (normal vs. tumor) was the initial level of diagnostic information
explored. Normal lymph node (green) and tumor (red) samples were appropriately
grouped as shown in Figure 3‐3, panel D. Dispersion of the tumor samples in the PCA
score plot, compared with the normal samples, is indicative of greater chemical
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heterogeneity within lymphoma – matching known diversity of the disease.(1) The
dispersion of the lymphoma samples appears to be related to tumor immunophenotype,
Figure 3‐3, panel E: normal (green), B‐cell lymphoma (blue), and T‐cell lymphoma (gold).
The PCA loading plot, displayed in Figure 3‐3, aided in understanding which lipids from
m/z 700 ‐ 1000 contributed most to PC2 and PC6 computations. Distinguishing NHL
subtypes represents a deeper level of diagnostic information, which commonly requires
IHC/ICC; the chemical information obtained by DESI may circumvent or augment such
protocols. The separation of B‐cell and T‐cell lymphoma is suggested in Figure 3‐3;
however, expansion of NHL subtypes is necessary to confirm this initial report. More
detailed exploration of the chemical differences was performed by iterative study of the
relationship between disease states rather than together as in Figure 3‐5. For example,
the chemical difference between B‐cell and T‐cell NHL tumors is more apparent upon
removal of normal samples. The separation noted must be taken as preliminary,
particularly for T‐cell tumors, based on the relatively small sample size and known
genetic diversity of lymphomas. The ability to subtype tumors using DESI‐MS has been
previously demonstrated, e.g. in brain and kidney tumors,(13, 15) but has not been
previously reported in lymphoma. Diagnostic information acquired by DESI would serve
to support pathological diagnosis, particularly relating to tumor subtyping as an
alternative to immunohistochemistry.
The discriminatory performance of DESI‐MS in determining disease state and
subsequently tumor subtype from tissue sections was explored via PCA‐LDA. Cross‐
validation was performed, Table 3‐2, resulting a sensitivity and specificity of 93.1% and
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100%, respectively. Further, PCA‐LDA was performed separately taking the lymphoma
subtypes into consideration, sensitivity and specificity per class (i.e. normal, B‐cell, and
T‐cell) are tabulated in Table 3‐3. Cross validation indicated two misclassifications (T‐cell
predicted as normal, and B‐cell predicted as T‐cell). The CV sensitivity of T‐cell
lymphoma (85.7%) was relatively poor in comparison to the other states (normal, 100%
and B‐cell lymphoma, 95.5%), likely the result of a smaller sample size (n=7) or the
presence of two different T‐cell subtypes (i.e. peripheral and T‐zone).

3.3.3 DESI‐MS Imaging of Fine Needle Aspirates
Histopathological evaluation of surgically excised lymph nodes, the gold standard
for lymphoma diagnosis, is an invasive procedure and therefore not suitable for rapid
preliminary diagnosis of NHL. Fine needle aspirate biopsy is a less expensive, less
invasive, and less technically demanding method, and therefore a reasonable alternative.
FNA smears are evaluated by cytology and tend to be less reliable than surgical biopsy,
due to the destruction of morphological information through smearing. However, DESI‐
MS analysis of FNA smears provided molecular information that is similar to that of
tissue sections and offers an alternative to FNA cytology, aimed at enhancing diagnostic
capability.
FNA smears, prepared using standard protocols, were analyzed without any pre‐
treatment. DESI‐MS imaging was performed on a small area of the smear, not the
entirety of the smear, representing a time reducing strategy for preliminary diagnosis.
An analogous similar time reduction strategy has been implemented for intrasurgical
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analysis of brain tumors using tissue smears, discussed later in this dissertation. It was
assumed that aspiration and subsequent smearing, was sufficiently homogenizing. The
MS data obtained from FNA smears were highly reminiscent of those for surgical biopsy
tissue sections; the average mass spectra for normal and B‐cell lymphoma are displayed
in Figure 3‐6. The chemical information obtained from FNA appears to be identical in
nature to that of tissue sections suggesting that the type of sample does not impact
ability to acquire chemical information correlated to disease state. The strategy of using
DESI spectra obtained from tissue sections serves as an important reference in this case,
having been used previously in other forms of cancer diagnosis, (11, 13, 15, 29) thus
allowing evaluation of FNA as a new type of sample for the same DESI methodology.
Unsurprisingly, subtle differences do exist between tissue sections and FNA
smears which did not preclude acquisition of mass spectral information but rather
influenced data quality. FNA smears were nearly always chemically homogenous, i.e. the
lipid profile was similar in all areas of the smear, supporting the assumption of sufficient
homogenization, while difference in the signal intensity were common. Two major
variables in FNA smears were found to affect MS intensity: the quantity of cellular
material aspirated and the degree of dilution due to smearing. The effect of quantity is
noted in the heterogeneity present in the ion images,
Figure 3‐7, which resulted from variable amount of material – signal intensity is
correlated with material quantity. The second variable is the degree of smearing of the
aspirated sample which dilutes the cellular material on the glass slide. This dilution is
necessary for cytologic evaluation using light microscopy, in which morphologic
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evaluation of isolated cells is desirable, but is deleterious for chemical analysis by DESI‐
MS. Slight modification to current FNA protocols that compensate for these effects is
likely to increase DESI reproducibility, MS data quality, and capability for molecular
diagnosis. Additionally, differences in the lipid profile were noted in cases of obvious
blood contamination of the aspirated sample, resulting in a visually red coloration to the
smear. The presence of blood contamination significantly increased one particular lipid,
m/z 810, which corresponds to PS 40:6, a major membrane constituent of erythrocytes
(30) and therefore easily detected. Minor blood contamination did not seem to
compromise the ability to determine disease state.
Figure 3‐8, subsequent staining of FNA smears (Wright’s stain) analyzed by DESI
and evaluation by light microscopy, indicated cellular damage, which could result from
physical damage during smearing or freeze thaw cycle. Certainly, DESI has the potential
to produce the observed cellular damage via physical (e.g. pneumatic) forces or
chemical fixation (i.e. organic solvent). An expert cytopathologist commented that the
morphologic changes in the cells appeared similar to those commonly observed in
samples exposed to formalin, a common chemical fixative, which supports the latter
reason for the observed effect. This observation is quite interesting in that it contrasts
the preservation of morphology during analysis of histologic tissue sections – no effect
on histomorphology is noted using dimethylformamide‐acetonitrile as a DESI solvent
system. One biological reason for this observation is the presence of stromal tissue and
extracellular matrix in histologic sections, which may minimize the cellular damage of
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DESI analysis relative to what was observed in FNA smears, which would presumably
contain less of these protective elements.

3.3.4 Differentiation of Disease State using FNA Smears
The chemical information obtained using DESI‐MS from FNA smears was
evaluated by multivariate statistics. In clinical practice, the information relevant in FNA
evaluation is the presence or absence of tumor, and serves only to provide a rapid,
preliminary diagnosis which requires subsequent confirmation by more accurate
methods such as histopathology. PCA‐LDA was applied and performed by building a
classification training set using tissue section data and evaluating the FNA smear data.
PCA‐LDA prediction of the FNA smears, Table 3‐4, provided a sensitivity of 89.3% and
specificity of 85.7%. The preliminary results displayed indicate that DESI‐MS analysis of
FNA smears has diagnostic potential. FNA smears, neither adapted nor optimized for MS
analysis, provided reasonable classification results, provided that FNA smears are known
to be less reliable than surgical biopsy samples evaluated by histopathology.
Beyond the rapid molecular diagnosis of NHL by DESI‐MS via FNA analysis, the
envisioned application, has the potential for rapid tumor subtyping. PCA cross‐validation
of tissue sections indicated the possibility for tumor subtyping; however, this could not
be explored based on FNA sample numbers. Surely, this requires a larger and more
diverse sample set, particularly with knowledge of NHL tumor heterogeneity. The
primary goal of FNA analysis by DESI was demonstrated: rapid molecular‐based
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dichotomous delineation of disease state (i.e. normal and tumor), which has potential to
be a significant advancement in the rapid diagnosis of non‐Hodgkin’s lymphoma.

3.4

Conclusions

Differences in the lipid profiles differentiated normal lymph node and NHL tumors
in tissue sections (obtained by surgical biopsy) analyzed by DESI‐MS imaging. Normal
lymph node tissue was chemically homogenous while differences in absolute signal
were noted between regions of normal lymph node anatomy, e.g. medulla and cortex.
Tumor samples were generally homogenous, particularly diffuse large B‐cell lymphoma
samples, matching known morphology. Multivariate statistics allowed for differentiation
of normal and tumor tissue sections with a sensitivity and specificity of 93.1% and 100%,
respectively. Further, subtyping of NHL tumors is suggested with an equal rate of
predicted classification. FNA smears, previously unexplored for use in diagnosis using
ambient ionization – mass spectrometry, provided the same chemical information
relevant to disease state differentiation detected from tissue sections. FNA smear data
applied to a tissue section‐based classification system resulted in a sensitivity of 89.3%
and specificity of 85.7%. MS signal was dependent on the composition (e.g. blood
contamination), aspirated material quantity and smearing. The act of smearing of FNA,
while ideal for cytology, dilutes the cellular material necessary for DESI‐MS lipid analysis.
Improvement in the protocols for FNA preparation, with tailoring specifically for MS
analysis is likely to improve results. The molecular information detected from FNA
smears are not subject to the same set of problems (e.g. physical damage of cells)
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experienced in cytopathology, and therefore could improve diagnostic yield. Cellular
damage was noted after DESI analysis upon FNA samples, affecting only subsequent
pathology and not the molecular information. The reason for this damage is presently
unknown, but might result from chemical damage or pneumatic pressure. The
informative but less invasive collection of FNA smears, also performed during diagnosis
of other cancers, particularly those of the breast, thyroid, and salivary gland, is clearly
best suited to answer the question of rapid preliminary diagnosis, “Is this sample normal
or cancerous?”
DESI‐MS analysis of tissue sections provided a means of exploring and establishing
the lipid profiles indicative of normal lymph node and NHL tumors. FNA smears mimic
those changes, primarily in GPL composition, which are certainly related to cellular and
morphological changes that occur with NHL. The polar lipids detected in the negative
ion mode represent only a fraction of metabolites, and further study of the metabolome
may reveal additional diagnostic information. The subtype prevalence, clinical behavior,
and chemical changes in GPL emulate that of human NHL, (27) supporting development
of canine comparative models. The methodology outlined here is applicable to dogs
while translation to humans is foreseeable.
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Figure 3‐1 Selected negative mode DESI‐MS ion images displaying the distribution of
ions m/z 281.5, 747.5, 788.4, 838.5, and 885.6 and the corresponding H&E stain. (A)
Specimen 18 is representative of B‐cell lymphoma samples in regards to chemical and
spatial homogeneity. (B) Specimen 31, B‐cell lymphoma, contained small regions of
perinodal adipose (outlined). (C) Specimen 42, illustrative of normal samples. The large
region of perinodal adipose (outlined) was chemically difference than that of normal
lymph node tissue.

Figure 3‐2 (A) Sample from specimen 31, H&E stain with annotated non‐neoplastic
regions in green. (B) DESI‐MS image, colors indicating chemical similarity. (C) PCA score
plot of pixels with subgrouping selected.
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Figure 3‐3 Average negative mode DESI mass spectrum, m/z 700 – 1000, of tissue
sections: (A) normal lymph node (n=22), (B) B‐cell lymphoma (n=22), and (C) T‐cell
lymphoma (n=7). (D) PCA score plot of normal (green) and tumor (red) samples. (E) PCA
score plot of normal (green), B‐cell lymphoma (blue), and T‐cell lymphoma (gold)
samples. (F) PCA loading plot corresponding to panel D&E with m/z annotated.

Figure 3‐4 (A) Metastatic carcinoma to lymph node, specimen 12, negative mode DESI‐
MS. (B) Zoomed region m/z 700‐1000 containing glycerophospholipids.
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Figure 3‐5 (A) PC2 vs. PC3 score plot for B‐cell and T‐cell lymphoma, color coded in
orange and blue respectively, and (B) corresponding PCA loading plot, loadings are
annotated as m/z values. (C) PC2 vs. PC3 score plot for normal (green) and B‐cell (blue),
and (D) PCA loading plot, loadings are annotated as m/z values. (E) PCA score plot for
normal (green) and T‐cell lymphoma (orange) and corresponding (F) PCA loading plot,
loadings are annotated as m/z values.
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Figure 3‐6 Average negative mode DESI‐MS spectrum, m/z 700 – 1000, for (A) normal
fine‐needle aspirate smears (n=7) and (B) B‐cell lymphoma fine‐needle aspirate smears
(n=28).

Figure 3‐7 DESI ion images of normal (top) and B‐cell lymphoma (bottom) fine‐needle
aspirate smears, the latter contains areas of higher intensity corresponding to amount
of material present.
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Figure 3‐8 Wright’s stained fine‐needle aspirate smears displaying (A) an even
distribution of material and (B) uneven distribution of material with corresponding
zoomed insets.

Table 3‐1 Tabulated negative ion mode DESI high resolution mass spectrometry data for
predominate ions observed in the negative mode with identifications.
`

Normal

B‐cell lymphoma

T‐cell lymphoma

Name

Ion formula

Theoretical
mass

Measured
mass

Mass error
(ppm)

Measured
mass

Mass error
(ppm)

Measured
mass

Mass
error
(ppm)

Palmitic acid

[C16H31O2‐H]‐

255.2324

255.2324

0.0

255.2323

‐0.4

255.2327

1.2

Oleic acid

[C18H32O2‐H]‐

281.248

281.2481

0.4

281.248

0.0

281.2483

1.1

Stearic acid

[C18H35O2‐H]‐

283.2637

283.2637

0.0

283.2636

‐0.4

283.264

1.1

Arachidonic acid

[C20H31O2‐H]‐

303.2324

303.2323

‐0.3

303.2323

‐0.3

303.2327

1.0

PG 34:1

[C40H76O10P‐H]‐

747.5176

747.5173

‐0.4

747.5171

‐0.7

747.5184

1.1

PS 34:1

[C40H75NO10P‐H]‐

760.5128

760.5128

0.0

760.5122

‐0.8

760.5136

1.1

PE 38:4

[C43H77NO8P‐H]‐

766.5386

766.5386

0.0

766.5383

‐0.4

766.5393

0.9

PG 36:2

[C42H78O10P‐H]‐

773.5332

773.5334

0.3

773.533

‐0.3

773.5342

1.3

PS 36:1

[C42H79NO10P‐H]‐

788.5441

788.5442

0.1

788.5439

‐0.3

788.5450

1.1

PC 34:1 + Cl‐

[C42H82NO8P+Cl]‐

794.5466

794.5465

‐0.1

794.5464

‐0.3

794.5471

0.6

PS 38:4

[C44H77NO10P‐H]‐

810.5284

810.5285

0.1

810.5282

‐0.2

810.5293

1.1

PS 40:4

[C46H81NO10P‐H]‐

838.5598

838.5597

‐0.1

838.56

0.2

838.5607

1.1

PI 38:4

[C47H82O13P‐H]‐

885.5493

885.5491

‐0.2

885.5488

‐0.6

885.5500

0.8

66
Table 3‐2 Cross‐validation confusion matrix of DESI‐MS in discriminating disease state
(normal vs. canine non‐Hodgkin’s lymphoma) in tissue sections
DESI‐MS Prediction

Histopathology

Tumora

Normal

Tumora

27

2

Normal

0

22

Table 3‐3 Cross‐validation confusion matrix for canine non‐Hodgkin’s lymphoma
subtyping of tissue sections by DESI‐MS

Pathology

DESI‐MS Prediction
Normal

B‐cell NHL

T‐cell NHL

Normal

22

0

0

B‐cell NHL

0

21

1

T‐cell NHL

1

0

6

100.0
96.4

95.5
100.0

85.7
97.7

Sensitivity (%)
Specificity (%)

Table 3‐4 Principal component analysis – linear discriminant analysis prediction of fine‐
needle aspirate smears analyzed by DESI‐MS
DESI‐MS Prediction

Histopathology

B‐cell
NHL

Normal

B‐cell NHL

25

3

Normal

1

6
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CHAPTER 4.

NEGATIVE ION MODE LIPID AND METABOLITE PROFILES OF HUMAN
BRAIN TUMORS

4.1

Introduction

The incidence of brain tumors is approximately the same as that of non‐Hodgkin’s
lymphoma, melanoma, and urinary bladder cancer in adults over 20 years of age.
Incidence rates in children and adolescents is even greater, more than five per 100,000.
Brain tumors include a number of subtypes with the most prevalent being meningioma
(~36%), glioma (~28%), and pituitary tumors (~15%); however, gliomas account for 80%
of all malignant brain tumors.(1) In many cases, surgical resection is the most effective
treatment option; maximal tumor excision is associated with an improved prognosis. (2)
Gliomas are particularly difficult to treat via surgery as they often infiltrate the
surrounding tissue and visually resemble normal brain tissue. Further, surgery must
contend with the dilemma minimizing unintended neurological deficits while maximizing
tumor removal. The gold standard for brain tumor diagnosis is histopathology.
Histopathology relies heavily on morphologic and cytologic features revealed by staining
of cellular structures (e.g. nucleus and cytoplasm). Surgical biopsies are taken during
tumor excision and sent for histopathologic evaluation as frozen tissue sections and
tissue smears. The pathologic information provided during surgery is limited, for
example tumor type (e.g. glioma) and grade (e.g. low grade), compared to final
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pathologic evaluation which is performed using fixed tissue sections. Pathologic analysis
can be repeated for infiltrative tumors to guide the extent of resection at the tumor
margins; however, the time required for such evaluation (upwards of 20 minutes per
sample) is limiting and prolongs surgery.
The potential diagnostic value of using ambient ionization and MS profiles,
especially those based on lipids,(3) is increasing concurrently with the growing number
of studies on lipid metabolism in cancer. (4, 5) Two schools of thought have emerged:
offline approaches in which measurements are performed ex vivo and online
approaches in which measurements are performed in vivo. (6) Desorption electrospray
ionization – mass spectrometry (DESI) is arguably the most developed offline approach
in which resected biopsies are analyzed ex vivo, but ideally within the operating room,
providing results on the minute timescale. MS analysis by offline approaches can
preserve tissue morphology allowing for subsequent histopathologic evaluation. Brain
and other cancers have been investigated using rapid evaporative ionization – mass
spectrometry, an online approach, a method which provides lipid–based differentiation
between cancerous and normal tissue and has been performed in vivo upon patients
undergoing surgical resection with promising results; however, electrocauterization is
destructive and does not allow validation by pathology.(7)
DESI‐MS detect biomolecules, e.g. lipids, in a profile, synonymous with mass
spectrum (m/z values and associated abundances), and uses the entire profile for
differentiation via multivariate statistics. This contrasts strongly with traditional
biomarker measurement in which the predominant philosophy is “one molecule for one
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disease.” Different methods of multivariate statistics, e.g. principal component analysis
(PCA), have been used for analyzing ambient ionization MS data. The use of any one
particular method must be tailored to match the question being asked. For example,
PCA does not offer any ability to classify unknown samples, rather it is used for
exploring the innate differences between samples in an unsupervised manner.
Supervised discriminate (e.g. linear discriminant analysis, LDA) and class modeling (e.g.
unequal class modeling, UNEQ) approaches allow for the classification of unknown
samples. In the case of brain cancer, establishing a robust classification method is vital,
and can only be implemented by including normal tissue. This is particularly difficult in
the case of brain tumors in which absolute normal rarely exists for scientific study.
The study of brain cancer by DESI‐MS has been an ongoing effort since 2010. (8)
The negative ion mode lipid profiles acquired via DESI‐MS imaging were found to be
different between glioma subtypes, grades, and tumor cell concentrations (relative
percent of tumor compared to parenchyma). (9) The lack of normal samples in that
study prevented any conclusions as to differentiation between glioma and normal brain
tissue. Surgically‐derived samples with corresponding stererotactic information were
analyzed, predicting tumor type (glioma or meningioma) and subtype, and illustrating
the potential for determining tumor cell concentration (via lipid profiles) near the
resection margins.(10) In a separate study, meningiomas, tumors which originate from
the meninges (connective tissue surrounding the brain), have also been studied by DESI‐
MS. The lipid profiles of meniginiomas were found to be different between the normal
dura mater and tumor. (11) There is little doubt that development of molecular
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techniques that rapidly discriminate cancerous tissue would be of great benefit to
supplement intraoperative decision making and pathologic evaluation. Herein the
development of a database of DESI‐MS spectra, which includes negative ion mode lipid
and metabolite profiles, from normal brain, grey and white matter, and gliomas is
discussed. Additional differentiating information was found in the positive ion mode
lipid profiles and is discussed in the next chapter. We also explored if negative ion mode
lipid and metabolite profiles are capable of differentiating gliomas, meninigiomas, and
pituitary tumors – types of tumors which represent ~80% of all brain and CNS tumors.
DESI‐MS analysis of tissue smears is detailed which greatly eases the implementation of
DESI towards intrasurgical analysis.

4.2

Experimental

4.2.1 Materials

4.2.1.1 Banked Frozen Human Specimens
Cryopreserved human neurological specimens were obtained from 74 patients,
58 of whom were included in the sample cohort for the results discussed in Jarmusch et
al. (12), by the Biorepository of Methodist Research Institute. The samples were
purchased from the Biorepository of Methodist Research Institute after Purdue IRB
determined that IRB review was not required (#1410015344). Tissue specimens were
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used to produce sections and smears. Details on the patient cohort are reported in the
supplementary appendix of Jarmusch et al., (12) Table S4 ‐ S5. The specimens were
codified based on pathologic evaluation as grey matter (N=23 patients), white matter
(N=14), gliomas (N=12) which consisted of 10 high‐grade and 2 low‐grade gliomas,
meningiomas (N=13), pituitary tumor (N=14), and brain parenchyma containing reactive
astrocytes (N=2). Subsequent to tissue sectioning and analysis, histopathologic
evaluation determined that a number of samples contained multiple regions with
different pathologies, hence the total number of patients for all classes does not equal
the total number in the patient cohort. Tissue sections were made using a cryotome
(Cryotome FSE, Thermo Scientific), 15 µm thickness, and thaw mounted onto glass
microscope slides (Superfrost Plus, 25 x 75 x 1 mm, Electron Microscopy Sciences).
Subsequently, tissue smears were prepared for each specimen by removing a small
piece of frozen tissue (~10‐50 mm3), placing the tissue onto a glass microscope slide,
allowing for the tissue to come to room temperature (20‐25°C), and then smeared using
a custom 3D printed device. (12) Tissue sections and smears were stored at ‐80°C prior
to analysis. Materials were properly disinfected or autoclaved prior to disposal.
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4.2.2 Methods

4.2.2.1 Negative Ion Mode Lipid and Metabolite Profiles via DESI‐MS Imaging
The analysis of tissue sections and smears was performed on a linear ion trap
mass spectrometer, model Finnigan LTQ (Thermo Electron Corporation, USA). The
modifications to the instrument were the installation of a custom DESI source, which
includes a source override adapter, an external cable for the application of high voltage,
and an extended ion transfer capillary. The extended ion transfer capillary measuring a
total length of 180 mm was constructed from stainless steel tubing (0.02” inner
diameter and 1/16” outer diameter), the length protruding from the MS vacuum system
was ~87.5 mm. Connection of the capillary with the threaded MS inlet was
accomplished using Swagelok stainless steel fittings machined so that the capillary can
be place all the way through the fitting and secured on one side with a ferrule and metal
nut.
DESI‐MS was performed using dimethylformamide‐acetonitrile (1:1 v/v) which
preserves tissue morphology for subsequent pathology.(13) Dimethylformamide and
acetonitrile were purchased from Mallinckrodt Chemicals and Sigma‐Aldrich,
respectively. Additional source parameters are as follows: solvent flow rate, 1.0 µL min‐
1; pressure of nitrogen gas, 160 PSI; applied high voltage, ‐5 kV; incident angle, 52°;
spray‐to‐surface distance, 2 ‐ 3 mm; spray‐to‐inlet distance, 5 ‐ 7 mm. Sections and
smears were subjected to two sequential negative ion mode DESI‐MS image acquisitions.
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The first image acquired data from m/z 200 ‐ 1000 with the mass spectrometer tuned
for maximum transmission of m/z 786. The moving stage was then reset to the origin
position, allowing for a subsequent image acquired from m/z 80 ‐ 200 (MS tuned for m/z
174). Further detail of the different tune methods and corresponding instrument
conditions and settings are reported in Jarmusch et al. (12)
DESI‐MS imaging was performed upon tissue sections and smears by affixing the
material to glass microscope slides and fixing these onto a custom two‐dimensional
precision moving stage. Images are collected as rows by coordinating linear motion of
the moving stage with MS acquisition rate, defining resolution of 250 µm in “x”, upon
completion of a row the moving stage resets to the original “x” position while stepping
250 µm in “y”. Upon completion of a sufficient number of “y” steps to cover the entire
tissue surface, the moving stage was reset to the origin and a second image was
acquired. The first image recorded data from m/z 200 ‐ 1000 with an MS scan time of
0.85 s (automatic gain control, AGC, was disabled), 350 ms injection time with 2
microscans. The corresponding speed of the moving stage was 294.117 µm s‐1. The
second image acquired data from m/z 80 ‐ 200 with an MS scan time of 0.62 s, 125 ms
ion injection time with 4 microscans ‐ a faster injection time was necessary to
compensate for greater MS abundance and lack of AGC. The linear motion of the
moving stage was increased to 403.225 µm s‐1, compensating for the change in MS scan
time, maintaining an average of one MS scan per 250 microns in the “x” dimension.
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4.2.2.2 Pathology
Tissue sections and tissue smears analyzed by DESI‐MS were stained after
analysis by hematoxylin and eosin. Slides were chemically fixed in methanol (100%) for 2
minutes and rinsed in nanopure water (10 dips). Then slides were stained in modified
Harris hematoxylin solution (Sigma‐Aldrich) for 1.5 minutes, rinsed in nanopure water
(10 dips), quickly dipped into Bluing Reagent (Protocol), and dipped 10 times in
nanopure water. Slides were then placed in Intensified Eosin Y (Protocol) for 8 seconds
and rinsed in ethanol (180 proof) in two sequential steps (10 dips each). The slides were
dipped a total of 12 times into xylenes. The slides were allowed to air dry and were
subsequently mounted using mounting media (Organo/Limonene Mount, Sigma‐Aldrich)
and glass coverslips (12‐545‐C, Fisher Scientific). Blind histopathologic evaluation by
expert pathologist, Dr. Eyas M. Hattab, of tissue sections and smears provided the
diagnosis (e.g. glioma), grading information (if possible), and an estimated tumor cell
percentage. Some of the stained tissue sections and smears were digitally scanned for
creation of publication quality figures using the Aperio whole slide digital imaging
system (Leica Biosystems, CA). The system imaged all slides at 20x. Additional pathologic
information such as IDH mutation status and final pathologic diagnosis were assessed
independently via standard of care protocols and provided to the researchers.
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4.2.2.3 Data Handling
DESI‐MS spectra were acquired using XCalibur 2.0 (.raw) and converted into .csv
or .mzXML files, and then imported into MATLAB (MathWorks, Inc., Natick, MA, USA) to
reconstruct the corresponding hyperspectral datacubes, which are composites of a
spatial domain (“x” and “y”), and a spectral domain, comprising the m/z value and the
corresponding m/z intensity. (14) Regions of interest (ROI) were selected in MATLAB
based on histopathologic review by Dr. Hattab, each ROI selection is the average
spectrum of 1 mm (4 pixels) x 1 mm (4 pixels). The number of such selections per tissue
section varied between two and more than a dozen, according to the dimension and
pathologically distinct regions in the tissue. In‐house MATLAB routines were used to
process all MS data and generate the corresponding plots, except the averaged mass
spectra that were exported from MATLAB and plotted in Origin Pro for improved
graphical quality. Figures were created and exported using Adobe Illustrator or
Microsoft Powerpoint.

4.2.2.4 Univariate Statistics
The Kruskal‐Wallis non‐parametric hypothesis test was chosen to verify the
occurrence of statistically significant differences of NAA between classes of tissue. NAA
signal was normalized to the total ion current prior to Kruskal‐Wallis. The null
hypothesis H0 affirms that there are no significant differences between the independent
populations under examination. A significant level (a two‐tailed P‐value) of 0.05
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(confidence interval = 95%) was chosen for the statistical test. When the experimental
P‐value is lower than the critical P‐value, the null hypothesis is rejected. As a post hoc
test, the Mann‐Whitney U test was performed. The statistical tests were performed in
OriginPro 2015 using built‐in statistics package upon data exported from MATLAB.
OriginPro 2015 was used to generate the box and whisker plots. The median line is
shown, the box corresponds to the interquartile range, whiskers represent ±1.5
standard deviation, and outliers are annotated.
Receiver operator curve (ROC) analysis was performed to estimate sensitivity
and specificity of NAA, determining the cut‐off value (i.e. TIC normalized ion abundance,
percentage) of 1.5% ‐ corresponds to the value displayed in the y‐axis of the box and
whisker plot for NAA. Further, the overall accuracy (area under the curve) in
discrimination of brain parenchyma and glioma was calculated.

4.2.2.5 Multivariate Statistics
Principal component analysis (PCA) was used to explore the DESI‐MS data in an
unsupervised fashion and to visualize groupings of samples based on chemical similarity.
All spectra were normalized using standard normal variate (SNV) transform, correcting
for baseline shift and variation in absolute intensity, and mean‐centered prior to PCA.
No background signal correction, smoothing filters, or data binning were applied. PCA
was also performed with a mid‐level data fusion approach, in order to comprehensively
visualize relationships among samples and variables coming from multi‐block
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experiments (lipid and metabolite profiles). The first round of PCA acts as an
unsupervised latent‐variable compression technique, informative features were
extracted from the raw signals of each block (i.e. profile) by PCA, individually, and then
combined into a new (reduced) fused dataset. The fused dataset is then analyzed by
PCA providing the multivariate statistical results of data fusion.
Linear discriminant analysis (LDA) was performed as a supervised discriminant
classification technique after unsupervised data compression using PCA. Discriminant
methods look for a delimiter that divides the global multidimensional data domain into
a number of regions, each assigned to one of the sample classes. This delimiter
identifies an open region for each class and such regions determine the assignment of
the samples to one of the classes. Model validation (i.e. evaluation of the predictive
ability of the model) was performed via cross validation (CV) using 5 deletion groups.
The number of principal components used was selected so that ~90% of the cumulative
variance in the data was included. The CV confusion matrix shows how many samples
belonging to a certain category were correctly/incorrectly assigned by the classification
rule to that category. Sensitivity and specificity are conventionally defined and were
calculated by conventional methods per class.
Canonical correlation analysis (CCA) is a way of measuring the linear relationship
between two blocks of multidimensional variables observed on the same specimens.(15)
We used CCA to compare the DESI‐MS spectra from tissue sections and smears. CCA
rotates the original variables in the two blocks, to obtain pairs of variables (one for each
block), called canonical variables, that maximize correlation between the two blocks.
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The canonical variables are linear combinations of the original autoscaled (i.e. unitary
variance) variables. The correlation coefficients between the canonical variables of the
two blocks of measurements are termed canonical correlation coefficients. In order to
overcome the high inter‐correlations across m/z values, CCA was performed after PCA,
which acts as an unsupervised data compression technique. CCA was performed using
the open access chemometric package V‐PARVUS 2010. (12)

4.3

Results and Discussion

4.3.1 Differentiation of Gliomas and Normal Brain Parenchyma using Negative Ion
Mode DESI‐MS Lipid Profiles
The negative ion mode lipid profiles of brain parenchyma (i.e. grey and white
matter) and gliomas acquired by DESI‐MS were explored and evaluated for their ability
in differentiating disease state (i.e. normal versus tumor). DESI‐MS imaging allowed the
selection of regions of interest (ROI) based on histopathologic evaluation of the same
tissue section. The average ROI mass spectra of grey matter, white matter, and glioma
were substantially different. Grey matter is comprised of glia and mostly unmyelinated
neurons and is associated with a very abundant negative ion mode peak at m/z 834,
Figure 1, identified by high resolution mass spectrometry (HRMS) and MS/MS
fragmentation as phosphatidylserine with 40 carbons with 6 units of unsaturation (40:6),
predominant acyl chains are 18:0 (stearic acid) and 22:6 (docosahexaenoic acid) as
indicated by MS/MS. Figure 4‐1, white matter is characterized by an increased relative
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abundance of m/z 788 (PS 18:1_18:0), 888 ((3’‐sulfo)GalCer 24:1), 906, and 916 in the
negative ion mode. Sulfatides, e.g. m/z 888, 904 ((3’‐sulfo)GalCer 24:1 (OH)), 906, and
916, are particularly abundant which correlates with the increased myelination of
neurons. Tentative identifications herein are based on nominal mass but are supported
by high resolution MS measurements tabulated in Table 4‐1 and Table 4‐2. The pattern
of ions that corresponded to grey and white matter was consistent with previous
studies of murine brain tissue.(16) The variations seen in the ratio of the signals
associated with m/z 834 and 888 does not compromise the differences in relative
abundance between grey and white matter (Figure 4‐2). The average mass spectrum for
gliomas, Figure 4‐1, was very different from that of normal brain parenchyma in that it
lacks the ions at m/z 834 and 888 characteristic of grey and white matter, respectively.
Rather, an increase in the abundance of m/z 794 (chloride adduct of PC 34:1) and m/z
885 (PI 18:0_20:4) was noted.
DESI‐MS imaging revealed that regions of different composition could be defined
spatially; however, areas of mixed composition were also noted. The different regions
associated with grey and white matter were easily detected using ion images, illustrated
in Figure 4‐3. The finger‐like projections of white matter (m/z 888) extend from the
major area on the right side of the tissue into an area of grey matter (m/z 834).
Differences in the lipid profiles were noted between anatomical regions of the brain,
such as the molecular layer (an anatomical substructure within the cortex) and the other
cortical layers. Note the decrease in m/z 788 around the white matter projections in
Figure 4‐3 which corresponds to the molecular layer of the cortex. Figure 4‐4, the ratio
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of m/z 788, 834, and 885 varied between the molecular layer, which surrounds a
meningeal blood vessel (apparent in the ion image of m/z 788), and that of the cortex
itself. Furthermore, multivariate analysis via interactive brushing (14) supports the
observed difference between the molecular layer of the cortex (red), the cortex (green),
and a region associated with the presence of some white matter (blue).
Principal component analysis (PCA) was performed on the lipid profiles selected
from pathology‐defined ROI of brain parenchyma and glioma tissue sections, Figure 4‐5.
Grey and white matter were well separated, based primarily on m/z 834 and 888,
respectively. The dispersed location of a few grey and white matter points, those that
fall between their respective groupings, corresponded to tissue of mixed composition as
reflected in the mass spectra. This observation reflects known parenchyma composition
which can contain mixtures of unmyelinated and myelinated neurons as well as glial
cells. Brain parenchyma, grey matter (green) and white matter (blue), and glioma (red)
were well separated in PCA space, indicating that the first level of pathologic evaluation,
“is this a glioma or brain parenchyma?” can be answered; however, the dispersion of
the glioma grouping represents a complex mixture between normal tissue and tumor as
well as mixed compositions of grey and white matter. Dispersion of glioma points along
the vector of grey and white matter separation (right‐left) is related to the relative
contribution of the background parenchyma to the detected lipid profile. It is possible
that the lipid profile differences between grey and white matter can overshadow more
subtle differences that might indicate the presence of invasive tumor cells, particularly
at relatively low tumor cell percentages (TCP), i.e. relative amount of cancerous cells as
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compared to normal cells. This observation does not preclude the differentiation of
normal tissue, infiltration, and gliomas, but rather confirms the known complexity of
brain tumors. The dispersion of the glioma class in the vertical direction in PCA score
space reflects the extent of infiltration of tumor cells or TCP. A likely contribution to the
observed dispersion of the glioma group is the presence of glioma subtypes (e.g.
astrocytoma and oligodendroglioma). For example, the lipid profile of an
oligodendroglioma might appear more similar to white matter, which is composed of a
greater number of oligodendrocytes than grey matter. Discrimination of glioma
subtypes had been previously studied(9) but the lack of normal samples in that study
limited discussion on which factor is more significant. Note, subsequent histopathologic
evaluation revealed that normal specimens commonly contained various levels of
secondary infiltration.
The grey and white matter classes were comprised of regions containing <25%
tumor cell concentration (mode was 10%) and one sample contained 40% tumor cell, as
determined by histopathology performed on the same sample analyzed, representing a
tissue composition that is reasonably expected near the surgical margin. Surgical
resection margin, the point at which tumor removal is stopped, is frequently not
equivalent to the tumor margin, the point at which no detectable tumor cells are
present. A few specimens were well separated from the glioma class in PCA space and
were found to be completely normal or contain no observable tumor cells (<5%) by the
pathologist. Glioma points which fell between the glioma group and either the grey or
white matter group illustrate the disease spectrum and the complexity in determining
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the disease state in the face of contributions from background parenchyma and
infiltration.
Linear discriminant analysis (LDA) was performed subsequent to PCA to estimate
disease classification performance of the negative ion mode lipid profile. The cross
validation results for grey matter, white matter, and gliomas were tabulated, Table 4‐3,
and sensitivity (i.e. the proportion of ROIs pertaining to that class that are correctly
identified as such) and specificity (i.e. the proportion of ROIs not pertaining to that class
that are correctly identified as such) were calculated per class (i.e. grey matter, white
matter, or gliomas). The mean of all classes provided an overall sensitivity and specificity
of 93.9% and 96.1%, respectively. Misidentified samples were generally those of mixed
composition, evident from their lipid profile and their location on the PCA score plot.
This result supports that the lipid profiles are characteristic of grey matter, white matter,
and gliomas; however, the rate of change observed in the lipid profile is not dynamic
enough to accurately reflect subtle differences in mixtures of grey and white matter or
between normal matter and glioma.

4.3.2 Differentiation of Gliomas and Normal Brain Parenchyma using Negative Ion
Mode DESI‐MS Metabolite Profiles including N‐acetyl‐aspartic acid
The negative ion mode metabolite profile (m/z 80‐200) acquired by DESI from
human brain tissue has not been previously explored or shown to be important for
differentiating disease state. The negative ion mode metabolite profile was acquired on
the same tissue after recording the negative ion mode lipid profile. The average ROI
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mass spectra of grey matter (green), white matter (blue), and glioma (red) are displayed
in Figure 4‐6, respectively. Lactic acid, identified by HRMS, was detected as a
deprotonated species at m/z 89 and was found to be slightly increased in abundance
between gliomas (4.39 ± 1.93, TIC normalized mean ± standard deviation) , n=158, and
brain parenchyma (3.74 ± 1.34), n=289. This observation is consistent with metabolic
aberrations inherent in cancer (e.g. high rates of aerobic glycolysis), as postulated by
Warburg and others, but it does not appear to be uniquely predictive of disease. By
contrast, a dramatic decrease in m/z 174 was noted between grey and white matter and
gliomas. The TIC normalized mean of normal brain parenchyma (grey and white matter,
n = 298) was 3.72 ± 2.10 (standard deviation); whereas, the mean for gliomas, n = 158,
was 0.36 ± 0.25. Figure 4‐7, a box and whisker plot supported that m/z 174 alone
provided discrimination of brain parenchyma from glioma (Kruskal‐Wallis p‐value
<0.001). HRMS and MS/MS data obtained by collision induced dissociation were used to
identify m/z 174 as N‐acetyl‐aspartic acid (NAA), detected as the deprotonated ion.
Furthermore, a receiver operating characteristic (ROC) curve of brain parenchyma and
glioma resulted in an area under the curve (AUC) of 0.998 (Figure 4‐8). The abundance
of m/z 174 was least in meningiomas, Figure 4‐7; the absence of NAA is supported by
previous NMR and LC‐MS studies (33) – thus serving as an endogenous positive control
(i.e. signal neither expected nor detected). Meningeal tissue, and presumably
meningiomas, lacks the N‐acetyltransferase necessary for the biosynthesis of NAA. DESI‐
MS ion images of specimen 20, Figure 4‐9, illustrated the considerable difference
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between grey matter, which contained m/z 834 and m/z 174 (NAA), and an invasive
boundary of a meningioma on the right‐side of the tissue section.
PCA was performed on the metabolite profile, Figure 4‐10, and yielded poor
separation of grey and white matter from each other but clear separation between grey
and white matter from glioma. The overwhelming significance of NAA in the
multivariate separation is notable in the positive loading values on PC2. Interestingly,
this finding supports previous MRSI studies which indicated NAA’s significance in
discriminating normal and diseased neural tissues(17, 18); however, MRSI is not a
common procedure used for tumor diagnosis. (19, 20) Detection of NAA in situ by MS
has greater molecular specificity and speed compared to the current means of detection,
primarily MRI and related techniques. NAA is an abundant molecule in the human
nervous system, the biological function of which is still to be unraveled but evidence
indicates a significant role in neural metabolism.(21) Ties to central metabolic processes
can be made via aspartic acid as well as acetate, including lipid metabolism, energy
production, amino acid synthesis, and gene regulation.(21) Further, NAA has been found
to decrease in many neurological diseases and disorders such as stroke, Alzheimer’s
disease, epilepsy, and multiple sclerosis.(21) The detection of NAA via MS appears to be
an important measure of overall neural health as specimens containing reactive
astrocytes (found in trauma, infection, ischemia, neurodegenerative disease, etc) was
associated with a reduction in the relative abundance of NAA. The metabolite profile
and PCA does not appear to differentiate grey matter from white, but the metabolite
profile did separate gliomas well. PCA‐LDA cross‐validation of all classes (grey matter,
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white matter, and glioma), Table 4‐4, resulted in an overall sensitivity of 71.6% and
specificity of 86.4%; however, the sensitivity and specificity for gliomas was >90%.
We hypothesized that if the abundance of NAA and the presence of tumor are
correlated than the reduction in signal would provide a means of determining tumor cell
percentage (TCP), i.e. relative measure of tumor cells to normal cells, previously dubbed
tumor cell concentration. ROIs selected from grey matter, white matter, and glioma
were given an estimated TCP by our collaborating pathologist, plotted on the x‐axis, and
the normalized NAA abundance was plotted on the y‐axis (Figure 4‐11). The trend
appeared to be exponential‐like decay in NAA abundance with increased TCP. Following
the observed exponential‐like decay, the data were replotted on a semi‐logarithmic plot
and linear regression was performed (Pearson’s r = ‐0.89). Further study of the observed
correlation and improved measurement is required.

4.3.3 Differentiation Meningioma, Glioma, and Pituitary Tumors using Negative Ion
Mode Lipid and Metabolite DESI‐MS Profiles
Meningiomas and pituitary tumors represent a large fraction of all brain tumors;
the lipid profile of the former was explored in a previous study [11]. We sought to
differentiate the following tumor types: glioma, meningioma, and pituitary tumor. The
average lipid mass spectra displayed differences in the relative abundances of m/z 788
(PS 36:1), 794 (chloride adduct of PC 34:1), and 885 (PI 38:4) between the tumor types,
Figure 4‐12. PCA performed upon glioma (N=158), meningioma (N=111), and pituitary
tumors (N=154) using the lipid information, provided good separation between all
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tumor types. PCA‐LDA cross validation provided an overall sensitivity (99.4%) and
specificity (99.7%), Table 4‐5. Whilst remarkable, this result is not surprising as the cells
and tissue from which the various tumors arise are quite different (e.g. glia versus
meninges), and this is reflected also in histopathologic evaluation. Note, the lack of
normal specimens from different tissue type precluded conclusion regarding the ability
to distinguish meningiomas and pituitary tumors from their respective normal tissues.
The metabolite profile, previously discussed as being differentiating between
grey and white matter and glioma, was observed to have small differences in the
average mass spectra between tumor types. Figure 4‐7, NAA signals were significantly
different between tumor types (p<0.001), although change was much smaller
(compared to that observed between normal brain parenchyma and glioma) and
therefore limits NAA’s predictive value for discriminating between tumor types.
Differential levels of NAA in gliomas, meningiomas, and pituitary tumors were reported
by MRSI and our data supports these previous findings.(18) The mid‐level fusion of lipid
and metabolite profile information did not substantially change the predicted
classification from using the lipids alone supporting the visual similarity of the
metabolite profile. Comprehensively, gliomas, meningiomas, and pituitary tumors can
be distinguished with little ambiguity, suggesting that an unknown sample from one of
these three types of tumor could be chemically recognized by the DESI‐MS lipid and
metabolite profiles.
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4.3.4 Improved Differentiation of Gliomas and Brain Parenchyma via Data Fusion
The best separation of grey and white matter and glioma was obtained when the
lipid and metabolite profiles were considered together using mid‐level data fusion,
Figure 4‐13. Grey matter (N=223), white matter (N=66), and gliomas (N=158), were well
separated and had little intra‐class dispersion. The ions that were important for
differentiating grey matter, white matter, and glioma in the lipid and metabolite profiles
were the same. However, it is clear that improved separation between brain
parenchyma and glioma is achieved when the lipid profile information is use in
conjunction with the metabolites, primarily NAA. Similarly, the lack of separation
between grey and white matter in the metabolite profile is compensated for by the lipid
profile information. PCA followed by LDA was performed to estimate classification
performance when fusing the two MS profiles. The cross‐validation of grey matter,
white matter, and gliomas resulted in an overall sensitivity of 97.4% and specificity of
98.5%, Table 4‐6. The major advantage of using the lipid and metabolite profile is that
the combination appears to more accurately reflect mixed compositions of grey matter,
white matter, and glioma. The two modes appear to compensate for each other
allowing subtler changes to be detected that would otherwise not be reflected in either
the lipid or the metabolite profile, independently.
We further evaluated the fused lipid and metabolite DESI‐MS profiles by
predicting the disease state and estimating the TCP of a pathologically ambiguous
specimen, Figure 4‐14, as an external validation. A false‐color plot of the PC1 scores of
individual pixels revealed a region associated with glioma (red pixels) and a region more

88
closely associated with white matter (blue). Pathologic evaluation of these two regions
was ambiguous with one clearly a glioma and the other being either a diffuse glioma or
an infiltrated region adjacent to the tumor region, qualitatively matching our findings of
two chemically different regions. Further evaluation was performed using PCA‐LDA as
shown in which classified a region of glioma (right) while classifying the adjacent region
as white matter. The region classified by LDA as white matter prompted further
examination for infiltration (because infiltration was not a part of the PCA‐LDA model)
via NAA abundance based estimation of the tumor cell percentage. The estimated TCP
in the glioma region was >75% while the other region had estimated TCP ranging from
approximately 50 to 30%, roughly matching with pathologic evaluation of 60%. This
illustrative example supports that MS profiles, processed using multivariate statistics,
can correctly discriminate gliomas and that they can also be used to detect diffuse and
infiltrative tumors, a particularly critical question during surgical resection.

4.3.5 DESI‐MS Analysis of Neural Tissue Smears
Intraoperative analysis by DESI‐MS is limited by the need for freezing and
generating tissue sections prior to analysis. DESI‐MS analysis of tissue smears is an
attractive alternative to the use of tissue sections. To date, DESI‐MS analysis of tissue
and cytological smears has been only briefly explored.(12, 22) Smears are commonly
performed by placing a minute amount of tissue onto a glass slide and then physically
spreading the material to achieve a relatively uniform and diffuse layer of cellular
material for staining and subsequent pathology. A custom tissue smear device was
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designed to confine the tissue to the middle of the glass slide (along the narrowest
dimension) and smear the tissue along the longest dimension with an approximate
thickness of 100 µm (Figure 4‐15).
Tissue smears were imaged over an area of ~75 mm2, exploring the MS quality
and the homogeneity of the chemical information. The absolute MS signal was generally
equal to that of tissue sections. Importantly, the relative abundances of the ions were
similar between tissue sections and tissue smears. The average metabolite and lipid
profiles of grey matter and gliomas, Figure 4‐16, mirror those of the tissue sections. For
example, the abundance of m/z 834 is notable in the grey matter spectrum and
dramatically reduced in the gliomas. Similarly, the statistical significance of NAA (m/z
174), p<0.001, allows for the discrimination of grey matter and gliomas (Figure 4‐17).
Canonical correlation analysis (CCA)(15) was performed to assess the similarity of the
chemical information obtained from tissue smears and sections, Figure 4‐18. The
correlation coefficients are notable (greater than 0.95) between the first three canonical
variables for both the lipid and metabolite profiles, emphasizing that the physical
change induced by smearing does not influence the chemical information. As a
precaution, it should be mentioned that the sample matrix and associated analytical
effect could influence the data obtained by MS but this effect was not observed in our
experiments. The lipid and metabolite profiles of smears were nearly identical to those
recorded from tissue sections indicating that sectioning can be foregone for more rapid
tissue smear analysis.
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4.4

Conclusions

The application of DESI‐MS in brain cancer resection requires knowledge of the
characteristic chemical features that distinguish brain parenchyma from glioma and
different tumor types from each other and this was explored here for the first time. The
strategy of using MS profiles to characterize tissue differs from the traditional use of
biomarkers in which a single molecule (or ion detected by MS) is used as an indicator of
disease. MS profiles are an integrated representation of downstream metabolism, or
chemotype, and provide important information which extends beyond tissue diagnosis
(e.g. in the case of 2HG it extends to prognosis).
We demonstrated that MS analysis of tissue sections revealed lipid‐derived and
metabolite signals that differ between grey and white matter and gliomas, facilitating
discrimination by multivariate statistics. Difference in the MS profiles revealed the effect
of brain parenchyma upon the signal obtained from glioma samples. This observation is
particularly significant as gliomas frequently invade along white matter tracts,
illustrating the need to understand the contribution of brain parenchyma and infiltration
in predicting disease state. The significance of NAA in discriminating brain parenchyma
and glioma is clear and immense. This study offers strong evidence that NAA is in fact an
oncometabolite and the first in situ detection of NAA by ambient MS. The importance of
NAA in glioma differentiation confirms nearly 20 year old MRSI data. NAA also appears
to be predictive of tumor cell concentration in unknown samples with an exponential‐
like decay in MS signal from brain parenchyma to glioma. Fusion of the lipid and
metabolite MS profiles provided the best discrimination of brain parenchyma (grey and
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white matter) and gliomas with an overall sensitivity of 97.4% and specificity of 98.5%.
Further, the MS profiles proved capable of discriminating tumor types (i.e. glioma,
meningiomas, and pituitary tumors) with a sensitivity and specificity >99%.
Surgical intervention of brain tumors could be simplified with intraoperative
analysis of tissue without extending operative times. Tissue smears were explored which
eliminate the need for tissue freezing and sectioning prior to DESI‐MS. The use of a
custom 3D printed smear device aided in the distribution of tissue during smearing
while maintaining a sufficiently thin smear for DESI‐MS. The observed lipid or
metabolite profiles were not significantly altered by the physical act of smearing and
their signal intensities were comparable to those of tissue sections. Further, the
chemical information obtained from tissue smears was equivalent to those of tissue
sections as determined by CCA.

The validation of tissue smears as samples for

discriminate analysis remains to be fully vetted; however, this work lays the foundation
for implementation of DESI‐MS intraoperatively.
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Figure 4‐1. Average negative ion mode lipid MS profiles (m/z 700 ‐ 1000) of (A) grey
matter (green, N=223), (B) white matter (blue, N=66), and (C) glioma (red, N=158). The
number of ROI is indicated by “N” and is the average spectrum recorded over a 1 mm by
1 mm area (16 pixels). The number of subjects from which the ROI originate is 58.
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Figure 4‐2. Plot of average negative ion mode mass spectra in selected mass windows.
(A) m/z 794, PC 34:1+Cl‐, (B) m/z 834, PS 18:0_22:6, and (C) m/z 888, (3’‐sulfo)GalCer
24:1, of grey matter (green), white matter (blue), and glioma (red). Mean denoted by
solid line with ± standard deviation illustrated by the shaded area between the dotted
lines.

Figure 4‐3. DESI‐MS ion images of specimen 40 with selected lipid ions (maximum
intensity plotted of each nominal m/z): m/z 788, 834, 885, and 888. Ion images are
displayed in false‐color, black to white (smallest to greatest intensity), and normalized
to the maximum intensity of the ion plotted in each panel. Pixel size is 250 μm by 250
μm as defined by the DESI‐MS imaging spatial resolution. H&E stain of analyzed tissue is
shown.
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Figure 4‐4. Chemical difference noted between neuroanatomical regions in specimen 44.
(A) DESI‐MS ion images of m/z 788, 834, and 885. Ion images are displayed in false‐color,
black to white (smallest to greatest intensity), and normalized to the maximum intensity
of the nominal mass of each ion plotted. (B) H&E stain with annotated pathology,
regions of white matter are annotated by pathologist in black marker. (C) Unsupervised
multivariate recognition of the molecular layer, an anatomical substructure within the
cortex (red); grey matter region (green); and white matter region (blue) via interactive
brushing (colored image). (D) Average DESI‐MS spectra obtained from interactive
brushing selections.
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Figure 4‐5. (A) PCA score plot using negative ion mode lipid profile information (m/z
700‐1000) for grey matter (green circles), white matter (blue circles), and glioma (red
circles). (B) PCA loading plot with m/z annotated.
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Figure 4‐6. Average negative ion mode metabolite MS profiles (m/z 80 ‐ 200) of (A) grey
matter (green, N=223), (B) white matter (blue, N=66), and (C) glioma (red, N=158). The
number of ROI is indicated by “N” and is the average spectrum recorded over a 1 mm by
1 mm area (16 pixels). The number of subjects from which the ROI originate is 58.
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Figure 4‐7. Statistical significance and identification of N‐acetyl‐aspartic acid, m/z 174 in
the negative ion mode. (A) Box and whisker plot for m/z 174, NAA (structure inset):
grey matter (GM), N=223; white matter (WM), N=66; glioma (G), N=158; pituitary (P),
N=154; and meningioma (M), N=111. The box represents the interquartile range with
median line and whiskers ±1.5 standard deviation with outliers represented by circles.
(B) Detection of NAA by high resolution MS in grey matter (upper) and high grade
glioma (lower) in specimen 51. Mass‐to‐charge and resolution are annotated. (C) CID‐
MS/MS fragmentation pattern obtained for NAA from grey matter in specimen 51.
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Figure 4‐8. Receiver operating characteristic (ROC) curve of m/z 174 for brain
parenchyma and glioma. The TIC normalized MS abundance collected in the negative
ion mode metabolite profile was analyzed. The area under the curve was 0.998.
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Figure 4‐9. Specimen 20, negative ion mode DESI‐MS ion images for m/z 89, 174, 281,
303, 788, 834, and 885. Ion images are compiled from metabolite (m/z 80 ‐ 200) and
lipid profiles (m/z 700 ‐1000), displayed in false‐color, black to white (smallest to
greatest intensity), and normalized to the maximum intensity of the ion plotted in each
panel. H&E shows a region of cauterized tissue on the left and invasive meningioma on
right with adjacent grey matter in between. Inset depicts the boundary between grey
matter and meningioma.
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Figure 4‐10. (A) PCA score plot using only negative ion mode metabolite profile
information (m/z 80 ‐ 200) for grey matter (green circles), white matter (blue circles),
and glioma (red circles). (B) PCA loading plot with m/z annotated. Note the good
separation of glioma but poor separation of grey and white matter from each other.

Figure 4‐11. (A) The TIC normalized NAA abundance of grey matter, white matter, and
glioma samples plotted versus tumor cell concentration. (B) Natural log of the TIC
normalized NAA abundance versus tumor cell concentration with a line of regression
(red line). The equation of the line was calculated as y = ‐ 0.03x + 1.45 with a Pearson’s r
of ‐ 0.89.
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Figure 4‐12. Average DESI mass spectra obtained from tissue sections for different
tumor types. (A) Average lipid MS and (B) metabolite MS for glioma (red), pituitary
tumors (purple), and meningiomas (grey). The primary ions were m/z 747 (PG 34:1), 768
(chloride adduct of PC 32:0), 788 (PS 36:1), 794 (chloride adduct of PC 34:1), 885 (PI
38:4), 89 (lactic acid), 147 (2‐hydroxyglutaric acid), and 174 (n‐acetyl‐aspartic acid).

Figure 4‐13. (A) PCA score plot resulting from mid‐level data fusion of metabolite and
lipid MS profiles. Grey matter (green), white matter (blue), and glioma (red). (B) PCA
loading plot with metabolite ions (red) and lipid ions (blue).
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Figure 4‐14. DESI‐MS predictions for specimen 65 and corresponding H&E. (A) PCA
projection, false‐color, indicates PC1 score values. (B) Hematoxylin and eosin stain. (C)
PCA‐LDA prediction of class and (D) calculated tumor cell concentration based on NAA
abundance.
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Figure 4‐15. Examples of tissue smears analyzed by DESI and subsequently H&E stained:
(A) specimen 51, (B) specimen 24, (C) specimen 20, (D) specimen 18, and (E) specimen
12.
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Figure 4‐16. (A) Average DESI‐MS lipid and (B) metabolite profile acquired from smears
for grey matter (green), white matter (blue), pituitary (purple), meningioma (grey), and
glioma (red). The primary ions were m/z 737, 747 (PG 34:1), 768 (chloride adduct of PC
32:0), 788 (PS 36:1), 794 (chloride adduct of PC 34:1), 834 (PS 40:6), 885 (PI 38:4), 888
((3’‐sulfo)GalCer 24:1), 89 (lactic acid), 147 (2‐hydroxyglutaric acid), 174 (n‐acetyl‐
aspartic acid), and 179 (C6 sugar).
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Figure 4‐17. Box and whisker plot for m/z 174, NAA (negative ion mode), from the DESI‐
MS analysis of tissue smears. The box represents the interquartile range with median
line and whiskers ±1.5 standard deviation with outliers represented by closed diamonds.

Figure 4‐18. Correlation plot resulting from CCA performed between tissue sections and
tissue smears upon (A) the metabolite MS profile and (B) the lipid MS profile.
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Table 4‐1. Tabulated DESI high resolution mass spectral data and ion identification for
grey matter, white matter, and gliomas
Grey Matter
Name
Lactic acid
2‐hydroxyglutaric acid
N‐acetyl‐aspartic acid
C6 Sugar
Ascorbic acid
Palmitic acid
Oleic acid
Stearic acid
Arachidonic acid
Docosahexaenoic acid
PG 34:1
PE 38:4
PC 32:0
PS 36:1
PC 34:1
PS 40:6
PI 38:4
(3’‐sulfo)GalCer 24:1
(3’‐sulfo)GalCer
24:1(OH)

White Matter

Glioma

Ion

Theoretical
Mass

Mass
Measured

Δ Mass
(ppm)

Mass
Measured

Δ Mass
(ppm)

Mass
Measured

Δ Mass
(ppm)

[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M+Cl]‐
[M‐H]‐
[M+Cl]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐

89.0239
147.0293
174.0402
179.0555
175.0242
255.2324
281.248
283.2637
303.2324
327.2324
747.5176
766.5386
768.5309
788.5441
794.5466
834.5284
885.5493
888.6234

89.0236
‐
174.0399
179.0552
175.0238
255.2322
281.2479
283.2635
303.2322
327.2321
747.5168
766.5382
‐
788.5437
794.5460
834.5279
885.5486
‐

‐3.4
‐
‐1.7
‐1.7
‐2.3
‐0.8
‐0.4
‐0.7
‐0.7
‐0.9
‐1.1
‐0.5
‐
‐0.5
‐0.8
‐0.6
‐0.8
‐

89.0236
‐
174.0399
179.0552
175.0238
255.2324
281.248
283.2636
303.2323
327.2322
747.5174
‐
‐
788.5440
794.5466
‐
885.5492
888.6230

‐3.4
‐
‐1.7
‐1.7
‐2.3
0.0
0.0
‐0.4
‐0.3
‐0.6
‐0.3
‐
‐
‐0.1
0.0
‐
‐0.1
‐0.5

89.0236
147.0288
174.0397
179.055
175.0238
255.2322
281.2479
283.2635
303.2322
327.2321
‐
766.5383
768.5306
788.5437
794.5462
834.5280
885.5486
‐

‐3.4
‐3.4
‐2.9
‐2.8
‐2.3
‐0.8
‐0.4
‐0.7
‐0.7
‐0.9
‐
‐0.4
‐0.4
‐0.5
‐0.5
‐0.5
‐0.8
‐

[M‐H]‐

904.6182

‐

‐

904.6181

‐0.1

‐

‐
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Table 4‐2. Tabulated DESI high resolution mass spectral data and ion identification in
meningiomas and pituitary tumors
Name
Lactic acid
2‐hydroxyglutaric acid
N‐acetyl‐aspartic acid
C6 Sugar
Ascorbic acid
Palmitic acid
Oleic acid
Stearic acid
Arachidonic acid
Docosahexaenoic acid
PG 34:1
PE 38:4
PC 32:0
PS 36:1
PC 34:1
PS 40:6
PI 38:4
(3’‐sulfo)GalCer 24:1
(3’‐sulfo)GalCer 24:1(OH)

Ion
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M+Cl]‐
[M‐H]‐
[M+Cl]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐
[M‐H]‐

Theoretical
Mass
89.0239
147.0293
174.0402
179.0555
175.0242
255.2324
281.248
283.2637
303.2324
327.2324
747.5176
766.5386
768.5309
788.5441
794.5466
834.5284
885.5493
888.6234
904.6182

Meningioma
Δ
Mass
Mass Measured
(ppm)
89.0235
‐4.5
‐
‐
‐
‐
179.055
‐2.8
‐
‐
255.2323
‐0.4
281.2479
‐0.4
283.2635
‐0.7
303.2322
‐0.7
‐
‐
‐
‐
766.5381
‐0.7
‐
‐
788.5436
‐0.6
794.5461
‐0.6
‐
‐
885.5486
‐0.8
‐
‐
‐
‐

Pituitary Tumor
Δ
Mass
Mass Measured
(ppm)
89.0236
‐3.4
‐
‐
‐
‐
179.0551
‐2.2
175.0239
‐1.7
255.2323
‐0.4
281.2479
‐0.4
283.2636
‐0.4
303.2322
‐0.7
‐
‐
747.5172
‐0.5
766.5383
‐0.4
‐
‐
788.5440
‐0.1
794.5456
‐1.3
‐
‐
885.5488
‐0.6
‐
‐
‐
‐

Table 4‐3. Negative ion mode lipid profile PCA‐LDA confusion matrix (5 deletion groups)
for grey matter, white matter, and glioma with calculated sensitivity and specificity for
each class.

DESI

Grey Matter
White Matter
Glioma
Sensitivity (%)
Specificity (%)

Grey Matter
208
2
13
93.3
95.8

Histopathology
White Matter
0
66
0
100.0
96.9

Glioma
9
9
140
88.6
95.5
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Table 4‐4. Negative ion mode metabolite profile PCA‐LDA confusion matrix (5 deletion
groups) for grey matter, white matter, and glioma with calculated sensitivity and
specificity for each class.

DESI

Grey Matter
White Matter
Glioma
Sensitivity (%)
Specificity (%)

Histopathology
Grey Matter
White Matter
129
25
86
38
8
3
57.8
57.6
88.6
76.7

Glioma
0
1
157
99.4
93.8

Table 4‐5. Negative ion mode lipid profile PCA‐LDA confusion matrix (5 deletion groups)
for glioma, meningioma, and pituitary tumors with calculated sensitivity and specificity
for each class.

DESI

Glioma
Meningioma
Pituitary
Sensitivity (%)
Specificity (%)

Glioma
155
3
0
98.1
100.0

Histopathology
Meningioma
0
111
0
100.0
99.0

Pituitary
0
0
154
100.0
100.0

Table 4‐6. Mid‐level fusion PCA‐LDA confusion matrix (5 deletion groups, 2 principal
components) for grey matter, white matter, and glioma with calculated sensitivity and
specificity for each class.

DESI

Grey Matter
White Matter
Glioma
Sensitivity (%)
Specificity (%)

Histopathology
Grey Matter
White Matter
218
0
1
66
4
0
97.8
100.0
99.1
97.9

Glioma
2
7
149
94.3
98.6
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CHAPTER 5.

FUSION OF POSITIVE AND NEGATIVE ION MODE LIPID PROFILES FOR
DIFFERENTATION OF HUMAN BRAIN CANCER

5.1

Introduction

Ambient ionization mass spectrometry (MS) has the potential to improve tissue
diagnosis and influence outcomes in patients undergoing surgical removal of cancer.
Ambient ionization MS provides the opportunity to study biopsied tissue rapidly
(seconds to minutes) and with minimal sample preparation (1). Currently, pathologic
diagnosis of gliomas, the most common malignant brain tumor, is performed upon
formalin‐fixed surgical biopsies via histopathology. However, this cannot be done on a
timescale amenable to surgical guidance. Frozen tissue histopathology is performed as
an alternative to provide the surgeon information but can take upwards of 20 minutes
per biopsy. Methodologies for rapid intraoperative molecular diagnosis are sparse, with
noteworthy ongoing interest in Raman spectroscopy (2) and fluorescence (3); mass
spectrometry, too, may meet this need. Several versions of ambient ionization MS have
been tested for clinical applications. They include rapid evaporative MS for in vivo
analysis of liver, lung, and colorectal cancers (4), desorption electrospray ionization
(DESI) for detection of MRI contrast agents within tumors (5) and for analysis of frozen
tissue sections, and substrate‐based ambient ionization analysis of cancerous tissues;
e.g.,

probe

electrospray

ionization

(6)

and

touch

spray

(7,

8).
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Lipids serve many physiological and structural functions and are increasingly being
considered as disease markers in cancer. Previous studies of prostate (7), bladder (9),
kidney (10), breast (11), lymphoma (12), and gastrointestinal cancer (13), amongst
others, have demonstrated that DESI‐MS lipid profiles (m/z values and corresponding
relative ion abundances) in combination with multivariate statistics, allow
differentiation of cancer from normal tissue as corroborated by traditional
histopathologic diagnosis. Further, these lipid profiles are not prone to degradation in
the native atmosphere over the timescale of analysis, and have so far proven to be
sufficiently reproducible, provided the same DESI conditions and solvents are utilized
(14). Lipid profiles acquired by DESI‐MS analysis of human brain tumors have been
studied previously; in particular those acquired in the negative ionization mode have
been exploited for differentiating normal tissue from diseased (15) as well as for
exploring the chemical differences among glioma grade. (16) Glioma subtype and tumor
cell concentrations (i.e., relative percentage of tumor cells compared with normal cells)
was also investigated. (17, 18). Differences in the positive ion mode DESI mass spectra
between different glioma grades was previously noted, (16) but analysis of normal
parenchyma and differentiation from diseased tissue using multivariate statistics was
not undertaken.
Recent studies of oncometabolites in human brain tumors have demonstrated the
usefulness of considering low molecular weight metabolites. Notable examples are 2‐
hydroxyglutaric acid (2‐HG) (19) and N‐acetyl‐aspartic acid (NAA) (15). When the
negative mode lipid profiles and additional sources of chemical information were used
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together, via data fusion, improved differentiation of cancer from normal brain
parenchyma (i.e., grey and white matter) was obtained (15).
This study is founded on the hypothesis that the positive ion lipid profile obtained
with DESI‐MSI will provide complementary chemical information and, in combination
with the negative ion lipid profile, improve differentiation of normal brain parenchyma
and glioma. This manuscript reports sequentially acquired positive and negative ion
mode DESI‐MSI of tissue sections from 39 human subjects. Multivariate statistical
analysis performed upon regions of interest (ROI) revealed that the positive and
negative ion mode data contained differentiating information. Further, the information
in the positive ion mode was nearly equivalent to the negative ion mode in regards to
sensitivity and specificity. This work serves to establish the diagnostic potential of DESI‐
MS information in both the positive and negative ion modes, either or both of which can
be transferred to intrasurgical measurements.

5.2

Experimental

5.2.1 Materials
Banked frozen tissue specimens from 39 human subjects were studied in
accordance with Purdue IRB protocol (#1410015344). Specimens were cryosectioned
(15 μm thickness) and thaw mounted onto glass microscope slides. All tissue sections
were stored at –80°C prior to analysis. Tissue sections adjacent to those used in a prior
study (15) were used in the study of the positive ion mode lipid profiles. Blind pathologic
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evaluation was subsequently performed on all tissue sections analyzed by DESI‐MS. In
most cases, the histopathologic evaluation did not change; however, some areas were
slightly smaller or larger between two tissue sections. Pathology provided disease state
(e.g. grey matter, white matter, or glioma), grade (sometimes), and tumor cell
percentage (TCP).

5.2.2 Methods

5.2.2.1 Positive and Negative Ion Mode Lipid Profiles via DESI‐MS Imaging
DESI‐MSI was performed on a linear ion trap mass spectrometer as described in
5.2.2.1. The mass spectrometer was tuned for maximum transmission of m/z 786
(dioleoylphosphatidylcholine) and 735 (dipalmitoylphosphatidylcholine) in the negative
and positive ion modes, respectively. Dimethylformamide‐acetonitrile (1:1 v/v) was
used for DESI‐MS imaging. DESI source parameters are as follows: solvent flow rate, 1.0
µL min‐1; pressure of nitrogen gas, 160 PSI; applied high voltage, ‐5.0 kV negative mode
and +4.5 kV in the positive mode; incident angle, 52°; spray‐to‐surface distance, 2 ‐ 3
mm; spray‐to‐inlet distance, 5 ‐ 7 mm. In‐source collision energy (35V) was applied in
the positive and negative mode. Images were collected in a series of rows by
coordinating linear motion of the moving stage (431.034 µm s‐1) with MS duty cycle. The
MS duty cycle was defined by the scan parameters: m/z 200‐1000, injection time of 500
ms with 1 microscan, and automatic gain control (AGC) was disabled. A lateral spatial
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resolution (“x”) of 250 µm was defined, upon completion of a row the moving stage
resets to the original “x” position while stepping 250 µm in “y”. This process was
repeated in order to acquire data from the entire tissue surface. The positive‐mode was
chosen first as ions detected were typically sodium or potassium adducts, and by
imaging for positive ions first we minimized any changes in adduct formation due to
prior analysis. Conversely, this was less of a concern in the negative mode as many of
the ions were detected as deprotonated species; however, important chloride adducts
of PCs were also detected (e.g. m/z 794).

5.2.2.2 Data Analysis
ROI were selected in MATLAB (MathWorks, Natick, MA USA) based on
histopathologic review of the tissue after MS analysis; each ROI selection was the
average spectrum of 1 mm (4 pixels) by 1 mm (4 pixels), which permitted accurate
correlation of the spatial and chemical information. The set of tissue used sections
provided 585 ROI; 32 selections were removed as they contained significant amounts of
ions related to Optimal Cutting Temperature Polymer in the spectra (S1 Fig). The
remaining selections were examined by principal component analysis from m/z 700 ‐
1000; the exclusion of lower m/z values improved separation as the lower mass‐to‐
charge signals (e.g., fatty acids) were more variable in intensity. Multivariate statistics
was performed using MATLAB routines and is detailed in the supplementary information.
Tentative attributions of m/z values to specific lipid structures were made based on
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HRMS and MS/MS. The statistical results are independent of lipid identification: only the
full scan mass‐to‐charge value and corresponding MS abundance are considered.

5.3

Results and Discussion

5.3.1 Sequential Positive and Negative Ionization Mode DESI‐MS Imaging
Lipid metabolism has been shown to be significantly different in cancerous and
non‐cancerous cells and tissues due to the roles of lipids in cell growth, membrane
fluidity, cell adhesion, and energy production (20). The analysis of biological specimens
in both MS polarities provides greater coverage of the lipidome; i.e., the totality of lipids
in a cell, tissue, or an organism. The lipids detected in this study are primarily membrane
phospholipids including phosphatidylcholine (PC), phosphatidylethanolamine (PE),
sphingomyelin (SM), ceramide (Cer), phosphatidylserine (PS), phosphatidylinositol (PI),
and sulfatide (ST). Some classes of membrane lipids preferentially ionize in the positive
ion mode (e.g., PC and SM) and others in the negative ion mode (e.g., phosphatidic acids,
PI, and PS) depending largely on the functionality of the polar headgroup (21). We
hypothesize that it is advantageous to maximize the acquired lipid information by
acquiring data in both polarities to characterize different disease states (e.g., cancer) in
order to increase diagnostic accuracy.
Janfelt et al. recently demonstrated acquisition of positive and negative DESI‐MS
data from the same specimen by alternating MS polarity every other line in the imaging
experiment (22). Their solvent system (methanol‐water 19:1) destroys tissue samples
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during analysis, precluding subsequent analysis or staining of the same tissue specimen.
We modified their approach by using morphology preserving solvents (e.g., DMF‐ACN
[1:1]) which allowed the same tissue section to be imaged multiple times using DESI‐MS
and subsequently stained for histopathology. Further, the same tissue section was
analyzed twice in succession, once in the positive and then in the negative ionization
mode, with mass spectra from m/z 200 – 1000 being obtained from each MS image pixel.
The acquisition of data in subsequent images, as opposed to line‐by‐line polarity
switching (22), reduces problems that might arise from incomplete charge equilibration
and thus spray stability is improved.
Representative DESI‐MS ion images for an illustrative specimen, 3003EPE, are
reported in Figure 5‐1. Specimen 3003EPE is comprised of a glioma region near the
bottom of the tissue section with adjacent grey and white matter regions, determined
by histopathology, and marked approximately in Figure 5‐1. Particular ions were
relatively more abundant in different histological regions; for example, m/z 798 ([PC
34:1 + K]+), 848 ([GalCer d32:2 + K]+), and 772 ([PE P‐38:5 + Na]+), in the positive ion
mode (Figure 5‐1) appear to be relatively more abundant in grey matter, white matter,
and glioma, respectively. The selected ion images are a small sampling of the many ions
that appear to be differentially abundant in the different histologic regions. Negative
ions characteristic of grey matter (m/z 834, PS 40:6), white matter (m/z 888, (3’‐
sulfo)GalCer 24:1), and glioma (m/z 794, chloride adduct of PC 34:1) were also observed
at different abundances (Figure 5‐1). The distributions of m/z 834 and m/z 888 in grey
and white matter, respectively, agree with prior DESI‐MSI studies of human (15) and
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other mammalian brains (23), as well as other ambient ionization methods such as
scanning probe electrospray ionization (24). The combination of the positive and
negative mode ion images provided visually distinct regions which matched well with
histopathologic evaluation.

5.3.2 Positive Ion Mode Lipid Profiles of Human Brain Matter and Gliomas
The average positive mode lipid profiles for grey matter, white matter, and
glioma are visually different (Figure 5‐2, respectively). Grey matter is associated with a
greater abundance of m/z 772 ([PC 32:0 + K]+) and 798 ([PC 34:1 + K]+). White matter
appears to have greater abundances of m/z 750 ([GalCer d36:1 + K]+ and [PE P‐36:2 +
Na]+), 832 ([GalCer d32:2 + Na]+), and 848 ([GalCer d32:2 + K]+). Interestingly, gliomas
appear to have greater abundances of m/z 754 ([PC 32:1 + Na]+), 756 ([PC 32:0 + Na]+),
and 782 ([PC 34:1 + Na]+). Tentative identifications were based on high resolution MS
and MS/MS, Table 5‐1. The data show that in some cases multiple lipid species are
present in a single nominal mass peak (e.g., m/z 750, [PE P‐36:2 + Na]+), while other
peaks are principally due to a single lipid species (e.g., m/z 754, [PC 32:1 + Na]+). The
measured profiles were consistent within classes given potential biological and
analytical variation. The differences between classes were typically greater than the
standard deviation of the average spectrum for ions important in distinguishing the class.
The observed increase in total PC abundance is consistent with magic angle spinning
nuclear magnetic analysis of glioma tissue (25) and reported changes in PC metabolism.
(26, 27) A greater abundance of SMs and ceramides in white matter versus grey matter
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has also been reported (28). Plasmalogens (e.g., 750) have been reported to compose
approximately 50% and 85% of the PE fraction in grey and white matter, respectively (29,
30). In addition, multiple metal adducts of the same lipid (e.g., m/z 782 and 798) were
detected and are likely due to differences in the concentration of the adducting species
(e.g., Na+ and K+) and that of the analyte (e.g., PC 34:1), matrix effects, and intrinsic
ionization efficiency differences. Regardless, the differences in ion abundance are
consistent between classes and appear to differentiate normal parenchyma from glioma.
The positive ion mode data were analyzed by principal component analysis (PCA),
an unsupervised multivariate statistical method, resulting in separation of grey matter
(green points), white matter (blue points), and glioma (red points) (Fig 2). Separation of
the groups in the PCA score plot of principal component 1 (PC1) vs PC2 (Figure 5‐2) was
less clear than separation in the PCA score plot of PC2 vs PC3 (Fig 2F). The ions
contributing to the observed separation in the PCA score plot are displayed in the
corresponding PCA loading plots (Figure 5‐2). The ions displayed in the PCA loading plots
recapitulate differences in the average mass spectra for grey matter, white matter, and
gliomas (Fig 2A–C, respectively). Linear discriminant analysis (LDA) was performed after
compression of the variables by PCA to estimate the predictive ability of the positive
ionization mode DESI‐MSI data. PCA‐LDA cross validation (six principal components, five
deletion groups) resulted in an average sensitivity and specificity of all classes (grey
matter, white matter, and glioma) of 93.2% and 96.6%, respectively. The sensitivity and
specificity of each class is tabulated in Table 5‐2. These values only provide an estimate
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of prediction performance; a study with a larger sample set is required for further
validation but is beyond the scope of this paper.

5.3.3 Negative Ion Mode Lipid Profiles of Human Brain Matter and Gliomas
The presence of m/z 834 ([PS 40:6 – H]–) and 888 ([3′‐sulfo GalCer 24:1 – H]–) are
indicative of grey and white matter, respectively (Figure 5‐3). Additional predominant
ions include m/z 788 (PS 36:1), 794 ([PC 34:1 + Cl]–), 885 (PI 38:4), and 906 ((3′‐sulfo)
GalCer 24:0(2OH)). Gliomas appear to have suppressed levels of m/z 834 and 888
relative to the grey and white matter average spectra, and therefore appear to have a
visually distinct lipid profile (Figure 5‐3). Tentative identifications are based on
previously published results (15, 17). PCA was performed on the negative ionization
mode DESI‐MSI data, and the resulting score and loading plots are displayed in Figure
5‐3. The separation of grey matter (green points), white matter (blue points), and
glioma (red points) as well as their lipid profiles are consistent with previous results (15)
which utilized the same tissue specimens. The similarity of the results is encouraging
because analyses were performed one year apart. The continuum of points observed
between the main grey and white matter groupings in the PCA score plot of Figure 5‐3,
reflect mixtures of grey and white matter that are present in normal neuroanatomy (31).
Similarly, the points which fall in between the normal parenchyma and glioma groupings
represent glioma infiltration into adjacent matter which is well known (32, 33). Points
(ROIs) falling in between the main groups had convoluted lipid profiles and support the
presence of mixed compositions of grey, white matter, and glioma. For example, Figure
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5‐4 shows an illustrative mass spectrum for a mixture of grey and white matter. In spite
of the continuum between grey matter, white matter, and glioma, good separation is
observed in additional PCA score plots; e.g., PC2 vs PC3 (Figure 5‐3). The PCA loading
plots (Figure 5‐3) display the importance of specific ions in the separations seen in the
PCA score plots.
Negative ionization mode PCA‐LDA cross validation (six PCs, five deletion groups)
resulted in an average sensitivity of 94.1% and specificity of 97.4%. The sensitivity and
specificity of individual classes can be found in Table 5‐3. The average values are
consistent with unreported PCA‐LDA results from our prior study which lie within ~5%
(15). Overall, the average positive and negative ionization mode sensitivity and
specificity values are similar and appear to be equivalently useful in separating grey
matter, white matter, and gliomas. The notable differences when comparing the classes
individually are as follows: the sensitivity of gliomas in the positive mode was higher
than the negative mode (93.0% versus 88.1%), respectively, while the sensitivity of
white matter was lower (89.8%, positive mode, versus 95.9%, negative mode). The
specificity of grey matter was greater in the negative mode than the positive mode (98.8%
versus 92.2%); the specificity of white matter was higher in the positive mode, 99.7%,
than in the negative mode, 93.9%. Comparison of the positive and negative mode cross
validation results show that each mode provides complementary diagnostic information,
while the average sensitivity and specificity of all classes are similar.
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5.3.4 Fusion of Positive and Negative Mode Lipid Profiles
Midlevel data fusion was applied considering the first six principal components.
PCA of the fused data resulted in clearer separation of grey matter, white matter, and
glioma, as shown in Figure 5‐5. The improved separation reduced overlap between the
groupings (e.g., grey matter and glioma). Separation was also noted in additional PCA
score plots (Figure 5‐7). Interestingly, the glioma class was split into two subgroups, one
closely associated with the white matter group and one more closely associated with
the grey matter group (approximately delineated left‐to‐right at a PC1 score of 0 in
Figure 5‐5). The glioma subgroups were not apparent in the positive or negative mode
lipid profiles individually or in our prior study in which data for the lipids and
metabolites in the negative ion mode were fused (15). The ROIs of each glioma
subgroup were averaged and are displayed in Figure 5‐6. The negative mode lipid profile
of the grey matter–associated glioma subgroup was similar to previously reported
glioma profiles (15, 18) and contained neither m/z 834 nor 888 at any appreciable
abundance. The negative mode lipid profile of the white matter–associated glioma
subgroup was similar to the negative mode white matter lipid profile. The positive mode
lipid profiles for the two subgroups were visually different from those of normal grey
and white matter. The PCA loading plot (Figure 5‐5) offers a basic understanding of the
correlation between positive and negative ions; vectors of similar direction indicate a
positive correlation; e.g., m/z 798 (positive mode) and 834 (negative mode) are
important in separating grey matter. Similarly, m/z 832 (positive mode) and 888
(negative mode) are important in separating white matter. The loading plot does not
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reveal deeper relationships (e.g., biological reason) for the correlation between ions,
only that they are correlated in separating the groups.
PCA‐LDA was performed on the fused data (six principal components, five
deletions groups) and resulted in the following cross validation results (Table 5‐4). The
average sensitivity and specificity of all classes was 94.7% and 97.6%, respectively.
These values are not substantially different than the positive or negative mode
separately. However, the sensitivity and specificity of individual classes was improved
with no value falling below 90%. Fusion of the data in some cases did slightly decrease
the sensitivity or specificity of individual classes compared to the positive or negative
mode results; e.g., specificity of white matter: fused (95.1%), positive mode (99.7%),
and negative mode (93.9%). The PCA‐LDA results support that information in the
positive and negative lipid profiles are complementary and aid in more confidently
distinguishing grey matter, white matter, and glioma.

5.3.5 DESI‐MS Detection of Tumor Cell Percentage
Tumor cell percentage (TCP), previously dubbed tumor cell concentration, is a
means by which to measure glioma infiltration. Its interrelationship with the lipid
profiles is poorly understood except that it is partially responsible for the spread of
points in the PCA score plots between groupings. The TCP, estimated via histopathology,
was plotted (Figure 5‐8); the PCA score plot indicated that the majority of the grey
matter associated glioma subgroup was of medium to high TCP (regions defined as
33%<x<67% and >67%, respectively) whereas the white matter associated glioma
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subgroup was comprised of ROIs with low (<33%) to medium TCP. The grey matter
associated glioma subgroup was better separated than the white matter associated
glioma subgroup from their respective normal groupings, potentially the effect of a
relatively higher TCP. Further, tumor grade and TCP are not completely independent as
gliomas of higher grade (WHO III and IV) tend to have greater TCP; differences between
tumor grades, plotted in Figure 5‐8, cannot be commented upon in this study due to the
low number of low grade gliomas (WHO I and II).
The complex nature of the molecular diagnosis of gliomas is illustrated in
specimen 3003KDE which contained regions of different TCP (40–60%). Illustrative ROI
mass spectra are displayed in Figure 5‐9. The positive and negative spectra of the ROI
associated with 60% TCP is less reminiscent of white matter than the spectra from the
40% TCP region. The ROIs of 3003KDE were projected onto the fusion PCA score plot
(Figure 5‐10) using a technique similar to that described in Bagnaso et al. (34) The ROIs
associated with lower TCP in 3003KDE were projected within the white matter group
while the ROIs associated with 60% TCP were projected within the white matter–
associated glioma subgroup. Similarly, specimen 3003ETP, a heterogeneous tissue
section, was comprised of a higher TCP glioma region (~80%) and a lower density tumor
(10% TCP) in mostly grey matter (one small area of white matter was also present)
(Figure 5‐11). The ROI associated with the 80% TCP region of 3003ETP lay within the
grey matter associated glioma subgroup, while the ROI associated with the 10% TCP
grey matter region lay within the grey matter group. Note, ROI 13 lay between the grey
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matter and white matter groups and corresponds to a selection near a grey and white
matter boundary.
Lipid changes associated with glioma, detected in the positive and negative mode
lipid profiles, appear to be too attenuated to be a useful discriminator in areas of lower
tumor cell percentage. Given that the future objective of this work is to assist in surgical
resection, it is necessary to measure TCP levels at the surgical resection margin which
may be in the 10–40% range, although no current information exists as to the actual
proportion of tumor cells at the surgical margin. Current practice determines resection
completeness via contrast enhanced MRI, which is an improvement over visual
inspection (35); however, this methodology relies on uptake of radiocontrast agent, can
be confounded by intracranial volume changes, and cannot be used to interrogate
specific regions that the neurosurgeon finds pathologically suspicious. For glioblastoma
patients, there is controversy as to the effect of completeness of tumor resection and
patient survival because the infiltrative nature of glioblastoma renders total surgical
resection an impossible task with current surgical techniques (36). Even in tissues that
appear histologically normal, malignant glioma cells can be isolated and cultured.
Indeed, the site of tumor recurrence is often within two centimeters of the resection
margin from non‐enhancing areas observed in MRI (37, 38). However, studies have
shown that near‐total tumor resection for low grade glioma patients significantly
increases patient survival and time to malignant progression (39, 40). Optimization and
evaluation of the DESI‐MS methodology to assist the surgeon in checking discrete areas
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within the operative field for residual tumor, via the determination of TCP based on
DESI‐MS lipid profiles, is the subject of future work.

5.3.6 DESI‐MS Analysis of Morphologically Effaced Tissue Sections
DESI‐MSI could also be used to complement glioma diagnosis (particularly on
frozen sections) as tumors commonly efface normal tissue morphology such that the
background parenchyma cannot be definitively identified. For example, we found in
specimen 3003UVH that the DESI‐MS data could be used to determine the background
parenchyma when histopathology was inconclusive (Figure 5‐12). Chemically, it was
quite clear that the background parenchyma of specimen 3003UVH was white matter
due to the presence of m/z 888. Such lipid information provided by DESI‐MSI could be
useful in clarifying current histopathologic evaluation and potentially enhance detection
of glioma infiltration in tissue sections.

5.4

Conclusions

The serial acquisition of DESI‐MS images in the positive and negative modes
provided spatial and chemical information (i.e., lipid profiles) that differentiated human
grey matter, white matter, and gliomas. The positive ion mode lipid profiles are
reproducible and allow differentiation of grey matter, white matter, and gliomas with an
average sensitivity and specificity of 93.2% and 96.6%, respectively. The inclusion of
normal brain parenchyma samples and differentiation via multivariate statistics expand
upon prior work which explored the differences in the positive mode lipid profile
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between different glioma grades and subtypes (16). The positive ion mode lipid profiles
yielded approximately the same differentiation ability as the negative ion lipid profiles.
The repeatability of the acquired lipid profiles is illustrated by the similarity of the
negative ion mode PCA, average mass spectra, and PCA‐LDA cross validation results with
that of a prior study (15). Our hypothesis was supported as the complementary
chemical information obtained from the positive and negative mode analyses slightly
improved PCA separation of grey matter, white matter, and glioma when used together
via data fusion. The fused data analyzed by PCA‐LDA provided an average sensitivity of
94.7% and specificity of 97.6%, and the individual class values all exceeded 90%.
Diagnosis of effaced glioma tissue specimens is complex, but DESI‐MS lipid profiles were
able to suggest, chemically, the background matter in such specimens. It is foreseeable
that providing pathologists with supplemental DESI‐MSI information would increase
their diagnostic confidence. Regarding use in the surgical resection of gliomas, we
observed the influence of glioma infiltration (assessed as TCP) on the lipid profiles and
discussed the possible uses and limitations of this measurement. The limited ability of
the lipid profiles to determine lower TCP emphasizes the need for further improvement
to the current DESI‐MS and multivariate statistical methods. One candidate solution is
to combine the negative and positive ion mode lipid profiles with chemical
measurements of oncometabolites, such as NAA, that distinguish normal and cancerous
neural tissue with high sensitivity and specificity. We envision that the intraoperative
use of DESI‐MS, collecting positive and negative mode lipid and metabolite data, will
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comprise an ex vivo tool to check discrete areas of tissue which are pathologically
ambiguous by visual inspection, potentially augmenting current surgical practice.
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Figure 5‐1. (A) Representative positive ionization mode ion images of specimen 3003EPE
and (B) representative negative mode ion images. The false‐color ion images are scaled
to the greatest intensity of the ion plotted in each image, the scale bar indicates the
absolute MS abundance (counts) detected. Scanned H&E‐stained tissue sections with
regions of grey matter (GM), white matter (WM), and glioma (G) approximated based
on histopathology.

Figure 5‐2. Average positive ion mode DESI spectra (m/z 700 – 1000) for (A) grey matter,
n=223; (B) white matter, n=98; and (C) gliomas, n=185. (D and F) PCA score plots: grey
matter (green), white matter (blue), and glioma (red). (E and G) PCA loading plots with
ion m/z annotated.
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Figure 5‐3. Average negative‐mode DESI spectra (m/z 700 – 1000) for (A) grey matter,
n=223; (B) white matter, n=98; and (C) gliomas, n=185. (D and F) PCA score plots and
corresponding (E and G) PCA loading plots. Grey matter, white matter, and glioma are
green, blue, and red in the PCA score plot, respectively. The m/z of each ion is
annotated in the PCA loading plot.
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Figure 5‐4. Illustrative (A) negative and (B) positive ion mode DESI‐MS spectra (m/z 700
– 1000) from a ROI of mixed grey and white matter composition. Both m/z 834 and 888
are abundant in the negative ion mode. Similarly, the positive mode lipid profile appears
to be a combination of grey and white matter.

Figure 5‐5. (A) Midlevel data fusion PCA score plot (m/z 700 – 1000) and (B) loading
plots. Score plot symbols: Grey matter, n=223 (green); white matter, n=98 (blue); and
glioma (red), n=185. Loading plot values: negative mode (blue) and positive mode (red).
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Figure 5‐6. (A) Negative and (B) positive mode average of the white matter associated
glioma subgroup. (C) Negative mode average of the grey matter associated glioma
subgroup. (D) Positive mode average of the grey matter associated glioma subgroup.
Major ions are annotated.

Figure 5‐7. (A) Mid‐level data fusion PCA score plot (m/z 700 – 1000), PC2 vs PC3, and (B)
loading plots. Score plot symbols: Grey matter, n=223 (green); white matter, n=98 (blue);
and glioma (red), n=185. Loading plot values: negative‐mode (blue) and positive‐mode
(red).
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Figure 5‐8. (A) PCA score plot (m/z 700 – 1000), PC1 vs PC3, for tumor cell percentage
(TCP): n/a (yellow), normal grey or white matter; low (orange), <33%; medium (red),
33%<x<67%; high (dark red), >67%. (B) PCA score plot for glioma grade: n/a (blue
heather), normal grey or white matter; low grade (light blue), glioma WHO grade I or II;
high grade (dark blue), glioma WHO grade III or IV.
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Figure 5‐9. (A) Negative and (B) positive ion mode lipid profiles (m/z 700 – 1000) of ROI
#1 with 40% TCP. (C) Negative and (D) positive ion mode lipid profiles of ROI #5 with 60%
TCP. Note, that the 40% TCP spectra look more reminiscent of normal white matter
while the 60% TCP spectra appear more like the white matter associate glioma subgroup,
e.g. altered ratio between m/z 794 ([PC 34:1 + Cl]‐) and m/z 888 ((3’‐sulfo)GalCer 24:1))
in the negative ion mode and altered ratio of m/z 798 ([PC 34:1 + K]+ or [PE P‐40:6 + Na]+)
and m/z 848 ([GalCer d32:2 + K]+) in the positive mode.
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Figure 5‐10. (A) Mid‐level data fusion PCA score plot (m/z 700 – 1000), PC1 vs PC3, with
ROI of 3003KDE projected (black squares). The points annotated correspond to specific
ROIs indicated on the H&E stained tissue in (B). Score plot symbols: Grey matter, n=223
(green); white matter, n=98 (blue); and glioma (red), n=185.
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Figure 5‐11. (A) Mid‐level data fusion PCA score plot (m/z 700 – 1000), PC1 vs PC3, with
ROI of 3003ETP projected (black squares). Score plot symbols: Grey matter, n=223
(green); white matter, n=98 (blue); and glioma (red), n=185. (B) ROI are annotated upon
the H&E stained tissue section. (C‐E) Selected negative ion mode ion images of m/z 834
(PS 40:6), 885 (PI 38:4), and 888 ((3’‐sulfo)GalCer 24:1), respectively, plotted in false‐
color with corresponding scale bar (absolute MS abundance). Note, the regions of
predominately normal grey (m/z 834) and white (m/z 888) contain approximately 10%
tumor cells.
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Figure 5‐12. (A) Negative and (B) positive ion mode lipid profile (m/z 700 – 1000) from a
specimen 30003UVH that was effaced, morphologically. The spectra appear similar to
that of white matter (via m/z 888 detection) and suggest the background parenchyma is
white matter.

Table 5‐1. HRMS and MS/MS data for selected ions detected in positive mode DESI‐MSI
of brain tissue and glioma specimens.
Theoretical Mass
(Monoisotopic)
750.5408

Measured
Mass
750.5407

Mass Error
(ppm)
‐0.1865

Major MS2 Fragment Ions

MS3 Fragment Ions

707 (‐43)

707‐>609, 587, 441

750.5854

750.5855

0.1332

588‐>570

[PC(32:1)+Na]+

754.5357

754.5362

0.6627

732 (‐18), 588 (‐162), 570
(‐180)
695 (‐59), 571 (‐183)

695‐>571, 549

+

756.5514

756.5530

2.1149

697 (‐59), 573 (‐183)

697‐>573, 551

772.5253

772.5281

3.6245

713 (‐59)

713‐>589, 551

772.5252

772.5281

3.7125

729 (‐43)

729‐>631, 489

Tentative Ion
Identification
[PE(P‐36:2)+Na]+
[GalCer(d36:1)+Na]

[PC(32:0)+Na]
[PC(32:0)+K]

+

+

[PE(P‐38:5)+Na]+
+

782.5670

782.5679

1.1705

723 (‐59)

723‐>599, 577

[PC(34:1)+K]+

798.5410

798.5415

0.6224

739 (‐59), 615 (‐183)

739‐>615, 577

[PE(P‐40:6)+Na]+

798.5408

798.5415

0.8728

755 (‐43)

755‐>657, 487

[PC(34:1)+Na]

[PC(36:2)+Na]

+

808.5827

808.5851

3.0226

749 (‐59), 625 (‐183)

749‐>625, 603

[GalCer(d32:2)+Na]+

832.6636

832.6642

0.6701

670‐>652

[GalCer(d32:2)+K]+

848.6376

848.6390

‐1.5979

814 (‐18), 670 (‐162), 652
(‐180)
686 (‐162), 668 (‐180)

686‐>668
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DESI

Table 5‐2. Positive ion mode PCA‐LDA confusion matrix (six principal components, five
deletion groups) for grey matter, white matter, and glioma with calculated sensitivity
and specificity for each class.

Grey matter
White matter
Glioma
Sensitivity (%)
Specificity (%)

Grey matter
216
1
6
96.9
92.2

Histopathology
White matter
9
88
1
89.8
99.7

Glioma
13
0
172
93.0
97.7

DESI

Table 5‐3. Negative ion mode PCA‐LDA confusion matrix (six principal components, five
deletion groups) for grey matter, white matter, and glioma with calculated sensitivity
and specificity for each class.

Grey matter
White matter
Glioma
Sensitivity (%)
Specificity (%)

Histopathology
Grey matter
White matter
219
2
4
94
0
2
98.2
95.9
98.8
93.9

Glioma
1
21
163
88.1
99.4

Table 5‐4. Data fusion PCA‐LDA confusion matrix with calculated sensitivity and
specificity for grey matter, white matter, and glioma. The average sensitivity, 94.7%, and
specificity, 97.6%, is the mean of the values for the individual classes.

DESI

Histopathology

Grey matter
White matter
Glioma
Sensitivity (%)
Specificity (%)

Grey
matter
216
5
2
96.9
98.9

White matter
2
94
2
95.9
95.1

Glioma
1
15
169
91.4
98.7
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CHAPTER 6.

INTRASURGICAL ANALYSIS OF HUMAN GLIOMAS BY DESORPTION
ELECTROSPRAY IONIZATION – MASS SPECTROMETRY

6.1

Introduction

A primary treatment for brain cancer is surgery, where the goal is to maximize the
extent of tumor resection while minimizing neurological damage. (1) Reliable intrasurgical
tools, i.e. within the operating room, for near real time tissue diagnosis are lacking. Mass
spectrometry might provide rapid intrasurgical determination of disease state, i.e. normal
versus tumor, at discrete points near the surgical margin. (2) Frozen section
histopathology remains the gold standard for obtaining intrasurgical information such as
type of tumor (e.g. glioma) and grade (e.g. low grade). This information is currently
obtained outside of the operating room taking upwards of 20 minutes per sample which
includes sectioning, staining, and expert interpretation. Tissue smears, in addition to
tissue sections, are used currently to obtain pathologic information from surgical biopsies
during tumor resection. Smears are used when rapid pathologic feedback is beneficial
during surgical resection of tumors. However, pathologic evaluation of tissue smears is
inherently less accurate than frozen tissue sections due to some loss of morphological
information. (3) Ambient ionization ‐ mass spectrometry (MS) allows rapid acquisition of
molecular information from tissue. The application of ambient ionization– MS in surgery
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is divided between offline and online approaches. (2) The offline approach follows current
protocols, e.g. biopsy, but inserts MS measurement in the sequence prior to
histopathology Ideally, analysis is transparent to morphology/cytology allowing for
subsequent analysis by pathology – improving correlation via supporting pathology. One
alternative online approach, the iKnife or intelligent scalpel, rapidly acquires MS data in
vivo but is destructive so cannot be corroborated by pathology. (4) Regardless of the MS
method, the chemical information provided is crucial in decision‐making and both
procedures have potential surgical applications.
Human brain tumors have been studied using desorption electrospray ionization
(DESI) – MS imaging since 2010. (5‐8) More recently, the ability to differentiate normal
brain matter from tumors (glioma, meningioma, and pituitary tumor) was demonstrated
using frozen tissue sections and tissue smears. (9) DESI‐MS analysis of tissue smears is a
substantial departure from DESI‐MS imaging which requires tissue freezing and sectioning
prior to analysis. The lipid and metabolite MS profiles acquired from tissue smears are
highly similar to those acquired from tissue sections. (9) A DESI‐MS method and
intrasurgical MS system, one that is used within the operating room, has been developed
that rapidly analyzes (<3 minutes per sample) tissue smears. DESI‐MS predicted disease
state, i.e. normal or tumor, was compared to pathologic evaluation performed on the
same sample analyzed. Additionally, tumor cell percentage (TCP), i.e. relative amount of
tumor cells compared to normal cells, was predicted via DESI‐MS measurement of N‐
acetyl‐aspartic acid (NAA) and compared with pathology. The preliminary data from the
first four cases are discussed.
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6.2

Experimental

6.2.1 Human Subjects
Subjects were enrolled in an IRB approved study (IU #1410342262) in which
biopsied tissue, removed following standard protocols, was analyzed intrasurgically at
Indiana University Health Methodist Hospital in Indianapolis, IN. Tissue biopsies were
provided by the surgeon, Dr. Aaron A. Cohen‐Gadol; the location (stereotactic position)
and location relative to the tumor resection was annotated, e.g. frontal margin. Magnetic
resonance imaging data was collected in accordance with regulations and following HIPPA
authorization.

6.2.2 Methods

6.2.2.1 Intrasurgical DESI Mass Spectrometer
We assembled and modified a commercial linear ion trap mass spectrometer (LTQ,
Thermo) such that the following features, not available in commercial instruments, have
be added for use in the operating room: encasement of the entire system (MS, vacuum
pumps, computer, etc.) using a stainless steel surface that can be sanitized, additional
vacuum pump noise reduction, integrated computer system with sealed keyboard, and
enclosed custom DESI ion source, including custom moving stage, small nitrogen and
helium gas tanks with regulators, and power converter (240 to 120V). Further, the custom
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DESI source is encased by an electrostatic dissipative housing that reduces solvent vapor
release and functions as a high voltage safety barrier.

6.2.2.2 Tissue Smearing and DESI‐MS Analysis
Biopsied tissue was smeared on a glass microscope slide using a 3D printed device,
illustrated in Figure 6‐1, detailed in Jarmusch et al. (9) The smeared tissue was then
immediately analyzed by DESI‐MS. DESI‐MS was performed using equal parts
dimethylformamide‐acetonitrile (v/v) which preserved tissue morphology for subsequent
pathology. (10) Additional source parameters are as follows: AGC activated, solvent flow
rate, 1.0 µL min‐1; pressure of nitrogen gas, 160 PSI; ±5.0 kV (depending on ionization
mode); incident angle, 52°; spray‐to‐surface distance, 2 ‐ 3 mm; spray‐to‐inlet distance, 5
‐ 7 mm. Each tissue smear was analyzed by DESI‐MS collecting five different types of mass
spectra, i.e. negative mode lipid profile, negative mode metabolite profile, MS/MS of N‐
acetyl‐aspartic acid, MS/MS of 2‐hydroxyglutaric acid, and positive mode lipid profile.
Each MS scan type was performed by moving the DESI‐MS spray spot in a series of three
lines across the narrowest dimension of the microscope slide, stepping 12.5 mm (along
the longest dimension) between lines – this process was repeated for the next MS scan
type offsetting the original spot by 250 microns.
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6.2.2.3 Pathology
Tissue smears analyzed by DESI‐MS were stained after analysis using hematoxylin
and eosin (H&E). Blind histopathologic evaluation of tissue smears was performed by Dr.
Eyas M. Hattab and the following information was provided when possible: disease state
(normal grey matter, normal white matter, glioma, or other), tumor cell percentage
(estimated percentage), and any additional comments.

6.2.2.4 Data Handling and Multivariate Statistics
DESI‐MS spectra were acquired using XCalibur 2.0 (.raw) and converted
into .mzXML files, and then imported into MATLAB (MathWorks, Inc., Natick, MA, USA).
In‐house MATLAB routines were used to process all MS data. Prediction of disease state
was performed using a PCA‐LDA model built using DESI‐MS data obtained from frozen
tissue sections, discussed in Jarmusch et al. (9) Tumor cell percentage was predicted via
NAA abundance. (9) MRI stereotactic data were recorded anonymously using an
intraoperative guidance system (StealthStation, Medtronic).

6.3

Results and Discussion

A DESI‐MS method for the analysis of tissue smears has been implemented at
Indiana University Health Methodist Hospital in Indianapolis, Indiana for the intrasurgical
analysis of human glioma. Tissue biopsies were taken from subjects undergoing tumor
resection, following standard protocols, and were analyzed intrasurgically using a custom
MS system. The biopsy tissue was analyzed by DESI‐MS immediately following smearing.
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The following types of MS scans were collected from each smear: negative mode lipid
profile, negative mode metabolite profile, MS/MS of N‐acetyl‐aspartic acid, MS/MS of 2‐
hydroxyglutaric acid, and positive mode lipid profile (data are neither shown nor
discussed for the latter three MS scan types). The total data acquisition time was ~2.75
minutes per smear. Tissue smears were stained after analysis and blindly evaluated by
pathology.
DESI‐MS negative mode lipid and metabolite profiles were used to predict the
disease state (i.e. grey matter, white matter, or glioma) and tumor cell percentage (TCP)
of each biopsy. The preliminary results from the intrasurgical study have been very
encouraging, provided only that enough tissue was present on the slide. The spectra are
of high quality and highly reminiscent of data obtained in vitro upon frozen tissue sections
and tissue smears. Smears of poor cellularity yielded poor DESI‐MS spectra and are
equally uninformative pathologically – in practice such smears would not be used to
render a diagnosis. DESI‐MS prediction of disease state was corroborated by pathology
with a few exceptions. Over 4 cases and 25 unique biopsies have been analyzed. Blind
pathologic evaluation determined that 21/25 biopsies were glioma with the remaining
number being infiltrative margin (4/25). DESI predicted that 19/25 were glioma and the
remaining 6 as either grey or white matter – DESI prediction of disease state matched
pathology 92% of the time. The majority of the glioma smears contained >67% tumor cells
while the infiltrative margin smears frequently contained <33%. DESI‐MS correctly
predicted grey matter and white matter in the pathologically‐defined infiltrative margin
smears (1 each), grey or white matter was not specified by the pathologist in two
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infiltrative margin samples, Table 6‐1. Two smeared biopsies from the same case were
predicted as white matter by DESI (35% TCP) which differed from pathology. Pathology
determined that these particular smears were gliomas, containing an estimated TCP of
50%. While the categorical call of disease state differed, the tumor cell percentages were
similar (within 15%). The pathologic call and DESI‐MS prediction of these smears should
be regarded as being similar rather than incorrect; the difference is a question of
definition.
Case 6 is illustrative of the intrasurgical data being collected. Biopsies #2‐4 and #7
were projected onto the PCA score plot, annotated black points (Figure 6‐2). The location
of each biopsy was recorded stereotactically during surgery, displayed in Figure 6‐3.
Biopsy #2 was from the frontal margin but contained a large percentage of tumor cells
(histopathology 90%, DESI‐MS predicted 93%); in this instance, the TCP remained
relatively high while approaching the surgical margin. In contrast, biopsies #3 (pathology
15% ‐ DESI‐MS 11%) and #7 (pathology 15% ‐ DESI‐MS 30%) contained relatively few
tumor cells, and were correctly predicted by DESI‐MS as grey and white matter,
respectively. The location of the projected biopsy #3 and #7 in the PCA score plot visually
indicated the matter into which the glioma was infiltrating. Note, the projected location
of the biopsies are relatively close to the glioma class (red) which likely reflects some small
fraction of tumor cells. Biopsy #4 is representative of the majority of the tumor volume –
pathologically diagnosed as high‐grade glioma with 70% TCP and DESI‐MS predicted
glioma with 76% TCP (prediction of grade by DESI is the objective of a future study). The
average difference (absolute) between pathologic evaluation and DESI‐MS prediction of
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TCP was 12.5% for all biopsies in case 6, and was 17.9% in all of the 25 unique biopsies
analyzed in four cases, Table 6‐1. The importance of understanding TCP in combination
with the pathologic diagnosis is evident as TCP appears to be heterogeneous within the
tumor volume.

6.4

Conclusions

The preliminary data obtained from four initial cases indicates DESI‐MS can
differentiate disease states and predict tumor cell percentage intrasurgically. The creation
of high quality tissue smears and their analysis was a critical development that makes
DESI‐MS analysis feasible in less than three minutes. In the initial cases, DESI‐MS analysis
of all biopsies from a particular case was completed before the traditional histopathologic
protocols provided information to the surgeon. The biopsies from Case 6 illustrated the
heterogeneity of gliomas and how the developed method could be used to detect residual
tumor cells in the infiltrative margin biopsies. The current MS system is capable of near
real‐time feedback, requiring only statistics to be performed on the same computer – we
intend to perform such data analysis when it becomes responsible and permitted by IRB
approval.
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Figure 6‐1. (A) Photograph of 3D printed smear device being used to smear tissue. (B)
Illustrative tissue smear after DESI‐MS analysis and H&E staining.
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Figure 6‐2. Projection of Case 6 biopsies #2‐4 and #7 (black squares) onto the negative ion
mode metabolite and lipid data fusion PCA score plot. Grey matter (green), white matter
(blue), and glioma (red).
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Figure 6‐3. T2‐weighted magnetic resonance images with stereotactic location, colored
point, of Case 6 biopsies (A) #2, (B) #3, (C) #4, and (D) #7. The location (provided by
surgeon), relative to tumor mass, is annotated. The bright region corresponds to the
location of the high‐grade glioma.
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Table 6‐1. Tabulated Pathologic Information and DESI‐MS Predictions from Intrasurgical
Cases 4 – 7. Replicate smears made from the same tissue biopsy have been excluded from
the table.

Sample ID

Diagnosis

TCP (%)

Diagnosis

TCP (%)

CASE4_1
CASE4_2
CASE4_3
CASE4_4
CASE4_5
CASE4_7
CASE4_9
CASE5_1
CASE5_3
CASE5_4
CASE5_5
CASE5_6
CASE5_7
CASE5_8
CASE6_1
CASE6_2
CASE6_3
CASE6_4
CASE6_5

Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Inf. Margin (Grey Matter)
Glioma
Glioma
Inf. Margin (matter not
specified)
Glioma
Inf. Matter (matter not
specified)
Glioma
Glioma
Inf. Margin (White matter)

50
20
70
50
90
90
30
90
60
80
50
60
80
80
50
90
15
70
50

Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Glioma
Grey Matter
Glioma
Glioma

100
58
56
100
100
100
95
100
63
90
80
62
73
91
76
93
11
76
71

Absolute
Difference
in TCP (%)
50
38
14
50
10
10
65
10
3
10
30
2
7
11
26
3
4
6
21

15

White Matter

30

15

90

Glioma

70

20

10

Grey Matter

0

10

50
50
10

White Matter
White Matter
White Matter

35
35
12

15
15
2

Pathology

CASE6_7
CASE7_1
CASE7_2
CASE7_3
CASE7_4
CASE7_5

DESI‐MS Prediction
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CHAPTER 7.

PERSPECTIVE

New tools in diagnostic medicine are crucial for improving pathology and surgery.
Pathology requires detailed information for use in diagnosis which is currently obtained
via histopathologic evaluation of tissue biopsies and genetic testing; however, this
process is fairly lengthy and ultimately renders a subjective decision. Surgery seeks to
answer simple diagnostic questions (e.g. “is this cancerous or not”) but contends with
much more difficult practical questions, such as “what is the relative good, compared to
harm, in surgically removing tissue.” There exists few tools aside from magnetic
resonance imaging that can assist surgeons during surgical removal of tumors. Analytical
measurements provide objective information that can assist pathology via chemical‐
based diagnosis and surgery through rapid tissue assessment, intrasurgically. Notable
analytical methods currently being developed include Raman spectroscopy, infrared
spectroscopy, and fluorescence. Ambient ionization – mass spectrometry (MS) also has
great potential to fulfill unmet needs in pathology and surgery. Reduced analysis time,
primarily due to relaxed sample preparation requirements, using ambient ionization
coupled with the molecular specificity and sensitivity of MS is a potentially powerful
capable combination. Further, many of the MS manufactures have or are currently
developing MS products that meet the criteria for Federal Drug Administration medical
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device approval which likely foreshadows widespread adoption of MS technology in
medicine.
A large body of scientific work supports the potential of using ambient ionization
– MS for cancer diagnosis. Numerous human cancers have been studied using ambient
ionization – MS and in all cases the pattern of lipids detected in the MS profile can be
used to differentiate normal from cancerous tissue. It is interesting that the lipid profiles
of each organ and the corresponding cancer of that organ also differ from one another.
The lack of similarity in the lipid profiles of different organs is not surprising as each has a
unique anatomy and physiology, viz. liver is very different from brain in both form and
function; however, the dissimilarity of lipid profiles between cancers was not necessarily
expected. Cancer biology suggest that cancer originates from a series of mutations – some
mutations are more frequent, e.g. KRAS, PTEN, AKT, mTOR, NF‐κB, etc. Therefore, one
might expect the downstream metabolism, including lipid metabolism, to be show overall
similarities in cancer. This is not the observation of the ambient ionization – MS studies,
but there are some commonalities such as the overall increase in phosphatidylcholines,
altered cholesterol metabolism and storage (e.g. cholesterol esters), and altered
phosphatidylinositols.
More recently, additional metabolite information is being sought to assist in
differentiating normal from cancerous tissue. N‐acetyl‐aspartic acid, a small molecule
metabolite (less than m/z 200), has proven to be extremely important in differentiating
human gliomas from normal brain parenchyma. 2‐hydroxyglutaric acid, a downstream
metabolite of IDH mutation in gliomas, is important for prognosis. The utility of small
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molecules metabolites detected by ambient ionization – MS for cancer detection will
likely be explored in future studies.
We sought to acquire differentiating molecular information rapidly within the
operating room. Two methods, touch spray and DESI, were developed for this purpose.
The molecular differences between normal and cancerous tissue were detected via direct
tissue analysis in vitro by touch spray ionization (TS) or by analyzing sectioned or smeared
tissue using desorption electrospray ionization (DESI). The physical form of the tissue, e.g.
in vitro sampling, sectioned, or smeared, was inconsequential in differentiating normal
from cancerous tissue; however, the spectra acquired by TS and DESI differed due to
differences in ionization processes. Touch spray is intended for in vivo sampling within
surgery to assist in determine the disease state of discrete areas that a surgeon finds
suspicious. The TS methodology aligns closely with standard online intrasurgical methods,
in vivo sampling and rapid analysis (seconds). The use of tissue smears for intraoperative
analysis falls under the offline intrasurgical analysis, and does not require major
modification to current practice. We imagine that intrasurgical MS analysis of smeared
biopsy tissue can offer the surgeon reliable pathologic information on a timescale ten
times faster than current pathology, which can also be corroborated via standard
pathologic evaluation. TS and DESI have potential for impacting surgical treatment of
tumors. The culmination of my research is the development and implementation of an
intrasurgical DESI‐MS analysis method and multivariate classification system for human
brain tumors. Preliminary results from the intrasurgical study are very promising and have
thus far proven to correlate well with pathology. We expect that similar results will be
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obtained over the planned 50 subjects to be enrolled in that study. The implementation
of this technology in additional hospitals around the world is expected. Positivity
impacting the lives of cancer patients via better molecular‐based tissue diagnosis using
ambient ionization –MS is very close to becoming a reality.
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Characteristic lipid proﬁles of canine
non-Hodgkin’s lymphoma from surgical biopsy
tissue sections and ﬁne needle aspirate smears by
desorption electrospray ionization – mass
spectrometry†
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Canine non-Hodgkin’s lymphoma (NHL) is a heterogeneous group of cancers representing approximately
15% of all canine cancers. Further, canine NHL mimics human disease in regards to histopathology and
clinical behavior and could function as a comparative model. Diagnosis is currently performed by histopathological evaluation of surgical biopsy specimens and ﬁne needle aspirate (FNA) cytology, an alternative and less invasive method for diagnosis. Desorption electrospray ionization – mass spectrometry
(DESI-MS) imaging was performed on tissue sections of surgical biopsies and FNA smears. Mass spectra
acquired from normal lymph nodes and NHL tumors were explored using multivariate statistics (e.g. principal component analysis). Tissue sections yielded a predicted sensitivity of 100% for normal and 93.1%
for tumor. Further, preliminary results suggest B-cell and T-cell lymphoma can be discriminated (CV sensitivity of 95.5% and 85.7%, respectively). Normal and B-cell NHL FNA samples analyzed by DESI produced
spectra that were similar to spectra obtained from surgical biopsies. FNA samples were evaluated using a
PCA-LDA classiﬁcation system built using tissue section data, exploring if the chemical information
obtained from the diﬀerent sample types is similar and whether DESI-MS performed on FNA samples is of
diagnostic value. FNA prediction rate for normal (85.7%) and B-cell NHL (89.3%) indicated that DESI-MS
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analysis of FNA, not previously explored, could provide rapid preliminary diagnosis. Certainly, MS provides
complementary molecular information to be used in conjunction with histopathology/cytology, poten-
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tially improving diagnostic conﬁdence. The methodology outlined here is applicable to canine NHL,
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further supports canine models of human NHL, and translation to humans is envisioned.

Introduction
Non-Hodgkin’s lymphoma (NHL) is a diverse group of cancers,
aﬄicting canines and humans. Rates of NHL in canines
exceed that in humans;1 nevertheless, NHL is the seventh most
common human cancer in the United States resulting in an
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estimated 20 000 deaths in 2014.2 NHL can be broadly defined
into two subgroups, B-cell and T-cell, correlated to the lymphocyte immunophenotypes from which the cancer originated.
B-cell lymphomas are the more common of the two, particularly diﬀuse large B-cell lymphoma, thus they are the primary
focus of this study. Canine lymphoma is currently being considered as a meaningful comparative model for human NHL,
while important in its own right.1,3 The gold standard for diagnosis of NHL is histopathological evaluation of surgically
removed lymph node (whole or in part), which is commonly
supported by immunohistochemical (IHC) analysis. Histopathological diagnosis is based on morphological and cytological features, such as morphological growth pattern,
nuclear size and shape, and mitotic index.4,5 A less invasive
alternative to surgical biopsy is fine needle aspirate (FNA)
biopsy, performed using a hypodermic needle that is inserted
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into a suspicious lymph node. A small amount of cellular
material is removed, expelled onto a microscope slide, and
smeared to form a cellular monolayer which may be evaluated
using light microscopy following cytochemical or immunocytochemical staining. FNA smears are suitable for screening and
rapid preliminary diagnosis; however, smaller sample size and
destruction of nodal architecture, a result of smearing, can
result in higher rates of false negatives and inconclusive diagnoses.6 FNA does have advantages over surgical biopsy and histopathology, in that it is less expensive, less invasive, and less
technically demanding.7,8 Both canines and humans with NHL
may be significantly debilitated at the time of initial cancer
diagnosis, and a minimally invasive diagnostic technique may
be better suited to these patients than surgical biopsy. Therefore, identifying methods to enhance the quality of diagnostic
information aﬀorded by FNA smears would be worthwhile.
A promising method for improving the diagnostic yield of
FNA biopsies is desorption electrospray ionization – mass
spectrometry (DESI-MS), an ambient ionization technique
which allows for chemical analysis of surfaces, including tissue,
at native atmospheric conditions (temperature, pressure, and
humidity). The mechanism of analyte desorption and ion generation has been extensively studied.9,10 Briefly, a stream of
charged droplets impact the surface, create a thin film of
solvent allowing analyte dissolution. Subsequent charged
droplet impact sputters small analyte containing droplets which
undergo evaporation and Coulombic fission generating ions via
electrospray-like processes. DESI can be operated in an imaging
mode, allowing chemical information to be mapped in two or
more spatial dimensions.11–16 DESI-MS imaging has been
applied previously in canine bladder cancer17 and human
cancers, including those of the liver,18 brain,19 kidney,20 prostate,21 and other organs.22 DESI-MS has been applied to human
brain tissue smears obtained during surgery,23 while diﬀering
from FNA smears in regards to collection and pathological
evaluation. The analysis of lipids that compose cells, structurally
and functionally, and tissue has been the focus of the previously
mentioned studies, allowing for diﬀerentiation of cancer from
normal tissue without exception. The lipid profile, i.e. type of lipid
and quantity as reflected in the measured mass spectrum, varies
with cell metabolism and signaling and is indicative of disease
state. The use of multivariate statistics for pattern recognition,
such as principal component analysis (PCA) followed by supervised classification techniques (e.g. linear discriminant analysis,
LDA), allows for visualization and classification of diﬀerences
between samples and complex relationships within large datasets.
In this paper we explore characteristic endogenous lipids
using DESI-MS from surgical biopsy tissue sections and FNA
smears for disease state diﬀerentiation (i.e. normal vs. tumor)
in canine NHL. DESI-MS imaging of tissue sections detected
lipid profiles indicative of disease state, which established a
data set with which to compare FNA smears. Needle biopsies
analyzed directly24 or indirectly by ambient ionization – mass
spectrometry have neither been demonstrated to be of diagnostic use nor shown to yield similar information to that of
tissue section. The characteristic lipid profiles obtained from
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surgical biopsies and FNAs corroborate histopathology and
cytology while providing unique chemical insight. Comparison
between previous data regarding the significant lipids in
human NHL and this canine study provide molecular support
for a canine comparative model.

Methods
Specimens
Specimens were provided by the College of Veterinary Medicine, Purdue University. All NHL specimens were collected
from pet dogs presented to the Purdue University Veterinary
Teaching Hospital (PUVTH) for medical treatment of their
cancer. At the time of presentation, fine needle aspirate
samples were collected from an aﬀected lymph node in each
dog using a 22 gauge hypodermic needle. FNA samples were
expelled onto glass slides, allowed to air dry, and then stored
at −80 °C until the time of DESI-MS analysis. Immediately following FNA, all dogs with NHL underwent surgical biopsy of
the same aﬀected peripheral lymph node. A portion of each
biopsy was fixed in 10% neutral buﬀered formalin and submitted for histopathologic confirmation of NHL. The residual
portion of each dog’s lymph node biopsy was snap frozen in
liquid nitrogen, and the samples were stored at −80 °C until
the time of DESI-MS analysis. Additional information pertaining to specimen 12, a metastatic carcinoma, can be found in
the ESI.† Lymph node samples from healthy, purpose-bred
research dogs served as normal controls. All control animals
had been humanely euthanatized as part of an academic laboratory course within the Purdue College of Veterinary Medicine
Doctor of Veterinary Medicine degree curriculum. Surgical
lymph node biopsy and FNA samples of peripheral lymph
nodes were collected immediately post-mortem from all
control animals in identical fashion to that described for pet
dogs with NHL. All lymph nodes from control animals were
confirmed to be histologically normal following light microscopic review of H&E stained sections from formalin-fixed
tissues by a board-certified veterinary pathologist. All medical
and surgical procedures conducted on both control animals
and pet dogs were approved by the Purdue Animal Care and
Use Committee (1111000308 and 1211000780).
DESI-MS analysis
Frozen surgical biopsy specimens were cryosectioned at 15 μm
thickness using a Cryotome FSE (Thermo, Waltham, MA, USA)
and thaw mounted on glass microscope slides (Gold Seal RiteOn Microscope Slides, Thermo). Prior to analysis, the slides
were allowed to come to room temperature and briefly dried
using an electronic desiccator (VWR, Desi-Vac Container,
Radnor, PA, USA) for approximately 10 minutes to remove any
frozen condensation resulting from storage. FNA smears were
also dried for ∼10 minutes prior to analysis, for the same
reason, and analyzed under the same conditions. Normal and
tumor samples were randomized over multiple days of analysis, surgical biopsy tissue sections and specimen matched
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FNA were analyzed on the same day. DESI-MS was performed
using a lab built prototype ionization source coupled to a
linear ion trap mass spectrometer (LTQ, Thermo). DESI-MS
was carried out in the negative ion mode using equal parts dimethylformamide (DMF) and acetonitrile (ACN), preserving
tissue morphology and allowing subsequent histopathology to
be performed on the analyzed tissue section.25 DESI analysis
was performed using the following major parameters: automatic gain control (AGC) oﬀ, maximum ion injection time of
250 ms with 2 microscans, 5 kV spray voltage, 180 PSI N2 (gas),
incident spray angle was 52°, capillary temperature of 275 °C,
spray-to-surface distance ∼2 mm, and spray-to-MS inlet distance ∼8 mm. Identical DESI-MS conditions were used to
acquire high resolution mass spectrometry data on an orbitrap
mass spectrometer (Exactive, Thermo). HRMS was interpreted
using XCalibur and monoisotopic formulae masses were calculated in Isopro3. Sample slides were analyzed by securing
them to the moving stage. The MS scan rate was coordinated
with the moving stage speed in the “x” dimension (i.e. rows),
defining resolution (200 μm). Upon the completion of each
row, the moving stage was stepped vertically in 200 μm increments defining the “y” resolution. The typical time required
for DESI imaging of a tissue section was less than 20 minutes.
Illustrative is specimen 42, ∼20 min, with an imaging area
approximately 8.4 mm (width) by 7.6 mm (height), including
the entirety of the tissue section roughly 6.2 mm (width) by
5.8 mm (height) in dimension.
Pathology
Histopathologic review, with tumor subtyping according to
World Health Organization criteria,4 was performed on formalin-fixed lymph node tissue sections as part of routine clinical
diagnosis, see ESI Table 1.† The clinical diagnosis was used
for DESI-MS data correlation. Samples demonstrating spatially
heterogeneous chemical features were evaluated post DESI-MS
analysis and annotated by histopathologic review of frozen
tissue sections. There were no cases in which histopathology
review diﬀered between frozen and formalin-fixed tissue sections. The annotated regions were used to define areas associated with non-malignant morphological features, unless
otherwise noted.
Cytology
Following DESI-MS analysis, all FNA slides were stained with
Wright’s stain and evaluated by light microscopy. FNA slides
were reviewed by an expert veterinary cytopathologist, who interpreted the nature of the sample (i.e. lymphoma vs. non-lymphoma), the distribution of cells within the sample (i.e.
homogenous vs. heterogeneous distribution of cellular material
within the smear), the density of cells within the sample (i.e.
densely cellular vs. sparsely cellular), and whether significant
red blood cell contamination of the sample was present.
Data analysis
DESI-MS ion images. Surgical biopsy and FNA smear data
acquired using XCalibur 2.0 (.raw) were converted with an in-
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house program into files compatible with BioMap software
(http://www.maldi-msi.org). BioMap was used to generate 2D
ion images (retaining spatial relationships and displaying relative mass spectral abundance of particular mass-to-charge
ratios), select regions of interest (ROI) based on pathology, and
export data for multivariate analysis. An in-house MatLab
(MathWorks, Inc., Natick, MA, USA) routine was used to
explore chemical features present in two dimensional DESI ion
images. PCA was performed upon MS hyperspectral datacubes,
the composite of spatial dimension (“x” and “y”), m/z value,
and corresponding m/z intensity, and plotted using an interactive brushing procedure,26 see ESI† for more details.
Multivariate analysis. PCA was used to explore DESI-MS data
and visualize the grouping of samples resulting from chemical
similarity.27 Multivariate analysis of tissue sections was performed using in-house MatLab routines. The mass range was
truncated (m/z 700 – 1000) for statistics, as it was empirically
found to contain less analytical variability, providing more
consistent and clear separation with regards to disease state
(i.e. normal vs. tumor). Two specimens were excluded from
statistics: one lymphoma sample (due to poor MS signal) and
a metastatic carcinoma. MS data were normalized by the total
ion current (TIC) and column-centered (i.e. mean-centered).
Neither background subtraction nor a smoothing algorithm
was applied to the MS data before PCA. LDA was performed for
discriminant classification after unsupervised data compression by PCA (i.e. PCA-LDA), as reported elsewhere.28 The
first 8 principal components (PCs), accounting for ∼90% of
total data variation, were used. Classification rates report the
correct classification of samples in the final PCA-LDA model.
Cross validation (CV) with 5 deletion groups was used to test
the prediction ability, reported as CV sensitivity and specificity.
Sensitivity was calculated as the percent of the objects in the
evaluation sets correctly accepted by the model. Specificity was
calculated as the percent of the objects of other categories correctly rejected by the model. Average DESI mass spectra
obtained from FNA smears were compared with those of surgical biopsy via multivariate statistics. A linear discriminant
model (i.e. PCA-LDA) was built in PARVUS (University of
Genova, Italy) using mass spectra from surgical biopsy tissue
sections, to which FNA smear mass spectra were classified.
The results and prediction rates are tabulated.

Results and discussion
DESI-MS imaging of lymph node tissue sections
Surgically excised lymph node biopsies were sectioned and
analyzed by DESI-MS imaging, providing chemical and spatial
information concurrently. The methodology employed follows
that of histopathological evaluation of tissue, while providing
molecular information. Tissue diagnosis by DESI-MS is performed with a spatial resolution larger than traditional histopathology (hundreds of microns versus tens of microns);
however, it provides chemical information otherwise unobtainable by traditional histopathology. DESI-MS analysis of tissue
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sections aims to explore and establish the lipid profiles indicative of normal and NHL tumor subtypes. Negative mode DESI
mass spectra showed ionized fatty acids (e.g. oleic acid, m/z
281), fatty acid dimers, and glycerophospholipids from m/z
700 – 1000 (e.g. PI(38:4), m/z 885), ESI Fig. 1 and Table 2.† The
major glycerophospholipids (GPL) ions observed included
major structural and signaling lipid classes: phosphatidylinositols (PI), phosphatidylserines (PS), phosphatidylethanolamines (PE), and phosphatidylglycerols (PG). The majority of
lymphoma-containing tissue sections displayed a conserved
pattern of lipids (i.e. ion, m/z, and corresponding relative
abundance), or lipid profile, that contrasted markedly with
that of normal tissue, and varied more slightly between B-cell
and T-cell subtypes. Minute analytical variances in the lipid
profile and signal intensity were attributed to freezing and sectioning artifacts. These small areas contributed insignificantly
upon averaging and did not compromise the ability to ascertain MS information.
DESI-MS ion images, two dimensional spatial distribution
of m/z versus the corresponding ion abundance represented in
false-color, revealed the majority of samples to be chemically
homogenous, i.e. to have similar lipid profiles. Diﬀuse large
B-cell lymphoma, Fig. 1A was particularly homogenous,
spatially and chemically, following the propensity of this
cancer to diﬀusely obliterate normal lymph node architecture.
Normal samples were also relatively homogenous in regards to
chemical composition and spatial distribution. Interestingly,
regions of normal lymph node anatomy, e.g. cortex and
medulla, yielded nearly identical lipid profiles although
diﬀering in absolute MS intensity. The similarity of the lipid
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profile was unexpected as anatomical distribution of B-cell and
T-cell lymphocytes is known to diﬀer in lymph nodes: B-cells
are found in densely packed follicles within the cortex and
T-cells are present in the surrounding paracortex. The medulla
contains a mixture of plasma cells, macrophages, and T-cells.
The absolute MS signal intensity varied between the cortex
and medulla, the latter yielded less signal. This intensity
diﬀerence might result from the anatomical diﬀerences
between the two regions that are not detected, such as the
greater density of blood vessels and vascular sinuses within
the lymph node medulla, which reduces the overall cellular
density. The spatial resolution of DESI-MS data acquisition
used does not allow for such anatomical structures to be visualized. MS imaging at higher resolution (<200 μm), possible by
secondary-ion MS, matrix-assisted laser desorption, DESI, and
nanoDESI,12–14,16,29 could visualize these anatomical regions
with a non-linear increase in analysis time (analysis time
increases with the reciprocal of the square of spatial resolution); however, investigation of normal lymph node anatomy is
beyond the scope of the intended application.
Diﬀerences in the chemical information within analyzed
tissue sections, disregarding previously discussed MS intensity
diﬀerences, were noted in some of the normal and tumor
specimens. In all of these instances (independent of tissue
disease state, i.e. normal versus tumor) the diﬀerence resulted
from the presence of perinodal adipose tissue, as determined
by post hoc histopathology. Specimen 31 is illustrative, Fig. 1B,
a tissue section comprised primarily of a B-cell tumor with
smaller regions of non-neoplastic, perinodal adipose tissue.
The tumor regions have a common lipid profile that is homo-

Fig. 1 Selected negative mode DESI-MS ion images displaying the distribution of ions m/z 281.5, 747.5, 788.4, 838.5, and 885.6 and the corresponding H&E stain. (A) Specimen 18 is representative of B-cell lymphoma samples in regards to chemical and spatial homogeneity. (B) Specimen 31,
B-cell lymphoma, contained small regions of perinodal adipose (outlined). (C) Specimen 42, illustrative of normal samples. The large region of perinodal adipose (outlined) was chemically diﬀerence than that of normal lymph node tissue.
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genous throughout the tumor region; however, the lipid profile
of small regions corresponding to perinodal adipose tissue
(outlined) are significantly diﬀerent and overall lower in absolute intensity as seen in the ion images ( particularly m/z 281.5).
The chemical diﬀerence of this region was further explored
using PCA and an interactive brushing procedure, see ESI
Fig. 2.† The PCA score plot, displaying each pixel of specimen
31, indicated three groups: B-cell lymphoma associated pixels
(red selection), perinodal adipose associated pixels (green
selection), and background associated pixels (black). The
results of visual interpretation and PCA correlated well with
the pathological assessment, considering the diﬀerences in
spatial resolution of MS imaging and histopathology. Perinodal adipose tissue was also detected in some normal lymph
nodes, for example specimen 42, as shown in Fig. 1C. The
diﬀerence in the lipid profile was again evident between the
two tissue types with negative mode GPL signal only noted in
the lymph node parenchyma. The lack of GPL signal in
adipose tissue is likely correlated to adipocytes (i.e. fat cells),
which typically possess a large cytoplasmic volume to GPL
membrane surface area ratio. Further, adipocytes contain
greater levels of triglycerides and cholesteryl esters which are
not readily detected in the negative mode with the solvent conditions chosen; however, previous DESI experiments have
detected such compounds in positive ion mode from biological material with relative ease as silver adducts.30
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Diﬀerentiating lipid profiles in NHL tissue sections
The lipid profiles of tissue sections were explored for molecular-based diﬀerentiation of disease state (normal versus
tumor) and NHL tumor subtype (i.e. B-cell versus T-cell). The
average DESI mass spectrum (from m/z 700 – 1000) of normal
lymph node (n = 22), B-cell lymphoma (n = 22), and T-cell lymphoma (n = 7) tissue sections, green, blue, and gold respectively, are displayed in Fig. 2A–C. The ratio of MS abundance of
m/z 788.3, 838.3, and 885.5 indicated, visually, molecular
diﬀerences between disease states. Nearly all B-cell samples
were diagnosed as diﬀuse large B-cell lymphoma, diﬀerences
in the lipid profile are noted in comparison to the average
normal spectrum. A small number of T-cell lymphoma tissue
sections were analyzed, diagnosed as peripheral T-cell lymphoma, not otherwise specified (n = 4) and T-zone lymphoma
(n = 3). Spectral diﬀerences were also noted between normal
and T-cell NHL, but the limited number of samples and multiple T-cell subtypes preclude definitive conclusions. Less
abundant peaks present in B-cell and T-cell lymphoma also
diﬀered in abundance from normal samples including m/z
747.4, 773.3, 786.4, 812.4, 883.5. These ions and their altered
relative abundance mirror those reported previously by Eberlin
et al. in murine and human lymphoma specimens.31 One
metastatic carcinoma, specimen 12, was analyzed and yielded
diﬀerent lipid profiles from normal and lymphoma with

Fig. 2 Average negative mode DESI mass spectrum of tissue sections: (A) normal lymph node (n = 22), (B) B-cell lymphoma (n = 22), and (C) T-cell
lymphoma (n = 7). (D) PCA score plot of normal (green) and tumor (red) samples. (E) PCA score plot of normal (green), B-cell lymphoma (blue), and
T-cell lymphoma (gold) samples. (F) PCA loading plot corresponding to panel D&E with m/z annotated.

This journal is © The Royal Society of Chemistry 2015

Analyst, 2015, 140, 6321–6329 | 6325

169

Paper

strong alterations in m/z 819, 834, 865, and 867 (ESI Fig. 3†).
Abbassi-Ghadi and coworkers have previously analyzed metastatic tumors in lymph nodes by DESI, concluding that the
chemical information corresponded to that of the primary
tumor and had clearly diﬀerent from adjacent normal lymph
node.32 Extrapolating from that work, the lipid profile of specimen 12 might correlate with that of the primary tumor;
however, biopsies of the primary tumor were not available for
analysis.
Principal component analysis was performed on the
average spectrum of each tissue section, oﬀering an unbiased
method for qualitatively assessing the molecular information
associated with the pathology-defined condition. Disease state
diﬀerentiation (normal vs. tumor) was the initial level of diagnostic information explored. Normal lymph node (green) and
tumor (red) samples were appropriately grouped as shown in
Fig. 2D. Dispersion of the tumor samples in the PCA score
plot, compared with the normal samples, is indicative of
greater chemical heterogeneity within lymphoma – matching
known diversity of the disease.1 The dispersion of the lymphoma samples appears to be related to tumor immunophenotype, Fig. 2E: normal (green), B-cell lymphoma (blue), and
T-cell lymphoma (gold). The PCA loading plot, displayed in
Fig. 2F, aided in understanding which lipids from m/z
700 – 1000 contributed most to PC2 and PC6 computations (see
ESI Fig. 4† for additional information). Distinguishing NHL
subtypes represents a deeper level of diagnostic information,
which commonly requires IHC/ICC; the chemical information
obtained by DESI may circumvent or augment such protocols.
The separation of B-cell and T-cell lymphoma is suggested in
Fig. 2E; however, expansion of NHL subtypes is necessary to
confirm this initial report. More detailed exploration of the
chemical diﬀerences was performed by iterative study of the
relationship between disease states rather than together as in
Fig. 2. For example, the chemical diﬀerence between B-cell
and T-cell NHL tumors is more apparent upon removal of
normal samples (ESI Fig. 5†). The separation noted must be
taken as preliminary, particularly for T-cell tumors, based on
the relatively small sample size and known genetic diversity of
lymphomas. The ability to subtype tumors using DESI-MS has
been previously demonstrated, e.g. brain and kidney
tumors,19,20 but has not been previously reported in lymphoma. Diagnostic information acquired by DESI would serve
to support pathological diagnosis, particularly relating to
tumor subtyping as an alternative to IHC.
The discriminatory performance of DESI-MS in determining disease state and subsequently tumor subtype from tissue
sections was explored via PCA-LDA. The classification rate in
PCA-LDA model creation was 100% for normal and tumor.
Cross-validation was performed resulting in the predicted sensitivity and specificity results displayed in Table 1. Further,
PCA-LDA was performed separately taking the lymphoma subtypes into consideration, modelling classification rates were
100%, 99% and 94% for normal, B-cell, and T-cell respectively.
CV indicated two misclassifications (T-cell predicted as
normal, and B-cell predicted as T-cell). The predicted sensi-
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Table 1 CV results of DESI-MS in discriminating disease state (normal
vs. tumor) in tissue sections

Pathological diagnosis

DESI-MS prediction

Normal
Tumor
(B- & T-cell NHL)

CV sensitivity (%)
CV specificity (%)

Table 2

Normal

Tumor
(B- & T-cell NHL)

22
0

2
27

100.0
93.1

93.1
100

CV results for NHL subtyping of tissue sections by DESI-MS

Pathological diagnosis

DESI-MS prediction
CV sensitivity (%)
CV specificity (%)

Normal
B-cell NHL
T-cell NHL

Normal

B-cell NHL

T-cell NHL

22
0
0
100
96.4

0
21
1
95.5
100

1
0
6
85.7
97.7

tivity and specificity for NHL subtyping is tabulated in Table 2.
The CV sensitivity of T-cell lymphoma (85.7%) was relatively
poor in comparison to the other states (normal, 100% and
B-cell lymphoma, 95.5%), likely the result of a smaller sample
size (n = 7) or the presence of two diﬀerent subtypes (i.e. peripheral and T-zone).
DESI-MS imaging of fine needle aspirates
Histopathological evaluation of surgically excised lymph
nodes, the gold standard for lymphoma diagnosis, is an invasive procedure and therefore not suitable for rapid preliminary
diagnosis of NHL. Fine needle aspirate biopsy is a less expensive, less invasive, and less technically demanding method, and
therefore a reasonable alternative. FNA tend to be less reliable
than surgical biopsy, in part due to the limited discriminatory
ability of cytology in comparison to histopathology. However,
DESI-MS analysis of FNA smears provided molecular information that is similar to that of tissue sections and oﬀers an
alternative to FNA cytology, aimed at enhancing diagnostic
capability.
FNA smears, prepared using standard protocols, were analyzed without any pre-treatment. DESI-MS was performed on a
small area of the smear, not the entirety of the smear, representing a time reducing strategy for preliminary diagnosis. It
was assumed that aspiration and subsequent smearing, was
suﬃciently homogenizing. The MS data obtained from FNA
smears were highly reminiscent of those for surgical biopsy
tissue sections. The average mass spectra for normal and
B-cell lymphoma are displayed in Fig. 3, with more detail provided in ESI Fig. 6.† The chemical information obtained from
FNA appears to be identical in nature to that of tissue sections
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Fig. 3 Average (–)DESI-MS spectrum for (A) normal FNA (n = 7) and (B)
B-cell lymphoma FNA (n = 28).

suggesting that the type of sample does not impact ability to
acquire chemical information correlated to disease state. The
strategy of using DESI spectra obtained from tissue sections
serves as an important reference in this case, having been
used previously in cancer diagnosis,17–23 thus allowing evaluation of FNA as a new type of sample for the same DESI
methodology.
Unsurprisingly, subtle diﬀerences do exist between tissue
sections and FNA smears which did not preclude acquisition
of mass spectral information but rather influenced data
quality. FNA smears were nearly always chemically homogenous, i.e. the lipid profile was similar in all areas of the
smear, supporting the assumption of suﬃcient homogenization, while diﬀerence in the signal intensity were common
(ESI Fig. 7†). Two major variables in FNA smears were found
to aﬀect MS intensity: the quantity of cellular material aspirated and the degree of dilution due to smearing. The eﬀect of
quantity is noted in ESI Fig. 8† in which the heterogeneity
present in the ion image results from variable amount of
material – signal intensity is correlated with material quantity.
The second variable is the degree of smearing of the aspirated
sample which dilutes the cellular material on the glass slide.
This dilution is necessary for cytologic evaluation using light
microscopy, in which morphologic evaluation of isolated cells
is desirable, but is deleterious for chemical analysis by
DESI-MS. Slight modification to current FNA protocols that
compensate for these eﬀects is likely to increase DESI reproducibility, MS data quality, and capability for molecular diagnosis. Additionally, diﬀerences in the lipid profile were noted in
cases of obvious blood contamination of the aspirated sample,
resulting in a visually red coloration to the smear. The presence of blood contamination significantly increased one particular lipid, m/z 810, which corresponds to PS(40:6), a major
membrane constituent of erythrocytes33 and therefore easily
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detected. Minor blood contamination did not seem to compromise the ability to determine disease state. Subsequent staining of FNA smears (Wright’s stain) analyzed by DESI and
evaluation by light microscopy, indicated cellular damage,
which could result from physical damage during smearing or
freeze thaw cycle. Certainly, DESI has the potential to produce
the observed cellular damage via physical (e.g. pneumatic)
forces or chemical fixation (i.e. organic solvent). An expert cytopathologist commented that the morphologic changes in the
cells appeared similar to those commonly observed in samples
exposed to formalin, a common chemical fixative, which supports the latter reason for the observed eﬀect. This observation
is quite interesting in that it contrasts the preservation of morphology during analysis of histologic tissue sections – no
eﬀect on histomorphology is noted using dimethylformamideacetonitrile as a DESI solvent system. One biological reason for
this observation is the presence of stromal tissue and extracellular matrix in histologic sections, which may minimize the
cellular damage of DESI analysis relative to what was observed
in FNA smears, which would presumably contain less of these
protective elements.
Diﬀerentiation of disease state using FNA smears
The chemical information obtained using DESI-MS from FNA
smears was evaluated by multivariate statistics, undertaken to
determine FNA’s potential diagnostic performance and explore
how translatable the chemical information obtained from
tissue sections are to FNA smears. In clinical practice, the
information relevant in FNA evaluation is the presence or
absence of tumor, and serves only to provide a rapid, preliminary diagnosis which requires subsequent confirmation by
more accurate methods such as histopathology. PCA-LDA was
applied and performed by building a classification training set
using tissue section data and evaluating the FNA smear data.
PCA-LDA prediction rates are displayed in Table 3. Prediction
of normal was 85.7% and tumor was 89.3%. The preliminary
results displayed indicate that DESI-MS analysis of FNA
smears has diagnostic potential. Further, the results support
that the chemical information relevant to disease state is
equivalently detected by DESI-MS. FNA smears, neither
adapted nor optimized for MS analysis, provided reasonable
classification results, provided that FNA smears are known to
be less reliable than surgical biopsy samples evaluated by
histopathology.

Table 3 PCA-LDA prediction of FNA smears analyzed by DESI-MS

Pathological diagnosisa

DESI-MS prediction
PCA-LDA prediction rate

Normal
B-cell NHL

Normal

B-cell NHL

6
1
85.7%

3
25
89.3%

a

Note four ROIs were taken for specimen 8, 13, and 19, and two ROIs
from specimen 35.
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Beyond the rapid molecular diagnosis of NHL by DESI-MS
via FNA analysis, the envisioned application, has the potential
for rapid tumor subtyping. PCA cross-validation of tissue sections indicated the possibility for tumor subtyping; however,
this could not be explored based on FNA sample numbers.
Surely, this requires a larger and more diverse sample set, particularly with knowledge of NHL tumor heterogeneity. The
primary goal of FNA analysis by DESI was demonstrated: rapid
molecular-based dichotomous delineation of disease state
(i.e. normal and tumor), which has potential to be a significant
advancement in the rapid diagnosis of non-Hodgkin’s
lymphoma.

Conclusion
Diﬀerences in the lipid profile, acquired by DESI-MS, allowed
diﬀerentiation of normal lymph node and NHL tumors in
tissue sections (obtained by surgical biopsy) and FNA smears.
DESI-MS imaging of tissue sections allowed chemical information to be obtained and explored. Normal lymph node
tissue was chemically homogenous while diﬀerences in absolute signal were noted between regions of normal lymph node
anatomy, e.g. medulla and cortex. Tumor samples were generally homogenous, particularly diﬀuse large B-cell lymphoma
samples, matching known histomorphology. Multivariate statistics allowed for diﬀerentiation of normal and tumor tissue
sections yielding an overall predicted CV sensitivity of 96%.
Further, subtyping of NHL tumors is suggested with an equal
rate of predicted classification.
FNA smears, previously unexplored for use in diagnosis
using ambient ionization – mass spectrometry, provided the
same chemical information relevant to disease state diﬀerentiation detected from tissue sections. FNA smear data applied
to a tissue section-based classification system yielded an
average prediction rate of 87.5% for disease states. MS signal
was dependent on the composition (e.g. blood contamination),
aspirated material quantity and smearing. The act of smearing
of FNA, while ideal for cytology, dilutes the cellular material
necessary for DESI-MS lipid analysis. Improvement in the protocols for FNA preparation, with tailoring specifically for MS
analysis is likely to improve results. The molecular information
detected from FNA smears are not subject to the same set of
problems (e.g. physical damage of cells) experienced in cytopathology, and therefore could improve diagnostic yield. Cellular damage was noted after DESI analysis upon FNA samples,
eﬀecting only subsequent pathology and not the molecular
information. The reason for this damage is presently
unknown, but might result from chemical damage. Analysis of
FNA material by other ambient methods such as PESI or paper
spray ionization represents another possible direction of development.34 The direct aspiration of material onto paper for PS
analysis eliminates smearing and may provide additional
advantages in regards to MS analysis. The informative but less
invasive collection of FNA smears, also performed during diagnosis of other cancers, particularly those of the breast,
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thyroid, and salivary gland, is clearly best suited to answer the
question of rapid preliminary diagnosis, “Is this sample
normal or cancerous?”
DESI-MS analysis of tissue sections provided a means of
exploring and establishing the lipid profiles indicative of
normal lymph node and NHL tumors. FNA smears mimic
those changes, primarily in GPL composition, which are certainly related to cellular and morphological changes that occur
with NHL. The polar lipids detected in the negative ion mode
represent only a fraction of metabolites, and further study of
the metabolome may reveal additional diagnostic information.
The subtype prevalence, clinical behavior, and chemical
changes in GPL emulate that of human NHL,31 supporting
development of canine comparative models. The methodology
outlined here is applicable to dogs while translation to
humans is foreseeable.
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Examination of tissue sections using desorption electrospray
ionization (DESI)-MS revealed phospholipid-derived signals that
differ between gray matter, white matter, gliomas, meningiomas,
and pituitary tumors, allowing their ready discrimination by multivariate statistics. A set of lower mass signals, some corresponding
to oncometabolites, including 2-hydroxyglutaric acid and N-acetylaspartic acid, was also observed in the DESI mass spectra, and these
data further assisted in discrimination between brain parenchyma
and gliomas. The combined information from the lipid and metabolite MS profiles recorded by DESI-MS and explored using multivariate statistics allowed successful differentiation of gray matter (n =
223), white matter (n = 66), gliomas (n = 158), meningiomas (n =
111), and pituitary tumors (n = 154) from 58 patients. A linear discriminant model used to distinguish brain parenchyma and gliomas
yielded an overall sensitivity of 97.4% and a specificity of 98.5%.
Furthermore, a discriminant model was created for tumor types (i.e.,
glioma, meningioma, and pituitary), which were discriminated with
an overall sensitivity of 99.4% and a specificity of 99.7%. Unsupervised multivariate statistics were used to explore the chemical differences between anatomical regions of brain parenchyma and
secondary infiltration. Infiltration of gliomas into normal tissue
can be detected by DESI-MS. One hurdle to implementation of
DESI-MS intraoperatively is the need for tissue freezing and sectioning, which we address by analyzing smeared biopsy tissue. Tissue
smears are shown to give the same chemical information as tissue
sections, eliminating the need for sectioning before MS analysis.
These results lay the foundation for implementation of intraoperative DESI-MS evaluation of tissue smears for rapid diagnosis.
ambient ionization
neurosurgery

| MS imaging | multivariate statistics | pathology |

among children. Gliomas (30%), meningiomas (33%), and pituitary tumors (15%) account for the majority of brain tumors in
adults (12). The brain parenchyma is comprised of glia (e.g., astrocytes and oligodendrocytes) and neurons. In many cases, surgical resection is the most effective treatment option; however,
surgery must contend with the dilemma of maximizing tumor excision while minimizing unintended neurological deficits. MRI, a
critical imaging method, aids in defining the location and size of
the tumor (13). The nuclear spin of hydrogen is exploited by MRI,
allowing visualization of different anatomical structures (e.g., T1weighted MRI) or pathologies (e.g., T2-weighted and contrastenhanced MRI). Additional information can be obtained by positron emission tomography, functional MRI, diffusion weighted
imaging, fluid-attenuated inversion recovery, and magnetic resonance spectroscopic imaging (MRSI). Raman spectroscopy performed in vivo seeks to provide chemical information that allows
rapid identification of cancerous tissue (14). Fluorescence imaging
uses appropriate molecular labels to visualize tumors during surgery (15, 16). The information provided by these methods is used
primarily to visualize the tumor and assist in surgical resection.
Histopathology performed on frozen tissue sections and tissue
smears is the most common source of important pathologic information, specifically the type of tumor (e.g., glioma) and grade
(e.g., low grade), which is provided during surgery. This pathologic
analysis is often repeated for infiltrative tumors to guide the extent
of resection at the tumor margins. Currently, this information is
obtained outside of the operating room, taking upward of 20 min
per sample and prolonging surgery. Histopathology relies heavily
on morphologic and cytologic features revealed by staining of
Significance

M

S is increasingly being used in medicine (e.g., in clinical
chemistry, pharmaceutical development, and proteomics).
Ambient ionization methods generate ions under atmospheric
conditions, with minimal to no sample preparation (1). Desorption electrospray ionization (DESI), an ambient method
that uses a spray of charged solvent as the projectile, provides
rapid chemical information while preserving tissue and cellular
morphology, allowing subsequent histopathology on the same
specimen (2). This feature allows integration of DESI-MS into
current workflows and postacquisition pathology. DESI-MS has
been used to study prostate cancer (3), bladder cancer (4), kidney
cancer (5), seminoma (6), lymphoma (7), gastrointestinal cancer
(8), and others. In each case, the recorded pattern of lipid signals
allows the differentiation of cancer from normal tissue. DESI-MS
has been previously used to explore chemical differences among
glioma subtypes, grades, and tumor cell concentrations (relative
percentage of tumor compared with parenchyma) (9, 10). Meningiomas have also been studied previously and were distinguished from normal dura mater (11).
The incidence of brain tumors is approximately the same as
that of non-Hodgkin’s lymphoma, melanoma, and urinary bladder
cancer in adults over 20 y of age, and it is even more prevalent
1486–1491 | PNAS | February 9, 2016 | vol. 113 | no. 6

Brain tumors can lead to a significant source of morbidity and
mortality. The primary treatment is microsurgical resection,
and the extent of resection is associated with length of survival. Unfortunately, reliable intraoperative tools for diagnosis
and safe maximal resection of the tumor mass are lacking.
Mass spectra (lipid and metabolite profiles) can be used to
distinguish between healthy and diseased tissues by comparison of patterns of peak intensities using multivariate statistics.
This experiment can be done on a timescale amenable to
intraoperative analysis using tissue smears. These data can
provide surgeons with near real-time pathologic information
and guide the intraoperative resection of the tumor at the
difficult to detect peritumoral borders.
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Results and Discussion
DESI-MS Imaging of Human Brain Tissue Sections. We explore the

chemical information obtained from banked frozen brain tissue
sections by DESI-MS performed in the imaging mode. Negative
ionization DESI-MS images were recorded using different MS
tune methods consecutively from the same tissue section. The
main features of the MS profiles in the ranges m/z 200–1,000 and
Jarmusch et al.

Differentiation of Gliomas and Brain Parenchyma. The chemical differences between brain parenchyma and gliomas were explored by
comparing the molecular information obtained in the two MS
profiles and evaluating their ability in differentiating disease state
(i.e., normal vs. tumor). DESI-MS imaging revealed that gray and
white matter mass spectra differ and could be defined spatially (SI
Appendix, Fig. S1); however, areas of mixed composition were also
noted. Gray matter (Fig. 1A) is comprised of glia and mostly unmyelinated neurons, and it is associated with a very abundant peak
at m/z 834 identified by high-resolution MS and MS/MS fragmentation as phosphatidylserine (PS) with 40 carbons with 6 units of
unsaturation (40:6); predominant acyl chains are 18:0 (stearic acid)
and 22:6 (docosahexaenoic acid) as indicated by MS/MS (SI Appendix, Fig. S2). White matter (Fig. 1B) is characterized by an increased relative abundance of m/z 788 (PS 18:1–18:0), 888, 906, and
916. Sulfatides [e.g., m/z 888; (3′-sulfo)GalCer 24:1] are particularly
abundant, which correlates with the increased myelination of neurons. The pattern of ions that corresponded to gray and white
matter was consistent with previous studies of murine brain tissue
(25). The variations seen in the ratio of the signals associated with
m/z 834 and 888 do not compromise the differences in relative
abundance between gray and white matter (SI Appendix, Fig. S4).
Additional information on the identification of ions detected in the
lipid profile can be found in SI Appendix (SI Appendix, Figs. S2 and
S3 and Table S1). Differences in the lipid profiles were noted between anatomical regions of the brain, such as the molecular layer
of the cortex and the other cortical layers (e.g., in the specimen
shown in SI Appendix, Fig. S5). The m/z 788, 834, and 885 varied
between the molecular layer, which surrounds a meningeal blood
vessel (apparent in the ion image of m/z 788) and that of the cortex
itself. Furthermore, unsupervised multivariate analysis by interactive brushing (26) supports the observed differences. Specific cases of special pathological or chemical interest like this
one are discussed throughout. The average mass spectrum for
gliomas (Fig. 1C) is very different from that of normal brain parenchyma, in that it lacks the ions at m/z 834 and 888 characteristic
of gray and white matter, respectively. Rather, an increase in the
abundance of m/z 794 [chloride adduct of phosphatidylcholine
(PC) 34:1] and m/z 885 [phosphatidylinositol (PI) 18:0_20:4]
was noted.
Principal component analysis (PCA) was performed on the
lipid profiles selected from pathology-defined regions of brain
parenchyma and glioma tissue sections (Fig. 1 D and E). Gray
and white matters were well-separated based primarily on m/z
834 and 888, respectively. The dispersed locations of a few gray
and white matter points, those that fall between their respective
groupings, corresponded to tissue of mixed composition as reflected
in the mass spectra (SI Appendix, Fig. S6). This observation
reflects typical parenchyma composition, which contains a mixture
of unmyelinated and myelinated neurons as well as glial cells. Brain
parenchyma and glioma were well-separated in PCA space, indicating that the first level of pathologic evaluation (is this a glioma
or brain parenchyma?) can be answered readily. Interestingly, the
glioma grouping was dispersed (Fig. 1D). Dispersion along the
vector of gray and white matter separation (right to left) is related
to the relative contribution of the parenchyma background to the
detected lipid profile. Specimen 42 (secondary infiltrated; with
∼40% tumor cell concentration) is illustrative of the juxtaposition
PNAS | February 9, 2016 | vol. 113 | no. 6 | 1487
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m/z 80–200 were found to be associated with glycerophospholipids
and metabolites, respectively, and are referred to throughout as the
lipid and the metabolite profiles, respectively. These two MS profiles, containing many ions with relative abundances characteristic
of tissue type, were evaluated separately and also, together by
data fusion. Appropriate selection of the DESI-MS solvent allowed
acquisition of multiple images from the same tissue section while
preserving tissue morphology for subsequent histopathology, allowing correlation of chemical, spatial, and pathologic information (2).
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cellular structures (e.g., nucleus and cytoplasm). However, brain
tumors exhibit large genetic variability and genomic instability, which
remain invisible to microscope-based pathology. Auxiliary testing,
frequently immunohistochemistry or genetic sequencing, supports
pathologic diagnosis and has been used to estimate treatment response (as in pharmacogenomics). Genetic testing remains timeconsuming [reporting of isocitrate dehydrogenase (IDH) mutation
status, a prognostic marker, can take weeks], creating delay in
pathologic diagnosis and rendering treatment. However, recently,
Shankar et al. (17) reported a genotyping method for IDH and
telomerase reverse transcriptase mutations, with results available
in 60 min.
Previous studies (3–11) have shown tissue discrimination by
mass spectral profiles (m/z values and associated abundances)
characteristic of different tissue types, including different disease
states. Rapid and direct analysis of tissue provides molecular
information on multiple compounds and is obtained on a timescale of seconds to a few minutes. In this way, ambient ionization
MS profiling stands in stark contrast to “-omics” techniques, which
are based on separation (e.g., liquid chromatography) before MS
and in which complex samples are extensively processed (e.g., by
desalting, extraction, and derivatization) to reveal, in detail, the
particular compounds present. Both the time required for analysis
and the complexity of high-performance hyphenated MS systems
mean that they are not amenable to intraoperative use.
The potential diagnostic value of using ambient ionization and
MS profiles, especially those based on lipids (18), is increasingly
being recognized as reflected by a growing number of studies.
Detection of metabolites by ambient ionization has also proven
useful in the detection of genetic mutations, such as IDH, but it
remains underexplored for potential diagnostic value. Differences in the lipid composition of renal cell carcinoma (19) and
colon cancer (20) from their respective normal parenchyma were
detected by positive ion probe electrospray ionization-MS. Touch
spray, a probe method allowing user-guided sampling, serves to
differentiate prostate cancer from normal tissue based on glycerophospholipid distributions (3). Similar methods of ionization
have been used for the detection of lipids from lung (21) and brain
cancer (22). DESI-MS imaging of stereotactically registered brain
tumor samples (23) gave results that correlated with histopathology and illustrated the potential for determining tumor cell concentration near the resection margins (10). The analysis of gastric
cancer surgical margins has been reported recently, including pixel
by pixel classification of heterogeneous tissue sections (8). Brain
and other cancers have been investigated using rapid evaporative
ionization-MS, a method that provides lipid-based differentiation
between cancerous and normal tissue and has been performed
in vivo on patients undergoing surgical resection with promising
results; however, electrocauterization is destructive and should
be used with discretion (24). Establishing a robust classification
method is of vital importance and best implemented by including
normal tissue. Obtaining normal tissue is particularly difficult in
the case of brain tumors, in which absolute normal rarely exists for
scientific study. Currently, intraoperative DESI-MS analysis is
limited by the need for freezing and cryosectioning before analysis;
therefore, we describe the use of tissue smears as a means to
quickly acquire differentiating chemical information. There is little
doubt that development of molecular techniques that rapidly discriminate cancerous tissue would be of great benefit to supplement
intraoperative decision-making and pathologic evaluation.
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Fig. 1. Average lipid (m/z 700–1,000) and metabolite (m/z 80–200) MS profiles for gray matter (n = 223), white matter (n = 66), and glioma (n = 158) with PCA
score and loading plots. Average normalized [total ion chronogram (TIC)] lipid MS profile for (A) gray matter, (B) white matter, and (C) glioma. (D) PCA score plot
[principal component 1 (PC1) vs. principal component 2 (PC2)] using lipid profile information for gray matter (green circles), white matter (blue circles), and glioma
(red circles). (E) PCA loading plot with m/z annotated. Average metabolite MS profile for (F) gray matter, (G) white matter, and (H) glioma. (I) Metabolite profile
PCA score plot for gray matter, white matter, and glioma and (J) corresponding PCA loading plot.

of gray and white matter regions (SI Appendix, Figs. S7 and S8) and
the contribution of the background parenchyma to the lipid profile.
The differences between gray and white matter can overshadow
more subtle differences that indicate the presence of invasive tumor cells. This observation does not preclude the differentiation of
normal tissue, infiltration, and gliomas but rather, confirms the
complexity associated with brain tumors. The dispersion of the
glioma class in the vertical direction in PCA score space (Fig. 1D)
reflects the extent of infiltration of tumor cells. A likely contribution to the observed dispersion of the glioma group is the presence
of glioma subtypes (e.g., astrocytoma and oligodendroglioma),
which are related to the glial cells from which the cancer is derived.
For example, the lipid profile of an oligodendroglioma might appear more similar to white matter, which is composed of a greater
number of oligodendrocytes than gray matter. Discrimination of
glioma subtypes has been previously studied (9) and is outside the
scope of this study. Note that subsequent histopathologic evaluation revealed that normal specimens commonly contained various
levels of secondary infiltration. The gray and white matter classes
were comprised of regions containing <25% tumor cell concentration (mode was 10%), and one sample contained 40% tumor
cell, representing a tissue composition that is reasonably expected
near the surgical margin. A few samples well-separated from the
glioma class in PCA space were considered completely normal and
found by the pathologist to contain no observable tumor cells
(<5%). Glioma points that fell between the glioma group and either the gray or white matter group illustrate the disease spectrum
and the complexity in determining the disease state with contributions of background parenchyma and infiltration.
The metabolite profile, acquired subsequent to the lipid profile,
has not been explored previously by DESI-MS in human brain tissue.
The average metabolite profile mass spectra obtained from gray
1488 | www.pnas.org/cgi/doi/10.1073/pnas.1523306113

matter, white matter, and gliomas are displayed in Fig. 1 F–H, respectively. The anion of lactic acid was detected at m/z 89 (identified
by exact mass measurements) (SI Appendix, Fig. S9 and Table S1)
and occurred in slightly increased abundance (128.9 ± 17.5%) in
gliomas vs. healthy tissue. This observation is consistent with metabolic aberrations inherent in cancer (e.g., high rates of aerobic glycolysis) as postulated by Warburg (27), but it does not seem to be
uniquely predictive of disease. By contrast, a dramatic decrease in
m/z 174 was noted between gray and white matter and gliomas. A
box and whisker plot (Fig. 2A) indicated that m/z 174 alone allows
discrimination of brain parenchyma from glioma (Kruskal–Wallis
P value <0.001). Furthermore, a receiver-operating characteristic
curve of brain parenchyma and glioma resulted in an area under
the curve of 0.998 (SI Appendix, Fig. S10). Exact mass (Fig. 2B) and
MS/MS fragmentation obtained by collision-induced dissociation
(Fig. 2C) were used to identify m/z 174 as N-acetyl-aspartic acid
(NAA) detected as the deprotonated ion. The dramatic difference
between gray matter and glioma tissue is illustrated in specimen 51
(Fig. 2D). The intensities of m/z values 174, 794, 834, and 888 are
plotted from individual pixels noted in Fig. 2E over the transition
region from glioma to gray matter (Fig. 2F). The changes in the
lipid ions correctly reflect the regions indicated as glioma and brain
parenchyma by pathology (SI Appendix, Fig. S11). The change in
NAA is evident with a similar rate of change to the lipids near the
boundary of the two regions (approximately at pixel 12).
PCA was performed on the metabolite profile (Fig. 1 I and J)
and yielded poor separation of gray and white matter from each
other but clear separation between brain parenchyma and glioma. The overwhelming significance of NAA in the multivariate
separation is notable. Interestingly, this finding supports previous
MRSI studies that indicated the significance of NAA in discriminating normal and diseased neural tissues (28, 29) and current use in
Jarmusch et al.

tumor diagnosis (13, 30). However, detection of NAA in situ by MS
has greater molecular specificity and speed compared with MRSI.
NAA is an abundant molecule in the human nervous system, the
biological function of which is still to be unraveled, but evidence
indicates a significant role in neural metabolism (31). Ties to central
metabolic processes can be made by aspartic acid as well as acetate,
including lipid metabolism, energy production, amino acid synthesis,
and gene regulation (31). Furthermore, NAA has been found to
decrease in many neurological diseases and disorders, such as
stroke, Alzheimer’s disease, epilepsy, and multiple sclerosis (31).
A reduction in the relative abundance of NAA was also noted in
specimens containing reactive matter (SI Appendix, Fig. S12); thus,
NAA seems to be an important measure of overall neural health.
2-Hydroxyglutaric acid (2HG; m/z 147) was also detected in
the metabolite profile in some of the glioma samples. 2HG is a
downstream metabolite of IDH mutations and serves as an important prognostic indicator (32, 33). The presence of m/z 147 in
specimen 51 was confirmed by MS/MS (SI Appendix, Fig. S13)
and found to correlate with the pathologically determined IDH
mutation status. The presence of m/z 147 in the metabolite
profile (full-scan mode) was indicative of 2HG presence, but
additional specificity and confirmation were achieved by MS/MS.
The detection of 2HG and its correlation with IDH mutation status
are outside the scope of this report, having been investigated previously (33). The ability to ascertain such information rapidly expands the value of DESI-MS methodology beyond tissue diagnosis.
The best separation of gray and white matter and glioma was
obtained when the lipid and metabolite profiles were considered
together using midlevel data fusion (SI Appendix, Fig. S14). Gray
matter (n = 223), white matter (n = 66), and gliomas (n = 158)
were well-separated and had little intraclass dispersion. PCA
followed by linear discriminant analysis (LDA) was performed to
estimate classification performance when fusing the two MS
profiles. The classification of gray matter, white matter, and
gliomas (SI Appendix, Table S2) had an overall sensitivity (i.e.,
measure of the proportion of positives that are correctly identified
as such) of 97.4% and a specificity (i.e., measure of the proportion
of negatives that are correctly identified as such) of 98.5%. The
methodology developed was further evaluated by predicting the
Jarmusch et al.

disease state and estimating the tumor cell concentration of a
pathologically ambiguous specimen (Fig. 3) as an external validation. A false-color plot of the PC1 scores of individual pixels
(SI Appendix, Fig. S15) revealed a region associated with glioma
(red pixels in Fig. 3A) and a region more closely associated with
white matter (blue pixels in Fig. 3A). Pathologic evaluation (Fig.
3B) of these two regions was ambiguous, with one clearly a glioma
and the other being either a diffuse glioma or an infiltrated region
adjacent to the tumor region, qualitatively matching our findings
of two chemically different regions. Additional evaluation was
performed using PCA LDA as shown in Fig. 3C, which classified a
region of glioma (on the right in Fig. 3C) while classifying the
adjacent region as white matter (on the left in Fig. 3C). The region
classified by LDA as white matter prompted additional examination for infiltration (because infiltration was not a part of the PCA
LDA model) by estimation of the tumor cell concentration. The
tumor cell concentration of each pixel (Fig. 3D) was calculated by
regression of a semilogarithmic plot of the natural log of NAA’s
TIC normalized abundance vs. tumor cell concentration (Pearson’s r = −0.89) (SI Appendix, Fig. S15). The estimated tumor cell
concentration in the glioma region was >75%, whereas the other
region had estimated concentrations ranging from ∼50% to 30%,
roughly matching with pathologic evaluation of 60%. This illustrative example supports that MS profiles, processed using multivariate statistics, can correctly discriminate gliomas and that they
can also be used to detect diffuse and infiltrative tumors, a particularly critical question during surgical resection.
Discrimination of Tumor Types. Meningiomas and pituitary tumors
represent a large fraction of all brain tumors; the lipid profile of
the former was explored in a previous study (11). We sought to
differentiate the tumor types investigated: glioma, meningioma,
and pituitary tumor. The average lipid mass spectra displayed
differences in the relative abundances of m/z 788, 794, and 885
between the tumor types (SI Appendix, Fig. S16). The metabolite
profile, previously discussed as being highly significant for glioma
discrimination, was less informative for meningiomas and pituitary
tumors, with small changes being noted in the average mass
spectra. PCA performed on glioma (n = 158), meningioma (n =
111), and pituitary tumors (n = 154) using the lipid information
PNAS | February 9, 2016 | vol. 113 | no. 6 | 1489
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Fig. 2. Statistical significance and identification of NAA. (A) Box and whisker plot for m/z 174: gray matter (GM), n = 223; white matter (WM), n = 66; glioma
(G), n = 158; pituitary (P), n = 154; and meningioma (M), n = 111. The box represents the interquartile range with a median line and whiskers ±1.5 SD; outliers
are represented by open circles. (A, Inset) NAA. (B) Detection of NAA by high-resolution MS in (Upper) gray matter and (Lower) high-grade glioma in
specimen 51; m/z and resolution are annotated. (C) Collision-induced dissociation (CID) MS/MS fragmentation pattern obtained for NAA from gray matter in
specimen 51. (D) Plot of intensity change of select ions [m/z 174 (black), 794 (red), 834 (blue), and 888 (green)] occurring with the transition between highgrade glioma and brain parenchyma in specimen 51. The pixels plotted in D (those of the horizontal scale bar) are indicated in the false-color image of a
summed set of ions (281, 303, 788, 834, 885, and 888) in E. (F) H&E image of specimen 51 with approximate location of pixels.
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Fig. 3. DESI-MS predictions for specimen 65 and corresponding H&E. (A) PCA projection (false color) indicates PC1 score values. (B) H&E stain. (C) PCA LDA
prediction of class and (D) calculated tumor cell concentration based on NAA abundance.

provided good separation between all tumor types and was supported by PCA LDA estimation of sensitivity (99.4%) and specificity (99.7%) (SI Appendix, Table S3). Although remarkable, this
result is not surprising, because the cells and tissue from which the
various tumors arise are quite different (e.g., glia vs. meninges),
which is also reflected in histopathologic evaluation. The midlevel
fusion of metabolite and lipid profile information did not substantially
change the predicted classification. However, the average metabolite
MS for meningiomas indicated the lowest amounts of m/z 89 (lactic
acid) and 174 (NAA). In the case of NAA, the absence is supported by
previous NMR and liquid chromatography-MS studies (34), thus
serving as an endogenous positive control (i.e., signal neither expected
nor detected). DESI-MS ion images of specimen 20 (SI Appendix,
Fig. S17) illustrate the considerable difference between gray
matter and an invasive boundary of a meningioma. Differential
levels of NAA in gliomas, meningiomas, and pituitary tumors were
reported by MRSI, and our data support these previous findings
(29) (Fig. 2A). NAA signals were significantly different between
tumor types (P < 0.001), although the lack of significant change
(such as that observed between normal brain parenchyma and
glioma) limits the predictive value of NAA for discriminating
between tumor types. Comprehensively, lipid and metabolite
profiles subjected to PCA yielded separation of gliomas, meningiomas, and pituitary tumors with little ambiguity, suggesting that
an unknown sample from one of these three types of tumor could
be chemically recognized by the MS profiles.
DESI-MS Imaging and Characterization of Human Brain Tissue Smears.

DESI-MS analysis of tissue smears is an attractive alternative to
the use of tissue sections, removing the need for tissue freezing
and sectioning. To date, DESI-MS analysis of tissue and cytological smears has been only briefly explored (7, 33). Smears are
commonly performed by placing a minute amount of tissue onto
a glass slide and then physically spreading the material to achieve
a relatively uniform and diffuse layer of cellular material for
staining and subsequent pathology. Smears are typically made
using less than 50 mm3 tissue. A custom tissue smear device was
designed to confine the tissue to the middle of the glass slide
(along the narrowest dimension) and smear the tissue along the
longest dimension with an approximate thickness of 100 μm (SI
Appendix, Fig. S18).
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Tissue smears were imaged over an area of ∼75 mm2, exploring
the MS quality and the homogeneity of the chemical information.
The absolute MS signal was generally equal to that of tissue sections. Importantly, the relative abundances of the ions were similar
between tissue sections and tissue smears. The average metabolite
and lipid profiles of gray matter and gliomas (SI Appendix, Fig.
S19) mirror those of the tissue sections. For example, the abundance of m/z 834 is notable in the gray matter spectrum and
dramatically reduced in the gliomas. Similarly, the statistical significance of NAA (m/z 174; P < 0.001) allows for the discrimination of gray matter and gliomas (SI Appendix, Fig. S20).
Canonical correlation analysis (CCA) (35) was performed to assess the similarity of the chemical information obtained from tissue smears and sections (SI Appendix, Fig. S21). The correlation
coefficients are notable (greater than 0.95) between the first three
canonical variables for both the lipid and metabolite profiles,
emphasizing that the physical change induced by smearing does
not influence the chemical information. As a precaution, it should
be mentioned that the sample matrix and associated analytical
effect could influence the data obtained by MS, but this effect was
not observed in our experiments. The lipid and metabolite profiles
of smears were nearly identical to those recorded from tissue
sections, indicating that sectioning can be foregone for more rapid
tissue smear analysis.
Conclusions
The application of DESI-MS in brain cancer resection requires
knowledge of the characteristic chemical features that distinguish brain parenchyma from glioma and different tumor types
from each other, and these differences are explored here for the
first time to our knowledge. The strategy of using MS profiles to
characterize tissue differs from the traditional use of biomarkers,
in which a single molecule (or ion detected by MS) is used as an
indicator of disease. MS profiles are an integrated representation
of downstream metabolism and provide important information
that extends beyond tissue diagnosis (e.g., in the case of 2HG
to prognosis).
In this study, we show that MS analysis of tissue sections revealed
lipid-derived and metabolite signals that differ between gray and
white matter and gliomas, facilitating discrimination by multivariate
statistics. Difference in the MS profiles revealed the effect of brain
parenchyma on the signal obtained from glioma samples. This
Jarmusch et al.
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Materials and Methods
Cryopreserved human neurological specimens were obtained from 74 patients (58 patients of whom were included in the sample cohort) through the
Biorepository of Methodist Research Institute. Tissue specimens were prepared as tissue sections and tissue smears on glass microscope slides and
stored at −80 °C before analysis. MS measurements were performed on a
linear ion trap mass spectrometer (Finnigan LTQ; Thermo Electron Corporation). High-resolution MS measurements were performed using an Orbitrap Mass Spectrometer (Exactive, Thermo). DESI-MS was performed using
dimethylformamide-acetonitrile (1:1 vol/vol), which preserved tissue morphology for subsequent pathology. Blind histopathologic evaluation was
performed by an expert pathologist. Sections and smears were subjected to
two sequential negative-mode DESI-MS image acquisitions (250-μm pixel
resolution). The first image included data from m/z 200–1,000, with the mass
spectrometer tuned for maximum transmission of m/z 786. The moving
stage was then reset to the origin position, allowing for a subsequent image
was acquired from m/z 80–200 (MS tuned for m/z 174). Data were exported
from XCalibur 2.0 into .csv files, which were then imported into MATLAB. Inhouse MATLAB routines were used to process all MS data unless otherwise
specified. Multivariate statistics, including PCA, midlevel data fusion PCA,
and CCA, were performed on the data. Kruskal–Wallis nonparametric test
was used to evaluate the statistical significance of NAA. Additional information and discussion of the materials and methods can be found in
SI Appendix.
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observation is particularly significant, because gliomas frequently
invade along white matter tracts, illustrating the need to understand
the contribution of brain parenchyma and infiltration in predicting disease state. The significance of NAA in discriminating
brain parenchyma and glioma is clear and immense. This study
offers strong evidence that NAA is, in fact, an oncometabolite and
the first in situ detection, to our knowledge, of NAA by ambient
MS. The importance of NAA in glioma differentiation confirms
nearly 20-y-old MRSI data. NAA also seems to be predictive of
tumor cell concentration in unknown samples with an exponentiallike decay in MS signal from brain parenchyma to glioma. Fusion
of the lipid and metabolite MS profiles provided the best discrimination of brain parenchyma (gray and white matter) and
gliomas, with an overall sensitivity of 97.4% and a specificity of
98.5%. Furthermore, the MS profiles proved capable of discriminating tumor types (i.e., glioma, meningiomas, and pituitary tumors) with sensitivity and specificity >99%.
Surgical intervention of brain tumors could be simplified with
intraoperative analysis of tissue without extending operative times.
Tissue smears that eliminate the need for tissue freezing and
sectioning before DESI-MS were explored. The use of a custom
3D-printed smear device aided in the distribution of tissue during
smearing while maintaining a sufficiently thin smear for DESI-MS.
The observed lipid or metabolite profiles were not significantly
altered by the physical act of smearing, and their signal intensities
were comparable with those of tissue sections. Furthermore, the
chemical information obtained from tissue smears was equivalent
to that from tissue sections as determined by CCA. The validation
of tissue smears as samples for discriminate analysis remains to be
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